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ABSTRACT 
Estrogens are best known for their roles in reproductive behavior and physiology, but they also 
contribute substantially to normal brain function. The effects of estrogens on brain and cognitive health 
are particularly important because should they live long enough, all women will undergo a dramatic loss 
of estrogen and progesterone through menopause. While the results of human studies remain mixed 
due to a variety of confounding factors, a large body of basic science research has shown that estrogens 
indeed modulate learning and memory. Importantly, estrogens do not globally improve cognition but 
have bi-directional effects depending on the cognitive task and neural systems engaged. Estrogens 
generally enhance learning and memory for tasks that are sensitive to function of the hippocampus but 
impair the performance of tasks that tap the dorsal striatum. These memory systems do not act in 
isolation but rather appear to interact extensively when an animal attempts to learn a given task, with 
estrogens acting to shift the relative contributions of each neural structure for the acquisition and 
performance of cognitive tasks. Specifically, estrogens promote the use of hippocampus-sensitive spatial 
strategies and impede the use of striatum-sensitive egocentric strategies. Additionally, estrogens act 
through a variety of receptor subtypes, which are expressed in the hippocampus and striatum with 
varying densities and localizations, to exert these behavioral effects. As women are increasingly exposed 
to substances with distinct estrogen receptor (ER) affinities, such as selective estrogen receptor 
modulators and botanical phytoestrogen supplements, it is important to characterize the role of each ER 
in estrogenic cognitive shifts.  
 The present work examines the contributions of ER subtypes to shifts in learning and memory in 
ovariectomized female rats. Endogenous estrogen levels were eliminated through the surgical removal 
of ovaries in young adult or middle-aged rats. Two days prior to cognitive testing, rats were treated with 
either estradiol benzoate, isoflavones, or compounds that selectively target ERα, ERβ, or GPER. Rats 
then underwent maze training on a hippocampus-sensitive place task or dorsal striatum-sensitive 
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response task. Our results reveal that treatment with estradiol, the isoflavone genistein, or selective 
agonists for ERα, ERβ, or GPER were all sufficient to enhance place learning and impair response 
learning. These findings emphasize that multiple receptor-mediated pathways contribute to estrogenic 
shifts in cognition, and that independent activation of a single receptor appears sufficient to induce 
these mnemonic changes. Importantly, a consistent feature of our results was the appearance of 
inverted-U dose response functions, whereby behavioral effects emerged at an optimal dose of 
estrogens but lower and higher doses were ineffective or produced opposing effects. This finding 
emphasizes the need for careful consideration of dose-response functions in experiment and treatment 
design. Lastly, activation of MAPK signaling was examined in the hippocampi and striata of rats used in 
prior experiments. Phosphorlyation of ERK, a member of the MAPK cascade, appears to play a critical 
role in both learning and estrogen signaling in the brain. Results from quantitative Western blot analyses 
show that patterns of estrogen-regulated ERK activation are nuanced, varying according to the level of 
learning task performance and the ER subtype targeted. Together, the findings of these studies elucidate 
some of the neurobiological mechanisms that underlie estrogen-induced shifts in learning and memory 
and may have implications for the development of new treatments aimed at preserving cognitive 
function over the lifespan.  
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
1.1 Introduction 
 Estrogens belong to a class of steroid hormones most commonly recognized for their role in 
reproductive physiology and behavior. However, estrogens also have powerful effects on cognition, 
acting to modulate many aspects of brain structure and function. The roles of estrogen in the brain are 
especially meaningful for women’s health, as many women experience marked changes in cognition and 
affect following natural or surgical menopause (Morrison et al., 2006). The potential “non-reproductive” 
actions of estrogens on learning and memory gained particular interest among basic scientists following 
findings that the hippocampus, a brain structure critical for certain types of cognition, undergoes 
substantial changes in neuron morphology and transmission in response to 17β-estradiol, the principal 
circulating estrogen in women prior to menopause(Gould et al., 1990; Woolley et al., 1990).  Estradiol 
was also found to induce structural and functional changes in other neural systems, including the 
striatum, amygdala, and cortex, aligning well with earlier reports of estradiol modulation of 
hypothalamic neurons (Carrer and Aoki, 1982). Behavioral studies in laboratory animals confirmed that 
changes in hormone levels lead to altered performance on memory tasks that engage these different 
brain areas (McEwen and Alves, 1999; Dohanich et al., 2009). Interestingly, estradiol does not uniformly 
alter cognition, as it can enhance, impair, or have no effect on learning and memory processes 
depending on the cognitive demands of a given task (Gold and Korol, 2010; Korol, 2004). Further studies 
showed that mnemonic outcomes following treatment with estrogens are sensitive to many other 
variables such as dose, timing, and duration of hormone deprivation prior to treatment (Dohanich et al., 
2009). Adding another layer of complexity, estrogens appear to exert their effects in the brain through 
novel signaling mechanisms, acting through membrane-associated cascades that may also influence the 
transcriptional activities of classical nuclear hormone receptors (Mani et al., 2012; Vasudevan and Pfaff, 
2008) or transactivate other neurotransmitter receptor systems (Meitzen and Mermelstein, 2011).  
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 Despite the substantial data from basic research that has built our understanding of the 
multifaceted roles of estradiol in cognition, little translation is seen in the clinical use of estrogen 
replacement therapy to menopausal women. Once a commonplace treatment to relieve menopausal 
symptoms, hormone replacement therapy is now seldom used following the startling and controversial 
findings of the Women’s Health Initiative (WHI), which included increased risks of cardiovascular 
incidents, cancer, and cognitive deficits associated with post-menopausal estrogen treatment with or 
without progesterone (Marjoribanks et al., 2012; Craig et al., 2005; Espeland et al., 2004). Many of these 
deleterious outcomes can be attributed to flaws in the WHI study design, such as the use of conjugated 
equine and synthetic hormone preparations and the inclusion of elderly subjects many years post-
menopause (Sherwin, 2009). However, many women remain fearful of traditional prescription hormone 
preparations and have instead turned to over-the-counter supplements marketed for menopausal relief 
(Zhao and Brinton, 2007). These products contain compounds from plants called phytoestrogens that 
activate estrogen receptors in the body with varying potency (Brzezinski and Debi, 1999; Kuiper et al., 
1998), and despite their hormone-like actions, such supplements are neither regulated by the FDA nor 
require physician supervision. The effects of phytoestrogens on brain and cognitive health are 
particularly understudied and may depend on the estrogen receptor pharmacology and mechanism of 
action for a given compound.  
1.2 Effects of estrogens on learning and memory 
 Estrogens regulate learning and memory processes in a dissociable manner based on attributes 
of the behavioral task and the neural systems engaged. A large body of data indicate that increased 
levels of estradiol generally enhance performance for spatial memory tasks that rely on the 
hippocampus, including the radial arm maze(Holmes et al., 2002; Fader et al., 1999; Luine et al., 1998; 
Daniel et al., 1997), swim task (Kiss et al., 2012; Markham et al., 2002; Bimonte and Denenberg, 1999; 
Packard and Teather, 1997), delayed matching-to-position (Gibbs, 2000), place task (Zurkovsky et al., 
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2007; Zurkovsky et al., 2006; Davis et al., 2005; Korol and Kolo, 2002), and object placement (Frye et al., 
2007; Luine et al., 2003). While improvements in hippocampus-sensitive cognition are typically observed 
with estradiol treatment, the magnitude and direction of memory modulation can vary according to 
factors such as age of the experimental animal, task difficulty, stress level, enrichment, estradiol dosage, 
and period of hormone withdrawal (for further discussion, see Dohanich et al., 2009).  
 Although estradiol largely promotes the use of cognitive strategies that engage the 
hippocampus, elevated hormone levels impede learning and memory processes that tap the striatum. 
Estradiol impairs the performance of tasks that require the use of stimulus-response or egocentric 
strategies, such as cued win-shift on a radial arm maze (Galea et al., 2001), the response task (Zurkovsky 
et al., 2011; Zurkovsky et al., 2007; Davis et al., 2005; Korol and Kolo, 2002), and cued swim task (Pleil et 
al., 2011). Additionally, increased estradiol detrimentally affects the performance of operant tasks that 
target the prefrontal cortex and also involve cortico-striatal interactions (Wang et al., 2008; Wang et al., 
2009). Thus, estrogens tend to interfere with memory formation that is sensitive to the function of the 
striatum.  
Estradiol does not influence learning capacity for certain tasks in an isolated manner, but rather 
shifts the use of cognitive strategies between brain systems that optimally process different kinds of 
information. These cognitive shifts are best illustrated by the use of behavioral tasks that can be solved 
in multiple ways, e.g. through the use of either extramaze spatial cues (engaging the hippocampus) or by 
performing egocentric maneuvers in response to local cues (that depend on the striatum). Rats with 
higher estradiol levels preferentially use spatial strategies in the dual solution T-maze while rats with 
low hormone concentrations demonstrate response strategies (Korol et al., 2004; Quinlan et al., 2008). 
In a swim task providing both extramaze cues and an escape platform landmark, estradiol treatment 
biased rats against the use of a cue-response strategy (Daniel and Lee, 2004). Overall, estradiol appears 
to facilitate the use of spatial strategies while diminishing the ability to use response strategies. 
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Therefore, estrogens do not strictly alter how much an animal can learn but also the ways in which they 
learn.  
1.3 Multiple memory systems 
 The opposing effects of estrogens on different types of cognition elegantly fit within the theory 
of multiple memory systems. Briefly, this hypothesis states that specific brain structures, such as the 
hippocampus, dorsal striatum, and amygdala, act as parallel processors for a given memory task, each 
optimized to handle particular types of information and relationships (White and McDonald, 2002). 
While certain tasks largely rely on the function of a single “processor”, the other components may 
continue to contribute to learning and memory formation, acting in either a cooperative or competitive 
manner to decrease or potentiate the performance of the canonical neural system.  
The hippocampus and striatum appeared to interact competitively, as lesion or chemical 
inactivation of one memory system improves the performance of tasks that tap the intact structure 
(Chang and Gold, 2003; White and McDonald, 2002). The findings that increased estrogens both 
improve place and impair response learning suggest that the hormone may produce a competitive 
advantage of hippocampus-sensitive place learning at the expense of striatum-sensitive response 
learning. The converse, that low hormone levels promote better response learning over place learning, 
provides further support for a competitive interaction between hippocampus and striatum. However, 
when estradiol is administered directly into the hippocampus or striatum of ovariectomized female rats 
followed by training on a place or response task, learning modulation occurred only when the brain 
region critical for each task was exposed to estradiol and not when treatment was infused into the 
theoretical competing locus (Zurkovsky et al., 2007). These results indicate that the local actions of 
estrogens in the hippocampus and striatum drive effects on memory formation, but also suggest a 
relatively independent relationship between memory systems during estradiol-induced learning shifts 
(Korol, 2004). While the multiple memory systems hypothesis provides an excellent framework for 
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considering the bidirectional effects of estradiol on distinct types of memory, definitive associations 
such as competition or independence likely over-simplify the complex interactions that occur between 
brain regions during learning. Indeed, data from a collection of studies indicate that the relationship 
between the hippocampus and striatum is dynamic, with each system participating in the processing of 
both place and response information and the relative activation of each structure changing over the 
course of learning (Jacobson et al., 2012; Pleil et al., 2011; Mizumori et al., 2004; Gold, 2004).  
 To test the effects of estrogens on learning across multiple memory systems, the place and 
response learning tasks are used. These maze-based tasks are ideal for targeting hippocampus- or 
striatum-sensitive cognitive processes as their demands are well-matched in all areas except the 
strategy needed to obtain a food reward. The place task requires rats to learn the spatial location of the 
reward using extra-maze cues by always going towards the same place in the testing room, while the 
response task requires the rat to adopt a consistent turning strategy to reach the goal (Tolman et al., 
1946). These tasks use the same apparatus, appetitive reinforcement, and pre-training handling regimen 
and thus have similar levels of stress and cognitive difficulty (Korol and Kolo, 2002). The balanced nature 
of the place and response tasks is very important as stress and aversive or appetitive conditions can 
differentially affect the outcomes of estrogen memory modulation (Dohanich et al., 2009). As estrogen 
has non-mneomic effects on motor function, motivation, and food drive (McEwen and Alves, 1999), the 
comparable features of the tasks used here allow for the dissociation of these confounding variables. 
Because estrogens shift the performance of these tasks in opposite directions, it appears that changes in 
non-cognitive behaviors minimally influence learning performance. In sum, the place and response task 
serve as model behavioral assessments for the mnemonic actions of estrogens and are used for all 
learning studies described in subsequent chapters.  
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1.4 Dose sensitivity 
 The mnemonic effects of estrogens vary by dose, even for established patterns of learning 
modulation. Moreover, behavioral dose-effect functions tend not to be monotonic, but rather 
demonstrate an inverted-U pattern in which cognitive changes are observed at an optimal dose of 
estrogens, while lower and higher doses have no effect or opposite effects. Estrogens generally enhance 
the performance of hippocampus-sensitive tasks at low to moderate levels but lose efficacy or impair 
performance at higher concentrations (Inagaki et al., 2010; Barha et al., 2010; McLaughlin et al., 2008; 
Holmes et al., 2002; Packard and Teather, 1997). Non-linear dose responses to estrogenic compounds 
are widely reported and occur across an array of physiological systems (Calabrese, 2001). Inverted-U 
dose response curves are also characteristic of memory modulation, occurring with many different 
treatments and behavioral tasks (Baldi and Bucherelli, 2005; Gold, 2006; Gold and Korol, 2010). 
However, even though non-monotonic dose-responses appear to be critical attributes of both estrogen 
actions and modulation of learning, such relationships are unfortunately overlooked in much of the 
current hormone and memory literature. When investigating the mnemonic effects of a compound, 
frequently only one dose is examined; the selected dose is sometimes chosen based on pharmacological 
or other properties but appears to often be picked arbitrarily. Importantly, conclusions may be drawn 
that a compound has no effect or unidirectional effects when in actuality its response is biphasic, simply 
because an insufficient number of doses were used. These types of myopic experiments can confuse and 
weaken the collective knowledge of a field and, even worse, endanger human health (Calabrese and 
Baldwin, 2003; Patisaul and Adewale, 2009).  
 The studies contained herein were designed with the motivation to maintain greater 
appreciation for dose-response functions. Experiments sought to follow the guidelines proposed for the 
creation of mechanistically-based dose-response modeling (Andersen et al., 1999), including the 
consideration of receptor binding profiles, pharmacokinetics, and pharmacodynamics in dose selection 
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and the use of multiple doses. In featuring dose-sensitivity, these studies adopt a fairly unique approach 
for the estrogens and memory field, a perspective that I believe makes our results more compelling and 
lends greater insight into the modes of estrogen-induced changes in learning. 
1.5 Estrogen receptor subtypes 
 Estradiol acts through multiple types of estrogen receptors (ER) in the brain. Subtypes of the 
classical nuclear receptor, ERα and ERβ, are found throughout the brain and can also be localized to the 
plasma membrane of neurons and glia (Milner et al., 2005; Milner et al., 2001; Shughrue et al., 1997). 
GPER, formerly called GPR30, is a novel seven-transmembrane domain G protein-coupled receptor 
located in the plasma membrane and densely expressed in other membrane-bound cellular structures, 
particularly the endoplasmic reticulum (Brailoiu et al., 2007; Matsuda et al., 2008). Other membrane-
associated estrogen receptors have been proposed but are not yet fully identified (Qiu et al., 2008; 
Toran-Allerand, 2005). ERα, ERβ, and GPER are all expressed in the hippocampus and striatum, but with 
differing neuronal localizations and densities. Because the mnemonic effects of estrogens appear to be 
due to their local actions in the hippocampus or striatum (Zurkovsky et al., 2007), the differential 
expression of ER subtypes between these structures may lead to different learning outcomes when a 
specific receptor is targeted. Investigating the contributions of distinct ER subtypes to shifts in learning 
and memory is valuable because certain natural compounds and pharmaceuticals, such as 
phytoestrogens and selective estrogen receptor modulators (e.g. tamoxifen) bind to estrogen receptors 
with varying selectivity, and their cognitive effects are largely unknown. Previous studies have mostly 
implicated the actions of ERβ as critical for the mnemonic effects of estrogens, but others point to ERα 
or both receptors; little is understood regarding why results vary.  A small group of recent reports show 
that activation of GPER can also enhance memory for tasks that engage the hippocampus. Additionally, 
while published studies have examined the roles of ERα, ERβ, or GPER in hippocampus- or prefrontal 
cortex-sensitive performance, there are no known investigations of the effects of these receptor 
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subtypes on striatum-sensitive learning. The following experiments used ER-selective agonists and 
phytoestrogens to characterize the possible contributions of ERα, ERβ, and GPER to shifts in place and 
response learning.  
1.6 Temporal mechanisms of estrogen action 
 Estrogen receptors are largely discussed as acting via two distinct pathways with different time 
courses. The “classical” mode of action involves estrogen receptors directly interacting with DNA to up- 
or down-regulate gene transcription. Classical nuclear estrogen receptors dimerize upon binding ligand 
and associate with a multitude of cofactors, including coactivators and corepressors, to form a 
transcriptional complex. This complex then binds to DNA at palindromic estrogen response elements 
(ERE) or through protein-protein interactions with other transcription factors at AP-1 or Sp1 sites to alter 
the expression of downstream genes, thus inducing cellular-level changes (Nilsson et al., 2001; 
Pettersson and Gustafsson, 2001). Because the classical actions of ERs rely on new protein production, 
effects are relatively slow, appearing over the course of several hours to days. However, estrogens can 
also cause substantial changes in neuronal structure and physiology within minutes, pointing to non-
classical, rapid signaling mechanisms (Woolley, 2007). 
As mentioned above, “non-classical” estrogen receptors are found in neuronal and glial 
membranes and are thus positioned to mediate rapid signaling events. GPER activates second 
messenger cascades through its associated G proteins (Prossnitz and Barton, 2009), while ERα and ERβ 
appear to couple to distinct metabotropic glutamate receptor subtypes (Meitzen and Mermelstein, 
2011) or interact with IGF-1 receptors (Etgen et al., 2006) to signal from the membrane.  Membrane-
initiated estrogen signaling activates multiple second messenger cascades, including the PI3K, 
phospholipase C, MAPK, protein kinase (PKA, PKC) pathways, and others (Roepke et al., 2011). These 
molecules can then act to change cell excitability by altering the conductance of ion channels, sensitivity 
and density of neurotransmitter receptors, intracellular Ca2+ dynamics, synaptic morphology, and 
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enzyme activity (Roepke et al., 2011; Srivastava et al., 2011), effects which are exerted within minutes 
and may persist up to several hours.  Several signaling cascades may ultimately lead to the activation or 
inactivation of transcription factors, such as CREB, and expression of immediate early genes, which 
themselves regulate further gene expression (Adams and Sweatt, 2002; Herdegen and Leah, 1998). In 
this way, the non-classical mode of estrogen signaling has both rapid, signaling-related components and 
slow components involving the transcription of new DNA products.  
An important distinction to make is that while the classical actions of estrogen receptors are 
commonly referred to as “genomic” and non-classical actions as “non-genomic”, these labels are not 
completely accurate. There is in fact a great degree of overlap between these two modes: the end 
points of intracellular signaling cascades are often changes in gene transcription, and even classical ERs 
have been proposed to participate in rapid signaling (Nilsson et al., 2001; Vasudevan and Pfaff, 2008). 
Therefore, it may be most congruous to separate mechanisms of ER action simply on timing. In this 
document, rapid or fast ER effects will refer to changes in cell physiology that occur within the first few 
hours of treatment, such as activation of signaling cascades and modulation of ion channel properties. 
While these events are generally above the cellular level of gene transcription and protein synthesis, 
fast-acting genotropic changes cannot be precluded. Conversely, durable or slow actions will refer to ER 
actions that are exerted several hours to days following treatment. Slow mechanisms of ER action 
largely represent genomic effects but may also include long-lasting alterations in cell physiology initiated 
by earlier rapid events. As discussed below, it is very likely that both slow and rapid molecular events 
contribute to estrogen-induced changes in cognition.  
1.7 The convergence of classical and non-classical estrogen signaling: implications for learning 
The classical and non-classical modes of ER action are usually separated based on receptor 
localization and time scale according to their transcription-dependent or –independent components. 
However, the various kinds of ER signaling do not operate in an isolated fashion but instead interact 
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extensively. In a neuroblastoma cell line, treatment with a membrane-impermeable estradiol conjugate 
activated several different rapid signaling cascades to potentiate later classical ERE-dependent 
transcriptional activity induced by free estradiol (Vasudevan et al., 2001). Similar results showing that 
rapid events can potentiate classical transcription were obtained in vivo using the rat reproductive 
behavior of lordosis as a behavioral assay. A pulse of membrane-limited estradiol followed by 
unconjugated estradiol increased lordosis, a behavior that is dependent on classical ER transcription 
(Kow and Pfaff, 2004). A few mechanisms have been proposed for how these rapid actions promote 
classical ER function, including that signaling events lead to stabilization of the ER complex, facilitate 
nuclear transport, or modify other proteins involved in transcription, largely through changes in 
phosphorylation states (Vasudevan and Pfaff, 2008; Hammes and Levin, 2007). Additionally, rapid 
estrogen signaling can lead to the activation of transcription factors capable of interacting with nuclear 
ERs for ERE-independent transcription, such as binding at AP-1 sites (Bjornstrom and Sjoberg, 2005). The 
classical and non-classical pathways of estrogen action may also converge on the same genomic targets. 
For example, expression of c-fos and BDNF is upregulated both by nuclear ER-driven transcription and by 
transcription factors activated via the MAPK cascade (Bjornstrom and Sjoberg, 2005). Lastly, rapid 
signaling cascades can affect the subcellular distribution of ERs, as phosphorylation states and post-
translational modifications regulate trafficking of ERα and ERβ to the plasma membrane and vesicles 
(Sellers et al., 2014; Tabatadze et al., 2012). In sum, despite much discussion of the classical and non-
classical modes of signaling as two separate pathways, there is a great amount of convergence and 
crossover between these mechanisms.  
The treatment and training paradigms used in subsequent experiments are subject to both the 
slow and rapid actions of estrogens and their points of convergence: transcription-dependent effects 
may be exerted over the 48 h of exposure, while signaling cascades may be activated rapidly after 
treatment or by circulating compounds just prior to behavioral testing and during learning. The rapid 
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effects of estradiol appear to be sufficient to modulate learning within a short time frame (see below) 
while results from the use of a classical ER antagonist indicate that the actions of nuclear receptors 
seem to be required for mnemonic improvements following days of estradiol exposure (Zurkovsky et al., 
2006).  However, little is known regarding the importance of converging estrogen signaling for memory 
modulation. Because specialized pharmacologic manipulations, such as membrane-impermeable 
estrogen conjugates, classical antagonists, or kinase blockers were not used in the experiments reported 
here, it is impossible to determine the specific contributions of classical and non-classical ER events that 
underlie our observed shifts in learning. Given that the following experiments all use treatment 
exposures of 48 hours, it is likely that converging genomic changes and rapid signaling events, as 
depicted in Fig. 1.1, influence plasticity and the neural substrates available for learning.  
1.8 Rapid estrogen actions and learning 
 The rapid actions of estrogen receptors appear to play a critical role in mediating the cognitive 
effects of estradiol. Estrogens impair response learning and enhance place learning within 2 hours of 
central administration (Scavuzzo et al., in preparation, Zurkovsky et al., 2011) and improve object 
placement, object recognition, contextual fear conditioning, and radial arm maze performance with only 
40 mins of exposure (Phan et al., 2012; Barha et al., 2010; Sinopoli et al., 2006). These treatment 
schedules are short enough to largely exclude genomic-level actions of estrogen receptors and thus 
point to rapid mechanisms of neuromodulation. Additionally, antagonizing GPER in cycling rats leads to 
impairments on the delayed matching-to-position task, indicating that membrane receptors play a key 
role in estrogen effects on spatial learning and memory (Hammond et al., 2012). Furthermore, rapid 
signaling mechanisms appear to be critical for estrogen-induced shifts in learning, as memory 
enhancements for hippocampus-sensitive tasks are abolished when the PKA (Lewis et al., 2008) or MAPK 
(Fan et al., 2010; Walf and Frye, 2008; Fernandez et al., 2008) pathways are blocked.  
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Of the signaling molecules activated by estrogens and associated with learning and memory 
processes, particular attention has been paid to extracellular signal-regulated kinase (ERK1/2), a 
member of the MAPK cascade. Of the two isoforms, ERK2 is considered vital for memory formation 
(Samuels et al., 2008; Satoh et al., 2007; Selcher et al., 2001) and is also activated by estradiol (Fan et al., 
2010; Fernandez et al., 2008; Bi et al., 2003) and learning (Atkins et al., 1998). Changes in hippocampal 
ERK levels also appear to be correlated to estrogen-induced changes in swim task performance 
(Wartman et al., 2012). ERK may be especially important for regulation of learning and plasticity because 
of its control and cascade structure. The MAPK pathway contains a serial three-kinase cascade of 
RafMEKERK capable of substantial signal amplification. This highly amplified system has been 
proposed to function as a biochemical switch, rapidly changing from a state of very low activity to 
maximal activation, conveying an all-or-none trigger for plasticity (Adams and Sweatt, 2002)—a 
molecular action potential of sorts, similar to the previously-described genomic action potential 
(Clayton, 2000). ERK is also hypothesized to operate as a biochemical coincidence detector, integrating 
various cellular signals into a single output with the potential to reflect past activity (Sweatt, 2001).  
Given the unique biochemical features of ERK and its apparent significance in estrogenic 
learning modulation, the final set of experiments examined the effects of estrogenic treatments and 
behavioral training on ERK activation. Brain samples from trained rats were probed for ERK and pERK 
levels to determine if ERK activation provides a molecular marker of 1) effective estrogen dosages and 2) 
the direction and magnitude of learning modulation. Unique to this work is that patterns of ERK 
phosphorylation were considered within a multiple memory systems framework, as activation may shift 
across neural systems according to learning task and maze performance (section 1.3). Together, these 
results lend insight to the cellular mechanisms by which estrogenic compounds exert their mnemonic 
actions.  
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1.9 Summary of Projects 
The work described here aims to characterize the cognitive actions of several estrogenic 
compounds with the goal of better understanding the receptor-mediated processes that modulate 
learning. Isoflavones from soy that are found in many women’s health supplements are investigated, as 
well as compounds that selectively activate particular estrogen receptor subtypes. Studies were 
conducted with an emphasis on dose-response functions, relationships that are critical to experimental 
design in disciplines such as pharmacology and toxicology but that are often overlooked by the 
hormones and memory field. Behavioral experiments used two maze-training tasks matched for non-
mnemonic effects, the place task and the response task, to investigate estrogenic modulation of 
learning that engages the hippocampus or striatum.  Rather than focusing on a single behavioral task or 
type of memory, these studies sought a holistic approach to examine modulation of cognition, allowing 
for bidirectional effects of estrogens to emerge across multiple neural systems. Brain samples from all 
trained rats were later analyzed by quantitative Western blot to examine changes in the cell signaling 
cascades involved in memory and estrogen activity. These biochemical results point to a dynamic and 
temporally-sensitive relationship between the hippocampus and striatum during learning. Overall, the 
results from these experiments lend insight to the neurobiology of estrogenic shifts in learning and 
memory and may have implications for the maintenance of cognitive function across many life stages 
with changing hormonal conditions, particularly women’s health and aging.   
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CHAPTER 2: ACUTE GENISTEIN TREATMENT MIMICS THE EFFECTS OF ESTRADIOL BY ENHANCING PLACE 
LEARNING AND IMPAIRING RESPONSE LEARNING IN YOUNG ADULT FEMALE RATS 
2.1 Introduction  
 Estrogen status regulates learning and memory strategy in a region- and task-specific manner. 
Elevated levels of estrogens generally enhance performance of spatial memory tasks that tap 
hippocampal function (Daniel et al., 1997, Packard and Teather, 1997, Luine et al., 1998, Fader et al., 
1999, Bimonte and Deneberg, 1999, Holmes et al. 2002, Korol and Kolo, 2002, Gibbs et al., 2004, Korol 
et al. 2004, Davis et al., 2005, Quinlan et al. 2008). However, the effects of estrogens on hippocampus-
sensitive tasks are not unidirectional, as memory modulation varies with task demand (Galea et al., 
2001, McLaughlin et al., 2008), estrogen dose (Packard and Teather, 1997, Holmes et al., 2002, 
McLaughlin et al., 2008, Barha et al., 2010, Inagaki et al., 2010), duration of hormone deprivation prior 
to treatment (Daniel et al., 2006, McLaughlin et al., 2008), stress (Bowman et al., 2009), and even daily 
handling (Bohacek and Daniel, 2007) and route of hormone administration (Garza-Meilandt et al., 2006).  
In addition to these nuanced results, estrogens differentially impact cognition according to the 
memory system engaged. Elevated estrogen levels impair performance on memory tasks that engage 
the striatum (Galea et al., 2001, Korol and Kolo, 2002, Daniel and Lee, 2004, Korol et al., 2004, Davis et 
al., 2005, Zurkovsky et al., 2007, Quinlan et al., 2008) and prefrontal cortex (Wang et al., 2008, Wang et 
al., 2009). Unlike the well-studied behavioral effects of estrogens in the hippocampus, less is known 
regarding confounding factors that may influence memory modulation of striatum-sensitive tasks. Given 
these opposing effects, estrogens appear to shift the contributions of the hippocampus and striatum 
within a multiple memory systems framework whereby behaviors that rely on hippocampal processing 
are potentiated and those that rely on striatal contributions are diminished (Korol and Kolo, 2002, Korol 
2004). These shifts in cognitive function are driven by the local actions of estradiol in the hippocampus 
and striatum (Zurkovsky et al., 2006, Zurkovsky et al., 2007).  
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Understanding how estrogens enhance or impair learning and memory is particularly important 
for women undergoing natural or surgical menopause, as declines in certain cognitive processes can be 
attributed to diminished estrogen levels. In some studies post-menopausal women demonstrate deficits 
in cognitive tasks that involve hippocampal function, such as declarative memory and verbal fluency 
(Maki and Hogervorst, 2003).  Until recently, estrogen replacement, both with and without 
progesterone, was a popular therapy to preserve cognitive function and treat other symptoms of 
menopause such as hot flushes.  However, the highly publicized findings from the Women’s Health 
Initiative, such as increased risk of cardiovascular events and breast cancer, forced early termination of 
the study and prompted many women to discontinue HRT despite critical shortcomings in the WHI study 
design and interpretation (Gibbs and Gabor, 2003, Wise et al., 2005). Still searching for relief from 
menopausal complications, women began to turn to over-the-counter phytoestrogen-containing 
supplements as a “natural” alternative to HRT (Zhao and Brinton, 2007). 
Phytoestrogens bind to estrogen receptors in vivo with mixed agonist/antagonist and tissue-
specific actions (Brzezinski and Debi, 1999). Isoflavones, the class of phytoestrogens found in soy and a 
main component in many botanical supplements, are detected in many tissues following exposure, 
including the brain (Chang et al., 2000, Coldham and Sauer, 2000, Lund et al., 2001, Gu et al., 2005, Tsai 
2005).  A large proportion of women aged 40 to 60 consume soy foods or supplements (Mahady et al., 
2003) despite a lack of research on the risks and benefits of isoflavone exposure, especially for brain 
health. Studies examining the effects of isoflavones on cognition are particularly sparse and document 
mixed results in humans (Lee et al., 2005, Zhao and Brinton, 2007). In experiments using laboratory 
rodents, isoflavones act like estradiol, enhancing performance for some memory tasks but impairing 
performance on others (Pan et al., 2000, Lund et al. 2001, Luine et al. 2006, Monteiro et al. 2008, Neese 
et al., 2010, Neese et al. 2012). Most research has focused on chronic isoflavone exposure, with few 
experiments examining the acute actions of isolated soy compounds commonly found in botanical 
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supplements.  Genistein, one of the most estrogenic isoflavones with twenty-fold selectivity for  
estrogen receptor (ER) β over ERα (Kuiper et al., 1998), is widely researched, yet only a handful of 
studies have investigated its mnemonic effects (Xu et al., 2007, Alonso et al., 2010, Huang and Zhang, 
2010, Neese et al., 2010, Neese et al., 2012). Additionally, there have been no examinations of 
phytoestrogen actions on striatum-sensitive memory to date, which is surprising given that the striatum 
responds to agonists that target ERβ (Morissette et al., 2008).  
 The current study compared the effects of acute estradiol and genistein treatment on place and 
response learning, tasks that rely on hippocampal and striatal function, respectively (Chang and Gold, 
2003). Young adult Long-Evans rats were ovariectomized to remove endogenous estrogens and placed 
on a purified phytoestrogen-free diet following surgery to control dietary isoflavone intake.  Three 
weeks after ovariectomy and forty-eight and twenty-four hours prior to behavioral training rats received 
acute doses of estradiol benzoate (single injections on each day), genistein (dosing throughout the day), 
or matching regimens of vehicle.   Genistein treatment mimicked estradiol-induced enhancement of 
place learning and impairment of response learning. Our results indicated that genistein has robust 
estrogenic effects on learning and memory and point to activation of ERβ and GPER possibly driving 
shifts in cognitive strategy.  
2.2 Materials and Methods  
2.2.1 Subjects 
Virgin Long-Evans female rats (75-90 days old) were obtained from Harlan (Barrier 202, 
Indianapolis, IN). Rats were individually housed in plastic cages on a 12:12 hour light:dark cycle, with ad 
libitum access to food and water prior to food restriction for behavioral training. At least two days after 
arrival and three weeks prior to training, rats underwent bilateral ovariectomies. From the day of 
surgery, rats were maintained on phytoestrogen-free AIN-93G chow (Research Diets, New Brunswick, 
NJ). Beginning ten days prior to training, rats were handled daily and food-restricted to 80-85% free 
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feeding weight plus 5 g to allow for normal growth. To reduce neophobia on the day of testing, rats 
were given five to ten sucrose tablets (45 mg; TestDiet, Richmond, IN), the food reward used during 
behavioral training, each day of food restriction. Estradiol, genistein, or control treatments were 
initiated 48 h before training. Rats were decapitated immediately following training and tissue collected 
for later analysis. 
 All procedures were approved by the University of Illinois Institutional Animal Care and Use 
Committee and were in compliance with the NIH Guide for the Care and Use of Laboratory Animals.  
2.2.2 Ovariectomy 
Rats were anesthetized with isoflurane and received injections of penicillin (100,000 units/kg, 
i.m.) and the analgesic carprofen (5 mg/kg, s.c.). Dorsolateral incisions were made through the skin, with 
fat and muscle layers bluntly dissected. The distal uterine horn was sutured at the oviduct and the ovary 
excised. Muscle and fat layers were individually sutured, and the incision closed with tissue adhesive 
and wound clips and treated with Bacitracin. Rats were given a post-operative injection of 10 mL 
physiological saline (s.c.) and a second carprofen injection 6-12 h after surgery for pain management.  
2.2.3 Histological determination of hormone status 
Vaginal smears were taken for five days before treatment to confirm ovariectomy and cessation 
of the estrous cycle. Small sterile calcium alginate-tipped swabs were moistened with sterile saline then 
gently inserted in the vagina to collect secretions. Cells were fixed to glass slides with ethanol, stained 
with hematoxylin and eosin, and coverslipped. Slides were examined on a light microscope and staged 
according to the methods of Long and Evans (1922).  
2.2.4 Treatments  
Estradiol 
Rats were randomly assigned to receive either estradiol or vehicle treatments. Forty-eight and 
24 hours prior to training, rats received a subcutaneous injection of either sesame oil (Sigma, St. Louis, 
25 
 
MO; n = 21), 4.5 μg/kg 17β-estradiol benzoate (EB; Sigma) in oil (Lo-EB; n =19), or 45 μg/kg EB in oil (Hi-
EB; n =17); (Fig 1A). The concentrations of EB solutions were 100 μg/mL for the 45 μg/kg dose and 10 
μg/mL for the 4.5 μg/kg dose, such that injection volume corresponded to body weight for all 
treatments at 0.45 mL/kg. 
Genistein 
Rats were randomly assigned to either genistein-treated or sucrose control groups. Genistein 
treated rats (n =17) were fed one 97 mg fruit punch-flavored sucrose tablet containing 485 μg genistein 
(TestDiet) every 4 hours during the light cycle beginning 48 h prior to training. This corresponds to 48 h, 
44 h, 40 h, 28 h, 24 h, 20 h, 16 h, 4 h and 30 mins before training (Fig 1B), for a total genistein exposure 
of 4.4 mg over two days. This dosing scheme was based on prior serum genistein dose-response data 
using these pellets (Neese et al., 2010) and was used to elevate serum genistein to levels physiologically 
relevant to humans consuming isoflavone supplements during the 48 h treatment period through 
behavioral training.  Vehicle control rats (n =17) received one 97 mg fruit punch sucrose pellet (TestDiet) 
at the same time points outlined above.   
Genistein pharmacokinetics 
A separate cohort of rats was ovariectomized, food-restricted, and assessed by vaginal smear as 
previously described (n = 17).  Rats were placed on the genistein dosing regimen described above (Fig 
1B) and randomly split into three groups.  For each group of rats, blood was only collected during a 
single day of treatment corresponding to one (t-2), two (t-1), or three days (t0) of genistein exposure (Fig 
2E).  Immediately prior to and 30 min following each genistein dose, blood was collected via tail 
puncture. The tail was warmed on a heating pad for approximately 30 s then punctured using a sterile 
21 gauge needle. Blood droplets were gently milked into small glass test tubes to obtain a volume of 20-
40 μL. The blood was allowed to clot then centrifuged at 2100g for 15 mins at RT, and the supernatant 
collected and frozen. Gentle pressure was applied to puncture sites with sterile gauze and topical 
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Bacitracin applied. Whenever possible, the scab of a previous puncture was gently re-opened for the 
next collection point to avoid making a new wound. Following the last blood collection, rats were 
decapitated as described below.  
2.2.5 Behavioral Training 
General Training Protocol 
Training procedures were adapted from Korol and Kolo (2002). Rats were trained in a single day 
approximately two to seven hours after lights on. Rats were allowed to acclimate to the training room in 
a clean holding cage for 10 mins prior to behavioral testing. The room was moderately lit by two floor 
lamps aimed at opposite ceiling corners and a standard house fan was used to mask extraneous noise.  
The training apparatus was a symmetrical plus-shaped maze made of black Plexiglas®, with arms 
measuring 105 cm long, 13 cm wide, and 7 cm high, and included a white center to emphasize the 
choice point. The maze was placed 70 cm off the floor on a small table in the center of the training 
room.  Each arm contained a food reward boat under which inaccessible sucrose pellets were placed to 
reduce the use of odor cues during training. Each trial began by baiting the goal arm food boat with an 
accessible sucrose reward. The rat was then placed into the start arm and allowed to choose a single 
arm to enter. A choice was recorded when all four paws of the rat crossed into the arm; rats had a 
maximum of two mins to make a choice. Rats were allowed to remain in the arm ten seconds or until 
they turned to leave, and were then returned to the holding cage for an intertrial interval of thirty 
seconds.  During the intertrial period, the maze was randomly rotated to minimize the use of intramaze 
cues. Rats were trained to one hundred trials. Criterion was set at 9 out of 10 correct choices, with at 
least six consecutive correct choices. Trials to criterion and percent correct choices over 10-trial blocks 
were used to assess learning.  
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Place task 
Rats (n = 50) were trained to learn the spatial location of the goal arm containing the food 
reward using extra-maze cues. Various visual cues were located around the perimeter of the room, such 
as a door, desk, bookcase, shelves, high-contrast posters, etc. The location of the goal arm remained 
constant while the start location was randomized and counterbalanced between east and west arms (Fig 
1C).  
Response task 
Rats (n = 41) were trained to find the food reward by making a specific body movement to reach 
the goal arm, i.e. a 90˚ right or left turn. Rats were randomly assigned to be trained to turn right or left 
at the choice point. Beige curtains were placed around the outer walls and over the ceiling to obscure 
visual cues. The start location was randomly counterbalanced between east and west arms of the maze 
(Fig 1D).                            
2.2.6 Tissue collection 
Immediately following training, rats were overdosed with sodium pentobarbital (75 mg/kg) and 
decapitated. Trunk blood was collected, allowed to clot for 1 hr at RT, and centrifuged at 2100g for 15 
mins. The serum supernatant was collected and frozen at -20˚C until analysis. Uterine horns were 
harvested, trimmed of fat and vasculature, measured, and weighed. 
2.2.7 Serum Analysis 
 Serum samples from rats that received injections were assessed for estradiol concentration 
using a commercially available RIA kit (DSL4800, Beckman Coulter, Brea, CA) with a minimum level of 
detection of 2.2 pg/mL. Serum genistein concentrations were determined for all rats that received 
sucrose or genistein treatments via liquid chromatography with electrospray mass spectrometry and 
tandem mass spectrometry (LC/MS/MS) detection as previously reported (Twaddle et al., 2002) with a 
detection threshold of 8-14 ng/mL for a 10 μL sample. For both serum estradiol and serum genistein 
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measurements, samples that fell below the minimum level of detection were assigned a concentration 
of zero.  
2.2.8 Statistical Analysis  
 Trials to criterion data were compared within place and response tasks using a one-way analysis 
of variance (ANOVA) with estradiol treatment as the independent variable. A priori planned paired 
comparisons were also conducted across groups receiving injections to assess dose-response differences 
versus control rats. The effects of genistein treatment on trials to criterion were assessed via unpaired t-
tests. Learning curves were generated by graphing percent correct choices over blocks of ten trials. 
Repeated-measures ANOVAs were used to evaluate treatment differences in task acquisition, with 
treatment as the between subjects variable, trial block as the within subjects variable, and percent 
correct choices within each block as the dependent measure. Differences in uterine horn weights, serum 
estradiol levels, and serum genistein levels across repeated days of dosing were tested using a one-way 
ANOVA to evaluate the measures according to treatment, followed by planned post hoc t-tests.   
Unpaired t-tests were used to compare serum genistein levels. All analyses were performed using α = 
0.05.  
2.3 Results  
2.3.1 Serum estradiol levels and bioactivity 
All rats demonstrated diestrous vaginal smears prior to estradiol treatment indicating a 
successful ovariectomy and cessation of the estrous cycle. Uterine horn wet weights increased according 
to treatment (mean uterine horn wet weight, mg/cm: oil = 14.1, Lo-EB = 32.6, Hi-EB = 40.9; F[2,53] = 
119.71; p < 0.0001, Fig 2A). Uterine weight differed significantly between each treatment group (all 
paired comparisons p < 0.0001) and increased in a dose-dependent manner, with greater uterine 
weights seen in Hi-EB rats than in Lo-EB rats. ANOVA revealed a significant treatment effect on serum 
estradiol levels (mean serum estradiol, pg/mL: oil = 2.2, Lo-EB = 11.12, Hi-EB = 120.86; F[2,53] = 127.86; 
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p < 0.0001, Fig 2B). Serum estradiol concentrations differed significantly between each treatment group 
(p < 0.0001).  
2.3.2 Serum genistein levels and bioactivity 
All rats treated with sucrose or genistein demonstrated diestrous smears prior to and 
throughout treatment. There was no effect of genistein treatment on uterine horn weight (mean uterine 
horn wet weight, mg/cm: sucrose = 12.5, genistein = 11.7; F[1,32] = 1.08; p > 0.30, Fig 2C).  Genistein-
treated rats had significantly elevated serum levels of total genistein, approximately 2% of which is 
aglycone (Holder et al., 1999; mean serum genistein, in ng/mL: sucrose = 6.75, genistein = 337; F[1,32] = 
35.53; p < 0.0001; Fig 2D). As expected, no detectable levels of the isoflavone daidzein or its metabolite 
equol were present in the serum of sucrose- or genistein-treated animals (data not shown).  
The serum concentration-time profiles for genistein dosing revealed spikes in serum levels 30 
min after each treatment, followed by a gradual decline over 4 h (Fig 2E). Serum genistein 
concentrations across days of dosing were statistically compared for the blood draw 30 min following 
the second genistein dose on each day of treatment. There was a significant effect of treatment on 
circulating genistein concentrations for each day of dosing (mean serum genistein, ng/mL: 4.5 h = 404, 
24.5 h = 482, 48.5 h = 1167; F[2,14] = 16.27; p < 0.0002; Fig 2E). Post-hoc tests showed that serum 
genistein levels were significantly elevated on the third day of treatment as compared to one and two 
days of dosing (p < 0.0003).  
2.3.3 Behavioral testing: place and response learning tasks 
Place learning 
 Two days of estradiol treatment enhanced place learning at the Lo-EB dose, but not the Hi-EB 
dose, suggesting an inverted U-shaped dose-response function. Rats that received Lo-EB injections 
demonstrated a significant decrease in the number of trials to reach criterion (mean trials to criterion oil 
= 59.4, Lo-EB = 43.4; p < 0.02; Fig 3A), indicating an improvement in place learning relative to oil 
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controls. An improvement in place learning was not observed in rats treated with Hi-EB injections (mean 
trials to criterion oil = 59.4, Hi-EB = 58.6; p > 0.9).  Due to the inverted dose-response function, there 
was no main effect of treatment (F[2,30] = 2.56; p > 0.09) 
Genistein treatment enhanced place learning compared to sucrose controls. Rats treated with 
genistein reached criterion in significantly fewer trials than did control rats (mean trials to criterion: 
sucrose = 68.8, genistein = 48.0; F[1,14] = 6.71; p < 0.03; Fig 3B). The trials to criterion data for the 
different treatment regimens (injection vs. oral, Fig 3A, 3B) revealed a similar magnitude of learning 
enhancement (approximately 30%) in rats treated with Lo-EB or genistein over the performance of the 
corresponding oil- or sucrose-treated controls.  
All oil- and estradiol-treated rats demonstrated learning, seen as significant changes in percent 
correct across trial blocks (F[9,270] = 104.68; p < 0.0001, Fig 3C). In contrast to trials to criterion data, 
there was no significant interaction between treatment and percent correct (F[9,270] = 0.80; p > 0.6) 
and no main effect of treatment (F[2,270] = 2.06; p > 0.1).  
Analysis of the learning curves for sucrose- or genistein-treated rats indicated that the genistein 
group learned the place task more quickly than did sucrose controls. All rats learned over trial blocks 
(F[9, 126] = 44.02; p < 0.0001, Fig 3D). There was a significant interaction between treatment and 
percent correct across trial blocks (F[9,126] = 1.98; p < 0.05) but a non-significant main treatment trend 
(F[1,126] = 3.79; p > 0.07).  
Response learning 
 In contrast to effects on place learning, estradiol treatment impaired response learning. 
Compared to oil controls, the groups treated with Lo-EB and Hi-EB both required significantly more trials 
to reach criterion (mean trials to criterion oil = 29.8, Lo-EB = 67.9, Hi-EB = 54. 7; F[2,19] = 28.14; p < 
0.0001; Fig 4A).  Performance between the Lo-EB group and the Hi-EB group did not differ significantly 
(p > 0.088). 
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Response learning speed was also significantly reduced by genistein exposure. Genistein-treated 
rats reached learning criterion at significantly later trials than did sucrose controls (mean trials to 
criterion sucrose = 29.1, genistein = 53.9; F[1,16] = 11.17; p < 0.004; Fig 4B). Genistein also mimicked 
estradiol impairment of response learning, as qualitative examination of the trials to criterion data 
shows similar performance in control (oil vs. sucrose) and treatment groups (Lo-EB and Hi-EB vs. 
genistein, Fig 4A, 4B). 
For the learning curves, all injected rats showed significant learning as percent correct increased 
across trial blocks (F[9,171] = 95.85; p < 0.0001, Fig 4C). In contrast to place learning, the results of 
hormone treatment on response learning across trial blocks were quite robust. There was a main effect 
of treatment (F[2,171] = 14.25; p < 0.0003) and a significant interaction between treatment and percent 
correct (F[9,171] = 6.91; p < 0.0001), as both Lo-EB and Hi-EB treated rats acquired the response task 
more slowly than did oil controls.  
Similar outcomes were observed with genistein treatment, as accuracy across training trials was 
diminished. All sucrose- and genistein-treated rats learned over trial blocks (F[9,135] = 52.69; p < 0.0001, 
Fig 4D). Repeated-measures ANOVA of the learning curves revealed a main effect of genistein treatment 
(F[1,135] = 8.37; p < 0.02) and a significant interaction of treatment and percent correct (F[9,135] = 6.59; 
p < 0.0001). 
2.4 Discussion 
 The current study examined the effects of 48 hours of treatment with low estradiol, high 
estradiol, or the soy isoflavone genistein on the hippocampus-sensitive place task and the striatum-
sensitive response task. Our results are consistent with previous experiments reporting estradiol-
induced enhancement of place learning and impairment of response learning, but here demonstrated a 
distinct dose-response relationship in rats free of dietary phytoestrogens. Moreover, acute treatment 
with a physiologically-relevant dose of genistein facilitated performance in the place task but slowed 
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learning in the response task. Genistein therefore mimics the opposing actions of estradiol-induced 
shifts in learning strategy, augmenting hippocampal-sensitive cognition while diminishing striatum-
sensitive cognition. These results point to task- and brain region-specific actions of genistein: like 
estradiol, isoflavones may facilitate or impair performance depending on cognitive demands and neural 
systems engaged.  
2.4.1 Estradiol and genistein bioactivity 
Estradiol treatments were physiologically active, as indicated by increases in uterine horn wet 
weights and serum estradiol levels. Despite being quite uterotrophic, the Lo-EB dose only moderately 
elevated serum estradiol levels. The seemingly low level of estradiol detected in serum from these rats 
could largely be due to the method of analysis, the direct RIA. The commercial estradiol RIA kit used 
here does not involve a steroid extraction step and has been optimized for use with human serum, 
opening the possibility for reduced accuracy due to the presence of serum binding proteins or inter-
species matrix differences as discussed by Klee (2004) and Ström et al. (2008). Additionally, the kit in 
question (DSL4800, Beckman Coulter) has previously been reported to yield serum estradiol values 
lower than other RIA kits or alternative methods of analysis (unpublished data; Stanczyk et al., 2003, 
Ström et al., 2008). Preliminary findings from pilot LC/MS/MS detection of estradiol in serum samples 
from treated animals detected 2-3.5 times greater concentrations than values obtained via RIA (data not 
shown).  
Genistein treatment failed to increase uterine horn wet weight, indicating a lack of appreciable 
ERα activation in the periphery. This was expected given the preferential binding affinity of genistein for 
the ERβ subtype and is consistent with reports indicating no uterine proliferation with low-to-moderate 
genistein exposures (Mäkelä et al., 1999, Whitten and Patisaul, 2001, Owens et al., 2003). Serum 
genistein concentrations paralleled those found in human adults consuming high-soy diets or isoflavone-
containing supplements (Adlercreutz 1998, Doerge et al., 2000, Gardner et al., 2009). Thus, the effective 
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doses of genistein for modulation of learning and memory are physiologically relevant to human 
isoflavone exposures.  
2.4.2 Place learning was facilitated both by low estradiol and genistein treatment 
 Rats treated with a low dose of estradiol benzoate (4.5 µg/kg) demonstrated enhanced learning 
in the place task, while treatment with a high dose of estradiol benzoate (45 µg/kg) had no effect on 
place learning. These findings contrast previous results from our laboratory reporting facilitated 
performance on the place task using the same treatment schedule and a similarly high dose of estradiol 
(10 µg; Korol and Kolo, 2002, Zurkovsky et al. 2006). An important distinction is that the current study 
used Long-Evans rats maintained on phytoestrogen-free chow while prior experiments used Sprague-
Dawley rats fed standard chow with variable isoflavone content, where the presence of dietary 
phytoestrogens that have mixed agonist/antagonist properties (Brzezinski and Debi, 1999) may have 
modulated estrogen signaling. Additionally, strain differences in estrogen sensitivity and metabolism are 
well described (Kacew and Festing, 1996, Diel et al. 2004, Chapin et al. 2008) and may contribute to 
differences in observed dose-response functions. However, no direct comparisons of the mnemonic 
actions of estrogens across rat strains have been published to date.  
Our results indicate that the enhancing effect of estradiol on hippocampal-sensitive place 
learning does not follow a monotonic dose-response function, but rather demonstrates an inverted U-
shaped pattern.   Inverted-U dose effects, whereby an optimal dose of estradiol enhances memory while 
lower and higher doses are ineffective or impairing, have been reported for a number of tasks that tap 
hippocampal function, including a spatial version of the swim task (Packard and Teather, 1997, 
McLaughlin et al., 2008), radial arm maze (Holmes et al. 2002), contextual fear conditioning (Barha et al. 
2010), and object placement (Inagaki et al. 2010). The inverted U dose-response is indeed a well-
documented pattern of neuromodulation, appearing across many treatments and memory tasks (see 
Baldi and Bucherelli, 2005, Gold and Korol, 2010, for review). Packard (1998) proposes that the effective 
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dose of estrogen results in optimal receptor activation required for hippocampal-dependent memory 
enhancements, with lower doses insufficiently activating receptors and hyper-activation at higher doses, 
leading to “neural noise” that interferes with information processing. Our data point to such an optimal 
dose for estrogenic modulation of place learning.  
 Forty-eight hours of genistein treatment enhanced place learning with a similar magnitude of 
improvement over controls as that obtained with estradiol treatment. While several published reports 
have examined the effects of chronic mixed isoflavone exposure on hippocampal-sensitive memory, few 
studies documenting the mnemonic actions of isolated genistein exist; to our knowledge, our findings 
represent only the second report of acute genistein effects on hippocampal-sensitive learning and 
memory. A single high dose of genistein (40 mg/kg) enhances memory in the swim task (Alonso et al., 
2010), as does chronic genistein treatment (Xu et al., 2007, Huang and Zhang, 2010). The mnemonic 
effects of extended exposure to mixed soy isoflavones have been more frequently described, with 
enhancements reported in the radial arm maze (Pan et al., 2000, Lund et al., 2001), object placement 
(Luine et al., 2006), and swim task (Monteiro et al., 2008, Lee et al., 2009, Pan et al., 2010). While the 
current study used only a single genistein dosage, other findings (Huang and Zhang, 2010) suggest that 
genistein may demonstrate a similar inverted-U pattern of spatial memory modulation, as rats 
chronically treated with low (15 mg/kg) but not high (30 mg/kg) doses of genistein showed memory 
enhancements in the swim task. Potential nonlinear effects of genistein on learning and memory are not 
surprising, as isoflavones demonstrate biphasic responses across a host of physiological systems 
(Calabrese 2001, Patisaul and Adewale, 2009).  Non-monotonic dose-response functions of these 
compounds may be particularly important given the widespread use of soy-based products and 
supplements: estrogenic botanical compounds may be harmful, beneficial, or ineffective depending on 
the doses and formulations in which they are used.   
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2.4.3 Estradiol or genistein treatment impaired response learning 
 Treatment with both a low (4.5 µg/kg) and high (45 µg/kg) dose of estradiol benzoate impaired 
response learning. These results are consistent with findings from previous studies demonstrating that 
absence or low levels of estrogens bias rats towards response strategies, while elevated hormone levels 
shift rats toward hippocampal-based strategies and thus impair performance of striatum-sensitive tasks. 
Elevated estradiol impairs acquisition of the cued win-stay task (Galea et al., 2001) and response maze 
learning (Korol and Kolo, 2002, Davis et al., 2005), biases rats against the use of a stimulus-response 
strategy in a water maze (Daniel and Lee, 2004), biases rats away from response strategies in the dual-
solution T-maze (Korol et al. 2004, Quinlan et al. 2008), and impairs performance of operant 
conditioning tasks that engage prefrontal cortex and cortico-striatal function (Wang et al., 2008, Wang 
et al., 2009). 
Experiments from our lab show that estrogens act in a site-specific manner to modulate 
memory: infusion of estradiol into the hippocampus enhanced place learning, while infusion into the 
striatum had no effect.  Conversely, estradiol infusion into the dorsal striatum but not the hippocampus 
impaired response learning (Zurkovsky et al. 2007). Taking the local actions of estrogens into account, it 
follows that dose-response effects on learning and memory will vary according to the estrogen receptor 
milieu of the brain structure critical for the cognitive task. Compared to the hippocampus, the striatum 
has a far lower density of ERs (Shughrue et al., 1997) and thus may be less sensitive to processing 
disruptions that occur with exposure to high doses of estradiol. In contrast to studies of hippocampus-
sensitive tasks, there is a paucity of research examining dose-response patterns for estrogen impairment 
of striatum-sensitive learning and memory. Our results across place and response learning support the 
contributions of site-specific sensitivity to the diverse effects of estrogen on various cognitive tasks.  
 Rats that received genistein treatment also showed impaired performance on the response 
learning task. To our knowledge, this is the first report of the mnemonic effects of phytoestrogen 
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treatment on a striatum-sensitive task. Our previous results indicate that genistein treatment impairs 
performance on operant conditioning measures of executive function in a delayed spatial alternation 
task that relies primarily on the prefrontal cortex but also engages cortico-striatal function (Neese et al., 
2010, Neese et al., 2012). Importantly, these findings of impaired learning indicate that isoflavone 
treatment does not produce global cognitive enhancements. The benefits of soy isoflavones and other 
phytoestrogens on brain health are oft-reported, with such treatments frequently proposed as 
alternatives to estrogen replacement therapy to protect against cognitive decline (Lee et al., 2005, Zhao 
and Brinton, 2007). However, like endogenous estrogens, our results demonstrate that the effects of 
genistein on learning and memory depend on the cognitive demands of the task and the brain structures 
that are engaged during training. Thus, like estradiol, phytoestrogens may in fact impair certain types of 
cognition.  
2.4.4 Genistein may modulate memory via activation of ERβ and GPER  
 Genistein treatment enhanced place learning and impaired response learning, mimicking the 
direction and magnitude of estrogenic effects on learning in these tasks. Unlike 17β-estradiol, which 
binds to both classical estrogen receptors ERα and ERβ with approximately equal high affinity, genistein 
binds to ERβ with a twenty-fold selectivity over ERα (Kuiper et al., 1998). The absence of a uterotrophic 
response following genistein treatment suggests that insufficient tissue concentrations were achieved to 
activate ERα. In the hippocampus, ERα and ERβ are expressed in a sub-region specific fashion, with both 
receptors detected at nuclear sites and in abundance at extranuclear sites, including dendritic spines 
and axon terminals (Shughrue et al., 1997, Milner et al., 2001, Milner et al., 2005, Milner et al., 2008). 
Low-to-moderate expression of both ERα and ERβ in the striatum has been detected via sensitive 
methodology, with ERβ predominantly expressed in striatal afferents; subcellular localization of the 
receptors has not been conclusive (Küppers and Beyer, 1999, Shughrue and Merchenthaler, 2001, 
Creutz and Kritzer, 2002, Mitra et al., 2003). However, results from our lab suggest extranuclear ER 
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signaling in the striatum contributes to modulation of response learning as impairments were observed 
following only two hours of exposure to intra-striatal estradiol (Zurkovsky et al., 2011). 
Non-classical receptors may also contribute to mnemonic effects, as genistein binds to the G-
protein coupled estrogen receptor (GPER) with relatively high affinity, approximately 7-fold less than 
that of estradiol and intermediate between genistein’s affinity for ERα and ERβ (Maggiolini et al., 2004, 
Kuiper et al., 1998).   Importantly, genistein potently activates downstream molecules believed to be 
involved in neural plasticity associated with learning and memory, such as cFos and ERK, likely through 
GPER signaling. (Maggiolini et al., 2004, Thomas and Dong, 2006). GPER has been detected in all major 
cell layers of the hippocampal formation (Brailoiu et al., 2007, Matsuda et al., 2008). In contrast to the 
relatively low levels of ERα and ERβ in the striatum, GPER is highly expressed (Brailoiu et al., 2007, 
Hammond et al., 2011).  Our behavioral results coupled with the distribution of ERβ and GPER in the 
hippocampus and striatum suggest that activation of these ER subtypes underlie the mnemonic effects 
of genistein.  
2.5 Conclusion 
 In sum, the results of the current study indicate that genistein mimics estradiol-induced shifts in 
hippocampal and striatal learning, enhancing performance in the place task and impairing performance 
in the response task. The pharmacology of genistein points to ERβ and GPER as possible receptor 
subtypes through which estrogens may exert their mnemonic effects on the tasks used here. Our data 
demonstrate that like estradiol, the cognitive effects of genistein can be dissociated by task attributes 
and neural systems engaged. Thus, phytoestrogen enhancements of certain types of memory do not 
generalize to global improvements in cognitive processes. The use of genistein-containing supplements 
should be approached with caution as this compound demonstrates robust estrogenic modulation of 
learning and memory that include impairments in some categories of cognition.  
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CHAPTER 3: ESTRADIOL TREATMENT ENHANCES PLACE LEARNING IN MIDDLE-AGED FEMALE RATS 
WHEREAS THE ISOFLAVONE METABOLITE EQUOL IS INEFFECTIVE 
3.1 Introduction 
 The use of post-menopausal hormone replacement therapy to prevent cognitive decline in 
women has been the subject of much debate. Preclinical studies in non-human animals have generated 
considerable data indicating that estradiol replacement administered close to the time of menopause 
improves certain types of cognition and markers of brain health (Daniel, 2012; Gibbs, 2010; Frick, 2009). 
However, results from the largest clinical study of hormone replacement therapy, the Women’s Health 
Initiative (WHI), found no cognitive benefits but rather an increased risk of dementia and other adverse 
outcomes, such as cancer and cardiovascular incidents, associated with post-menopausal hormone 
treatment (Marjoribanks et al., 2012; Craig et al., 2005; Espeland et al., 2004). The design of the WHI 
study has been criticized as substantially flawed in many areas, such as the inclusion of aged, unhealthy 
subjects many years post-menopause and the use of non-bioidentical hormone therapies, i.e. 
conjugated equine estrogens and medroxyprogesterone acetate (Gibbs and Gabor, 2003; Maki, 2004; 
Sherwin and Henry, 2008). These shortcomings have been attributed to underlie the negative findings of 
the WHI, which stand even in contrast to several human studies reporting memory benefits with post-
menopausal estrogen treatment, with and without adjuvant progesterone (Maki et al., 2001; Duff and 
Hampson, 2000; Steffens et al., 1999).  
 Fearful of the adverse health risks associated with hormone replacement therapy but seeking 
relief from menopausal symptoms, many women have turned to plant-derived dietary supplements 
(Zhao and Brinton, 2007). Touted as natural and safe “menopausal support” supplements, these 
formulas contain compounds from plants with affinity for the human estrogen receptor (ER), termed 
phytoestrogens. A particularly popular class of substances contained in botanical supplements is the 
isoflavones, phytoestrogens derived from soy. Genistein and daidzein are the principal isoflavones and 
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demonstrate variable potencies, with genistein having fairly high binding affinity (~15% that of estradiol) 
and selectivity (440-fold preference) for ERβ while daidzein is mildly selective for ERβ (4-fold preference) 
but is an extremely weak agonist with less than 0.5% the relative binding affinity of estradiol (Muthyala 
et al., 2004; Kuiper et al., 1998). However, daidzein is unique in that it is converted to a higher-affinity 
metabolite, equol, by intestinal bacteria in a portion of the human population (Setchell et al., 2005). The 
S-enantiomer of equol is the exclusive steroisomer produced in vivo and has nearly 80-fold higher 
affinity for ERβ than its parent molecule daidzein (Muthyala et al., 2004). Interestingly, equol production 
appears to be related to diet, as only 25-30% of Western populations are equol-producers, while the 
frequency is estimated to be 50-60% among Asian populations and in Western vegetarians (Setchell and 
Clerici, 2010). Laboratory rodents readily convert daidzein, producing high serum levels of equol with 
isoflavone consumption (Gu et al., 2006) and thus provide a good model to test the effects of equol on 
brain.  
 The ability to produce equol has been proposed to be associated with greater health benefits 
from consuming dietary isoflavones, including the alleviation of conditions due to hormone loss such as 
hot flushes and osteoporosis (Jackson et al., 2011; Setchell et al., 2002). Studies examining the cognitive 
effects of isoflavones in humans have mixed results, reporting enhancements, impairments, and no 
effect (Lee et al., 2005; Zhao and Brinton, 2007). Only two human studies have correlated equol 
production status with cognitive performance following isoflavone treatment: both found neither 
cognitive improvements with isoflavones nor significant interactions according to equol-producing 
phenotype (Henderson et al., 2012; Kreijkamp-Kaspers et al., 2004). In contrast to work in humans, 
mixed isoflavone treatment enhances hippocampus-sensitive learning and memory in rodents (Zhao et 
al., 2011; Pan et al., 2010; Lee et al., 2009; Monteiro et al., 2008; Luine et al., 2006; Lund et al., 2001; 
Pan et al., 2000). However, these mnemonic actions could largely be due to genistein, the most 
abundant and estrogenic isoflavone, which improves hippocampus-dependent memory when used in 
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isolation (Ch.2; Pisani et al., 2012; Huang and Zhang, 2010; Alonso et al., 2010; Xu et al., 2007). 
Additionally, there have been no studies of the actions of isolated S-equol, the physiologically relevant 
steroisomer, on learning and memory in rodents to date. 
 The current study aimed to compare the effects of 48 h of estradiol to S-equol (simplified as 
“equol” in following text) treatment on hippocampus-sensitive learning in middle-aged female rats. 
One-year-old retired breeders were ovariectomized to model the hormone status of multiparous, peri-
menopausal women. Rats received 48 h of treatment with estradiol, equol, or vehicle prior to behavioral 
testing on the place task, a learning paradigm that taps the hippocampus. We found that estradiol 
treatment improved place learning in middle-aged rats, but S-equol, the natural metabolite of the 
isoflavone daidzein, did not. These findings indicate that treatment with estradiol near the time of 
menopause may enhance certain classes of cognition, while supplements containing equol or the equol-
producing status of women likely have little effect on learning and memory processes following 
reproductive senescence.  
3.2 Materials and Methods  
3.2.1 Subjects 
 Twelve-month-old female Long-Evans rats (n = 25) were acquired from Harlan (Indianapolis, IN) 
as retired breeders. Rats were housed individually in clear plastic cages on a 12-hour light-dark cycle 
with free access to food and water before initiation of food restriction procedures. Vaginal smears were 
taken daily to assess estrous status prior to removal of the ovaries. Approximately two weeks after 
arrival and three weeks before behavioral training, rats were bilaterally ovariectomized. Following 
surgery, rats were switched to purified AIN-93G chow (Research Diets, New Brunswick, NJ) to eliminate 
dietary consumption of phytoestrogens. Rats were food restricted to 80-85% of their ad libitum feeding 
weight beginning 10 days before testing. Rats received 5-10 sucrose tablets (45 mg; TestDiet, Richmond, 
IN), the reward for maze learning, each day of food restriction to reduce neophobia. Equol, estradiol, or 
52 
 
control treatments were initiated 48 h before training. Rats were decapitated immediately following 
training and tissue collected for later analysis. 
 All procedures were approved by the University of Illinois Institutional Animal Care and Use 
Committee and were in compliance with the NIH Guide for the Care and Use of Laboratory Animals.  
3.2.2 Ovariectomy 
Rats were anesthetized with isoflurane and injected with the analgesic carprofen (5 mg/kg, s.c.) 
and penicillin (100,000 units/kg, i.m.). Ovaries were then removed using a dorsolateral approach and 
examined for any pathologies that might result in abnormal hormone levels. Rats were given a post-
operative injection of 10 mL physiological saline (s.c.) and drinking water supplemented with ibuprofen 
(Children’s Motrin®, 2.35 mL/500 mL water) for overnight pain management. 
3.2.3 Histological determination of hormone status 
Vaginal smears were taken for ten days prior to surgery to determine reproductive status and 
post-operatively for five days before treatment to confirm removal of ovarian hormones.  A small sterile 
calcium alginate-tipped swab was soaked in sterile saline and gently inserted in the vagina to collect 
secretions. Cells were fixed to glass slides with ethanol, stained with hematoxylin and eosin, and staged 
according to the methods of Long and Evans (1922). Estrous cycle status was then defined as regular for 
cycles of 4-5 days, irregular for cycles of 6-10 days, or extended estrus for 3 or more consecutive estrous 
smears (Fentie et al., 2004) 
3.2.4 Treatments  
Rats were assigned to one of three treatment groups: vehicle, equol, or estradiol. To control for 
injections in the estradiol group and for exposure to the tablets, all rats received injections (s.c.) 24 and 
48 h before testing and two 97 mg sucrose tablets (TestDiet) orally every 4 h during lights on beginning 
48 h prior to testing, corresponding to 48 h, 44 h, 40 h, 28 h, 24 h, 20 h, 16 h, 4 h and 30 mins before the 
behavioral task (Fig 3.1A and 3.1B). The vehicle group received sesame oil injections and 2 plain sucrose 
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tablets. The equol treatment group was injected with sesame oil and received 2 sucrose pellets each 
containing 485 µg S-equol at the time points outlined above, for an equol consumption of 970 µg per 
dosing and a total exposure of 8.7 mg over two days.  The estradiol group received injections of 4.5 
μg/kg 17β-estradiol benzoate (Sigma-Aldrich, St. Louis, MO) in sesame oil and 2 sucrose tablets. An 
estradiol group was included as a positive control in this study as we have previously only reported 
peripheral estradiol treatment to improve place learning in young adult (3 mo) or very old (24 mo) OVX 
rats (Korol et al., 2007; Korol and Kolo, 2002; Pisani et al., 2012).  
Dose selection 
 Estradiol was previously found to improve place learning in young ovariectomized Long Evans 
rats at a dose of 4.5 µg/kg (Ch. 2). The equol dose was selected based on pilot data examining serum 
levels (Neese et al., 2014). Previously, treatment with 485 µg genistein on a similar dosing schedule 
produced blood levels comparable to those found in humans consuming isoflavone supplements, with 
2% of total genistein present as the biologically-active aglycone (Pisani et al., 2012). Equol has an affinity 
for ERβ similar to genistein (Muthyala et al., 2004), but pilot data showed equol dosing to result in only 
0.5-0.75% unconjugated aglycone in serum (Neese et al., 2014). To compensate for the low aglycone 
levels and better parallel those from genistein experiments, the equol dose was doubled from that of 
genistein to 970 µg per treatment. Unfortunately, due to the scarcity of S-equol and middle-aged rats, 
the use of multiple doses was not logistically feasible.  
3.2.5 Behavioral Training 
Training apparatus and environment 
 A plus-shaped black Plexiglas® maze with arms measuring 105 cm long, 13 cm wide, and 7 cm 
high was used for behavioral testing. Each arm contained a food boat with inaccessible sucrose pellets 
to minimize the use of odor cues during learning. The maze was placed in the center of the training 
room on a small table 70 cm above the floor. Two symmetrically placed floor lamps provided ambient 
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lighting. The room contained many two- and three-dimensional extra-maze visual cues, such as high-
contrast posters, hanging items, shelves with books, a door, a desk, etc. Cues were placed approximately 
1-2 m outside the maze in equal densities on each wall of the training room. 
Place task procedure 
Training took place in a single day during the light phase. Rats were placed in a clean holding 
cage and allowed to acclimate to the testing environment for 10 mins. In this task, rats are required to 
learn the spatial location of the goal arm containing the sucrose reward using extra-maze cues. The start 
location was semi-randomly counterbalanced between east and west arms of the maze while the 
location of the goal arm remained constant.  Each trial began by baiting the goal arm with sucrose 
pellets then placing the rat into the designated start arm. Rats had a maximum of 2 mins to enter one 
arm to find the food reward. A rat was allowed to remain in the arm for 10 s or until it turned to leave, 
and was then placed in the holding cage for a 30 s intertrial interval. During the intertrial interval, any 
urine and fecal boli were removed and the maze thoroughly cleaned with dilute enzymatic solution 
(Alconox ®, White Plains, NY) and randomly rotated to the use of intra-maze cues. One hundred trials 
were conducted.  
3.2.6 Tissue collection 
Immediately after testing, rats were injected with an overdose of sodium pentobarbital (75 mg/kg, i.p.) 
and decapitated. Brains were removed and the hippocampi and striata isolated by blunt dissection, flash 
frozen on dry ice, and stored at -80˚C until homogenization. Trunk blood was collected, allowed to clot 
for 1 hr at RT, centrifuged, and the serum supernatant frozen at -20˚C. Uterine horns were excised, 
cleaned of fat, and weighed.  
3.2.7 Serum Analysis 
 Serum equol concentrations were determined for equol- and vehicle-treated rats by liquid 
chromatography with electrospray mass spectrometry tandem mass spectrometry (LC/MS/MS) 
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detection as previously described (Twaddle et al., 2002). Detection threshold for a 10 µL sample was 0.1 
pmol/μL.  
3.2.8 Statistical Analysis  
 Trials to criterion and percent correct choices over 10-trial blocks were used to assess learning. 
Learning criterion was defined as 9 out of 10 correct choices, with at least six consecutively correct 
choices. Trials to criterion and uterine horn data were analyzed via one-way ANOVA, with treatment as 
the between subjects factor. Post-hoc paired comparisons between each treatment group were made 
using Fisher’s PLSD tests. Percent accuracy over blocks of ten trials was plotted to generate learning 
curves, which were assessed using repeated-measures ANOVAs with percent correct choices as the 
dependent measure, trial block as the within subjects variable, and treatment as the between subjects 
variable. Unpaired t-tests were used to compare serum equol levels.  All analyses were performed using 
α = 0.05.  
3.3 Results 
3.3.1 Equal and estradiol equol bioactivity 
Prior to ovariectomy, approximately 30% of 12-month-old rats were cycling regularly, 40% 
demonstrated irregular cycles, and 30% had extended periods of estrus, consistent with previous 
estropause observations in the Long-Evans strain (Fentie et al., 2004). Rats with these varying pre-
surgical estrous statuses were equally distributed throughout the treatment groups. Following surgery 
and prior to treatment, all rats demonstrated diestrous smears consistent with successful ablation of 
ovarian hormones. Treatment had a main effect on uterine horn wet weight (F[2,19] = 78.54, p < 0.0001) 
with estradiol significantly increasing uterine horn size compared to vehicle treatment(p < 0.0001, Fig 
3.2A). There was no uterotrophic effect of equol treatment (p = 0.59).  
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Equol treatment significantly elevated total serum equol levels over vehicle controls (F[1,14] = 
4.60, p < 0.0001; Fig 3.2B), indicating effective absorption of orally-administered pellets. Approximately 
0.6% of the total 14.91 pmol/µL serum equol was aglycone (data not shown). 
3.3.2 Place learning and estrogenic treatments 
 Estradiol administration enhanced learning as demonstrated by a reduction in the number of 
trials to reach learning criterion and faster acquisition of the place task over trial blocks. Although rats 
that received equol performed at levels intermediate between the estradiol and vehicle groups, place 
learning was not significantly improved with equol treatment.  There was a main effect of treatment on 
trials to criterion (F[2,19] = 5.04, p < 0.05), with the estradiol-treated group reaching criterion in 
significantly fewer trials than the vehicle group (p < 0.01, Fig 3.3A) while the equol-treated group did not 
significantly differ from vehicle (p =0.27). Examination of learning curves shows that all treatment 
groups made more correct choice as training progressed, with the estradiol group reaching high levels of 
accuracy earlier in the training period than did the other groups.  There was a main effect of treatment 
on place task acquisition (F[2,171] = 6.11, p < 0.01), an effect of trial block on accuracy (F[9,171] = 46.62, 
p < 0.0001) and a significant interaction between percent correct over trial blocks and treatment 
(F[18,171] = 2.20, p < 0.005; Fig 3.3B).   
3.4 Discussion 
The results of this study indicate there are no significant effects of acute treatment with the soy 
isoflavone metabolite S-equol on hippocampus-sensitive learning in middle-aged OVX rats. The 
modulatory actions of estradiol on spatial tasks are well characterized, with elevated hormone levels 
enhancing place learning, an effect replicated in the current experiment. S-equol, which has been 
promoted as a safer botanical-based alternative to estrogen replacement therapy, failed to mimic the 
cognitive effects of estradiol in a rodent model of the peri-menopausal woman. 
3.4.1 Estradiol and equol bioactivity 
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 Estradiol treatment was uterotrophic, indicating that injections successfully delivered 
physiologically active hormone. Equol did not increase uterine horn wet weights, consistent with 
findings that it has no uterotrophic effect even with chronic exposure or very high doses (Schwen et al., 
2012; Yoneda et al., 2011). Lack of equol activity at the uterus is likely due to its ER pharmacology: 
uterine proliferation is dependent on the actions of ERα (Couse et al., 1995), which equol binds to very 
weakly, having 1000-fold lower affinity for ERα than estradiol (Muthyala et al., 2004).  
 Equol treatment greatly elevated serum concentrations, showing substantial absorption by the 
gut in middle-aged Long Evans rats. Blood levels achieved by our dosing regimen parallel those occurring 
in humans after consuming a high dose of S-equol and are about 10-fold greater than serum 
concentrations in humans after taking a therapeutic dose of 10-20 mg (Jackson et al., 2011; Setchell et 
al., 2005). The proportion of unconjugated equol, the biologically active form, in serum was similar to 
fractions observed in humans and other animals following equol supplementation, with less than 1% of 
total equol existing in circulation as the aglycone form (Jackson et al., 2011; Schwen et al., 2012).  
3.4.2 Estradiol enhanced place learning but equol did not 
 Treatment with estradiol improved place learning in ovariectomized middle-aged rats, 
consistent with modulation previously observed in ovariectomized young adult rats (Korol and Kolo, 
2002; Pisani et al., 2012; Zurkovsky et al., 2006). Estradiol generally enhances performance for memory 
tasks that tap the hippocampus, and these effects continue to be observed in rodents through middle 
age, around the time of reproductive senescence (for review, see Frick 2009). In middle-aged rodents, 
estradiol treatment enhances spatial memory on the swim task (Talboom et al., 2008; Bimonte-Nelson 
et al., 2006; Markham et al., 2002), radial arm maze performance (Daniel et al., 2006; Rodgers et al., 
2010), and object recognition (Fernandez and Frick, 2004). These findings, together with the results of 
the current study, indicate that the hippocampus remains sensitive to the mnemonic actions of estradiol 
through aging at least to midlife. 
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Estradiol treatment can lead to cognitive improvements in middle-aged rats when administered 
immediately or within a few months following ovariectomy, but is often not effective subsequent to a 
prolonged period of hormone deprivation (Daniel et al., 2006; Gibbs, 2000). This loss of estrogen-
responsiveness through aging and extended hormone withdrawal occurs in structural and molecular 
measures as well (Daniel, 2012), and together with behavioral findings informs the window of 
opportunity hypothesis (Resnick and Henderson, 2002). Briefly, this theory proposes that estrogen 
treatment can be beneficial for brain and cognitive health only when initiated in close proximity to 
natural or surgical reproductive senescence, while treatment with estrogens outside of this critical 
window may have no effect or even be detrimental. Our results are consistent with this hypothesis, as 
estradiol treatment administered 3 weeks after ovariectomy enhanced learning in middle-aged rats. 
However, other experiments from our lab found estradiol-induced enhancements in very old (24 mo) 
rats using a difficult place training paradigm (Korol et al., 2007), suggesting that cognitive demand may 
interact with hormone responsiveness of the brain through aging.  
In contrast to estradiol treatment, oral administration of equol to OVX middle-aged rats had no 
significant effect on place learning. Single isoflavone compounds are capable of enhancing 
hippocampus-sensitive learning, as a similar course of genistein treatment over 48 h improved 
performance of the place task in young ovariectomized rats (Ch. 2, Pisani et al., 2012). Many other 
studies report memory enhancements for tasks that tap the hippocampus with extended exposure to 
mixed soy isoflavones, which either include equol or would lead to increased equol production from 
daidzein (Zhao et al., 2011; Pan et al., 2010; Lee et al., 2009; Monteiro et al., 2008; Luine et al., 2006; 
Lund et al., 2001; Pan et al., 2000). At first glance, our results seem surprising given the cognitive 
enhancements demonstrated by other investigators and in our own previous experiment with genistein. 
However, it is important to note that isolated equol is a weak ER agonist and the ER binding profiles and 
neural activities of purified isoflavones are modified when these compounds are used in combination, 
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becoming more specific and higher-affinity for ERβ (Zhao et al., 2009). S-equol has a binding affinity for 
ERβ comparable to genistein but has very weak transcriptional potency at ERβ, with only 10% the 
activity of genistein in transcriptional assays. Additionally, S-equol loses its ER specificity at the level of 
gene expression, similarly low transcriptional potencies at both ERα and ERβ (Muthyala et al., 2004). 
Thus, there is a dissociation in the overall pharmacological potency of equol: the compound binds to ERβ 
effectively but has weak, non-selective genomic actions. Given these properties, it is likely that genistein 
is the primary compound responsible for the cognitive actions of mixed isoflavone treatments. 
The pharmacology of equol likely underlies its failure to enhance place learning in the current 
study. While agonism of ERα or ERβ can both dose-dependently enhance place-learning (see Ch. 4), the 
genomic actions of ERβ are most frequently implicated as critical for the cognitive enhancement of 
hippocampus-sensitive tasks (Frick et al., 2010; Liu et al., 2008), with ERα appearing to contribute via 
rapid actions (Frye et al., 2007; Phan et al., 2011). Because equol does not potently stimulate gene 
transcription via ERβ and has extremely low affinity for ERα, it fails to activate the two pathways that 
appear to be responsible for mnemonic improvements. However, it is important to note that only a 
single dose of equol was used in this study. As discussed extensively in previous chapters, using multiple 
doses to elucidate dose-response patterns is critical for fully determining the mnemonic actions of a 
compound. Perhaps the use of a higher dose of equol would affect learning via rapid signaling, thus 
compensating for its lack of transcriptional potency. Notably, rats treated with chronic equol at doses 
higher and lower than that used here showed no changes in operant task measures of executive 
function, tasks that are impaired by chronic treatment with estradiol, genistein, or ERβ agonists (Neese 
et al., 2010; Neese et al., 2010; Neese et al., 2012; Neese et al., 2014; Wang et al., 2009) . Together, 
these results indicate that equol has extremely limited effects on cognition, neither enhancing nor 
impairing learning and memory processes.  
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3.5 Conclusions 
 The results of the current study demonstrate that middle-aged ovariectomized rats show 
improvements in hippocampus-sensitive learning following acute estradiol treatment, while the 
isoflavone metabolite equol had no effect on place learning. Equol has been proposed to be a valuable 
therapeutic compound to combat the detrimental effects of hormone loss in menopause, but has no 
discernible mnemonic effects in the brain. While there may be a role for equol in reducing other 
climacteric symptoms, it does not appear to be a candidate treatment for the attenuation of cognitive 
shifts associated with loss of female sex hormones.  
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CHAPTER 4: ESTROGEN RECEPTOR ALPHA- AND BETA-SELECTIVE AGONISTS MODULATE LEARNING IN A 
DOSE- AND TASK-SPECIFIC MANNER 
4.1 Introduction 
Estrogens have varying effects on learning and memory, improving or impairing cognition 
according to the behavioral task and neural system engaged or other variables such as stress status 
(Dohanich et al., 2009; Korol, 2004). Substantial data from rodent studies indicate that increased levels 
of estradiol generally enhance performance in spatial memory tasks that rely on the hippocampus, 
including the radial arm maze (Daniel et al., 1997; Fader et al., 1999; Holmes et al., 2002; Luine et al., 
1998), swim task (Bimonte and Denenberg, 1999; Kiss et al., 2012; Markham et al., 2002; Packard and 
Teather, 1997), delayed matching-to-position (Gibbs, 2000), place task (Davis et al., 2005; Korol and 
Kolo, 2002; Zurkovsky et al., 2006; Zurkovsky et al., 2007) and object placement (Frye et al., 2007; Luine 
et al., 2003). While estradiol largely promotes the use of cognitive strategies that engage the 
hippocampus, elevated hormone levels impede learning and memory processes that tap the striatum. 
Estradiol impairs the performance of tasks that require the use of stimulus-response or egocentric 
strategies, such as cued win-shift on a radial arm maze (Galea et al., 2001), the response task (Korol and 
Kolo, 2002; Davis et al., 2005; Zurkovsky et al., 2007; Zurkovsky et al., 2011), and cued swim task (Pleil et 
al., 2011). Additionally, estradiol treatment decreases performance on operant tasks that target the 
prefrontal cortex and also involve cortico-striatal interactions (Wang et al., 2008; Wang et al., 2009).   
Thus, estrogens regulate learning and memory in a dissociable manner, enhancing hippocampus-
sensitive learning but impairing striatum-sensitive learning and prefrontal-cortical dependent functions.   
Direct infusions of estradiol into the hippocampus and striatum mimic the effects of systemic 
treatments on place and response learning, respectively (Zurkovsky et al., 2007; Zurkovsky et al., 2011).  
Moreover, intra-hippocampal or intra-striatal treatment with an estrogen receptor (ER) antagonist 
attenuates the enhancements and impairments on the respective place and response learning tasks, 
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suggesting that modulation of cognition is mediated through the activation of local ERs in these discrete 
brain structures (Kent et al., 2005; Zurkovsky et al., 2006). 
 ERα and ERβ, the two principal subtypes of classical estrogen receptors, are both expressed in 
the hippocampus and striatum but have differential nuclear and extra-nuclear distributions in each 
neural structure (McEwen et al., 2012; Meitzen and Mermelstein, 2011; Mhyre and Dorsa, 2006). ERα 
and ERβ are abundant in the hippocampus, found in cell nuclei and associated with membranes in 
discrete neuronal and glial populations (Milner et al., 2005; Milner et al., 2001; Shughrue et al., 1997). In 
the striatum, expression of nuclear ERs is extremely low if not absent (Shughrue et al., 1997), but 
moderate levels of ERα and ERβ are detected at extranuclear sites in striatal neurons and glia (Almey et 
al., 2012; Grove-Strawser et al., 2010; Kuppers and Beyer, 1999; Schultz et al., 2009). Indeed, the 
membrane-initiated actions of ERs appear to play a predominant role in the striatum as rapid responses 
to estrogen treatment have been observed (Becker, 1999; Mermelstein et al., 1996). Given the 
bidirectional effects of estrogens on hippocampus- and striatum-sensitive learning and the unique 
distribution of ER subtypes between these two structures, we are interested in determining the roles of 
ERα and ERβ in estrogen-mediated cognitive shifts.  
A number of investigators have examined the mnemonic functions of ERα and ERβ through 
rodent studies using either estrogen receptor knockout mice (ERKOs) or subtype-selective estrogen 
receptor agonists. ERβ is largely considered to be essential for the enhancement of hippocampus-
mediated memory; however results vary according to behavioral task and treatment regimen. Many 
experiments using hippocampus-sensitive tasks such as the radial arm maze (Liu et al., 2008), object 
placement and recognition (Frick et al., 2010; Jacome et al., 2010), and social transmission of food 
preference (Clipperton et al., 2008) report memory enhancements with ERβ-, but not ERα-, selective 
compounds following several hours to days of exposure. Others found improvements in object memory 
only with ERα-selective treatments administered short-term (Frye et al., 2007; Phan et al., 2011). Yet 
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additional studies observed both ERα- and ERβ-mediated memory enhancements in object placement 
and recognition (Boulware et al., 2013) and the delayed matching-to-position spatial task (Hammond et 
al., 2009) with 1-2 days or several weeks of treatment, respectively. Therefore, it appears that 
independent activation of either ERα or ERβ is sufficient for cognitive enhancements, but the relative 
roles of each subtype in rapid versus durable mechanisms of memory modulation remain unclear.  
While several studies have examined the roles of ER subtypes in hippocampus-sensitive 
memory, the contributions of ERα and ERβ to estrogen-induced impairments in dorsal striatum-
dependent learning remain unknown. ER localization data from others suggest that ERα may play the 
principal role in mediating striatal function due to locally high expression (Almey et al., 2012; Schultz et 
al., 2009), whereas ERβ is found predominantly on striatal afferents (Creutz and Kritzer, 2002; Kuppers 
and Beyer, 1999; Mitra et al., 2003; Shughrue and Merchenthaler, 2001). To our knowledge, this is the 
first study to use ER selective agonists to directly test shifts in learning and memory, whereby the 
activation of discrete ER subtypes may up- or down-regulate cognition based on the neural structure 
engaged. The maze-based place and response learning tasks used here are ideal for targeting 
hippocampus- or striatum-sensitive processes as their demands are well-matched in all areas except the 
strategy needed to obtain a food reward (discussed in Korol and Kolo, 2002). Additionally, most studies 
that examine the cognitive effects of signaling through ER subtypes lack adequate dose-response 
experiments that may be particularly crucial considering the non-monotonic dose-effect patterns 
characteristic of both estrogenic compounds (Calabrese, 2001) and memory modulators (Baldi and 
Bucherelli, 2005; Gold, 2006). 
In the present study, ovariectomized young adult rats were treated systemically with 
compounds selective for ERα (propyl pyrazole triol—PPT) or ERβ (diarylpropionitrile—DPN; or Br-ERb-
041, a brominated analog of the non-steroidal compound also known as WAY-200070 Malamas et al., 
2004) prior to training on either a hippocampus-sensitive place learning task or a dorsal striatum-
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sensitive response learning task. To elucidate dose-response relationships, the compounds were each 
tested at four different doses. Treatment with PPT, DPN, or Br-ERb-041 enhanced place learning and 
impaired response learning at doses specific to each compound and task. These findings suggest that 
signaling through ERα or ERβ is sufficient to modulate different types of learning that tap hippocampus 
or striatum function.   
4.2 Materials and Methods  
4.2.1 Subjects 
Young adult (75-90 days old) virgin female Long-Evans rats from Harlan (Barrier 202, 
Indianapolis, IN) were individually housed in translucent cages with a 12 h light: dark cycle and free 
access to food and water until the start of food restriction procedures. After at least 48 h of acclimation 
to the vivarium, rats were bilaterally ovariectomized. Following surgery, rats were maintained on corn 
oil modified AIN-93G chow (Research Diets, New Brunswick, NJ) to eliminate dietary phytoestrogen 
intake. Beginning ten days before training, rats were handled daily and food restricted to 80-85% ad 
libitum feeding weight (plus 5 g for normal growth). Each day of food restriction, rats received a sample 
of the food reward used during behavioral testing (five to ten 45 mg sucrose pellets; TestDiet, 
Richmond, IN) with their daily chow allotment to prevent neophobia during training. Seven days prior to 
behavioral testing, vaginal smears were taken on glass slides, stained, and staged by microscope to 
validate ovariectomy. At the conclusion of testing, rats were overdosed with anesthetic and tissue was 
collected for later analysis.  All animal procedures adhered to the NIH Guide for the Care and Use of 
Laboratory Animals and were approved by the University of Illinois and Syracuse University Institutional 
Animal Care and Use Committees.  
4.2.2 Ovariectomy 
Rats were bilaterally ovariectomized under isoflurane anesthesia using a dorsolateral approach. 
Injections of analgesic (carprofen, 5 mg/kg, s.c.) and antibiotic (penicillin, 100,000 units/kg, i.m.) were 
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given pre-operatively. Following surgery, rats received a saline injection (10 mL, s.c.) for hydration and 
Children’s Motrin® in their water bottles (2.35 mL/500 mL water) overnight for pain management.  
4.2.3 Treatments  
PPT, DPN, and Br-ERb-041 were generously provided by the Katzenellenbogen laboratory and 
synthesized as previously described (Lee et al., 2012; Meyers et al., 2001; Stauffer et al., 2000). Dosing 
solutions of PPT and DPN were prepared by suspending the finely pulverized compounds in sesame oil 
then diluting each solution to the proper injection concentrations.  Br-ERb-041 was first suspended in 
100% ethanol then brought to final injection concentrations in sesame oil, with a final ethanol content 
of 0.88%. The concentrations of all agonist solutions were standardized so that injection volume 
corresponded to body weight at 0.45 mL/kg. Forty-eight and 24 h prior to training, rats were injected 
with specific doses of the ER agonists, either 0 (sesame oil vehicle), 33, 100, 333, or 1000 µg/kg PPT; 0 
(sesame oil vehicle), 33, 100, 333, or 1000 µg/kg DPN; or 0 (sesame oil with 0.88% ethanol vehicle), 10, 
33, 100, or 333 µg/kg Br-ERb-041 (please see Supplemental Methods for further background regarding 
dose selection). 
Supplemental Methods  
Dose Selection 
 Doses of PPT, DPN, and Br-ERb-041 were chosen based on available data for receptor binding 
affinities, pharmacokinetics, and previous behavioral studies. PPT binds ERα with a 410-fold preference 
over ERβ and 50% the relative binding affinity of estradiol (Stauffer et al., 2000). Administered 
subcutaneously, PPT reaches maximal serum levels in 1 h then steadily declines, consistent with 
relatively rapid transfer to tissues (Sepehr et al., 2012). PPT appears to cross the blood-brain barrier and 
induces ERα-dependent transcription at doses of 8—3000 μg/kg (Harris et al., 2002). Improvements of 
hippocampus-sensitive memory in rodents have been reported with 900-2000 μg/kg PPT (Phan et al., 
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2011; Frye et al., 2007; Walf et al., 2006). Because no previous studies have examined low to moderate 
systemic PPT doses, we chose to use a slightly lower dose range of 33, 100, 333, or 1000 µg/kg PPT.  
 Like PPT, DPN levels also rise rapidly in the serum after subcutaneous injection, reaching 
maximum concentrations 30 min after treatment (Sepehr et al., 2012). 1000 μg/kg of DPN crosses the 
blood-brain barrier and occupies estrogen receptors in the brain, where it appears to have a long half-
life of nearly 8 h (Lund et al., 2005). DPN binds ERβ with 18% the relative affinity of estradiol and a 72-
fold binding preference over ERα. DPN has been reported to enhance hippocampus-sensitive memory 
and impair executive function at doses between 20 and 3000 μg/kg (Frick et al., 2010; Jacome et al., 
2010; Neese et al., 2010; Rhodes and Frye, 2006; Walf et al., 2006; Walf et al., 2008); we selected doses 
within this range (33, 100, 333, or 1000 µg/kg).  
 Br-ERb-041 is less well characterized. The unbrominated analog ERb-041 reaches maximum 
plasma and brain levels 15 and 30 mins, respectively, following injection. It also has very good blood-
brain barrier penetration, with 70% of serum levels reaching the brain (Liu et al., 2008). Br-ERb-041 has 
high affinity and selectivity for ERβ, binding with 50% the affinity of estradiol and having 500-fold 
selectivity over ERα (Lee et al., 2012). The few behavioral analyses available used very high doses of 
unbrominated ERb-041 in rats and mice, 10 and 90 mg/kg, and observed improvements in performance 
of hippocampus-sensitive tasks (Clipperton et al., 2008; Liu et al., 2008). However, given the high affinity 
and selectivity of Br-ERb-041 for ERβ (greater than that of DPN and unbrominated ERb-041), the 
compound was administered at lower doses of 10, 33, 100, and 333 µg/kg in our study, more closely 
matching our previous findings with estradiol (Korol and Kolo, 2002; Pisani et al., 2012; Zurkovsky et al., 
2006). 
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4.2.4 Behavioral Training 
General Training Conditions and Procedures 
Three weeks after ovariectomy and 24 h after the second treatment, rats were trained on a 
place or response learning task that required navigation of a land-maze to find a sucrose pellet reward. 
Training took place in a single session during the lights-on phase of the light:dark cycle. The training 
room was moderately lit by two symmetrically placed floor lamps. A plus-shaped maze made of black 
Plexiglas® with arms measuring 105 cm long, 13 cm wide, and 7 cm high was placed in the center of the 
room on a small table 70 cm above the floor.  For both place and response training, all four arms of the 
maze were open and accessible. To reduce odor cues, inaccessible sucrose pellets were placed at the 
end of each arm. An accessible sucrose pellet placed in the goal arm prior to the start of each trial 
served as the reward.  
Rats were kept in a clean holding cage and allowed to acclimate to the testing room for 10 min 
before training.  Each trial (maximum 2 min) began by placing the rat in the start arm and allowing it to 
enter a single arm. A choice was recorded when the rat crossed into an arm with all four paws. Rats 
were allowed to remain in the choice arm for 10 s or until they turned to leave, and were then placed 
back in the holding cage for a 30 s intertrial interval.  The maze was randomly rotated during the 
intertrial interval to minimize the use of intramaze cues. Any urine and fecal boli were removed and the 
maze cleaned with dilute enzymatic solution (Alconox ®, White Plains, NY). Rats were trained to 100 
trials. Learning criterion was defined as 9 out of 10 correct choices with at least 6 consecutive correct 
choices. Learning was assessed according to trials to criterion and percent accuracy over 10-trial blocks.  
Place task 
Rats (n = 128) were trained to reach the sucrose reward by learning the spatial location of the 
goal arm using extra-maze cues. Various 2D and 3D cues including bookshelves, a desk, lamps, high-
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contrast posters, etc. were placed in the training room.  The start location was quasi-randomized and 
counterbalanced between east and west arms while the location of the goal arm remained constant.   
Response task 
Rats (n = 135) were trained to make a specific turn, either 90˚ right or left, to reach the goal arm 
and obtain the sucrose award. To prevent the use of spatial strategies and eliminate visual cues, beige 
curtains were placed along the walls and ceiling of the training room. The direction of turn, right or left, 
was randomly assigned across rats and the trial start location was quasi-randomly assigned between 
east and west arms.   When appropriate, all assignments were counterbalanced across treatment 
groups. 
4.2.5 Tissue collection 
Rats were overdosed with sodium pentobarbital (75 mg/kg) and decapitated immediately after 
training.  Brain samples were collected and stored at -80°C for later Western blot analyses.  A portion of 
uterine horn was excised, trimmed of fat and vasculature, measured, and weighed. 
4.2.6 Statistical Analysis  
 All statistical analyses were performed within drug treatment group (PPT, DPN, or Br-ERb-041) 
and task (place or response).  Two measures were used to assess learning:  changes in accuracy across 
training and number of trials to reach criterion. Accuracy was depicted with learning curves generated 
by graphing percent of correct choices across blocks of ten trials.  One-way repeated-measures analysis 
of variance (ANOVA) tests were used to assess the effects of treatment on task acquisition, with dose as 
the between subjects variable, trial block as the within subjects variable, and percent correct choices 
within each block as the dependent measure. To determine the specific effects of treatment dose on 
learning across trial blocks, planned comparisons were made for each drug dose versus vehicle using 
one-way repeated-measures ANOVAs.  Trials to criterion and uterine horn weights were compared using 
one-way ANOVAs with dose as the independent variable, followed by post hoc pair-wise tests using 
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Fisher’s PLSD analyses.  A priori paired comparisons were made versus vehicle controls to assess the 
dose-response function of each compound.  All analyses were performed with α = 0.05. Tests with 
results in which p > 0.05 but p ≤ 0.12 were reported as trends.  
4.3 Results 
4.3.1 Selective agonist bioactivity 
All rats demonstrated diestrous vaginal smears prior to initiation of treatments, indicating 
ovariectomies were effective in reducing circulating estradiol. PPT dose-dependently increased uterine 
horn wet weights at each treatment concentration (F[4,85] = 169.31, p < 0.0001; Fig 1). DPN (F[4,84] = 
0.635, p = 0.64) and Br-ERb-041 (F[4,82] = 0.759, p = 0.55) had no measurable uterotrophic effects (data 
not shown).  
4.3.2 Effects of PPT on place and response learning 
 PPT improved place learning with a significant enhancement observed for the 333 µg/kg dose, at 
which rats reached learning criterion in significantly fewer trials compared to vehicle-treated rats (p < 
0.005; Fig 2A). There was a main effect of PPT treatment on trials to criterion (F[4,40] =2.97, p < 0.05), 
but  doses lower and higher than 333 µg/kg did not significantly differ from vehicle controls (all p > 
0.30), suggesting an inverted-U dose-response function. Visual inspection of the place task learning 
curve (Fig 2C) shows that all rats began training at similar, near-chance performance and gradually 
increased in accuracy over the course of training.  Rats in the 333 ug/kg group appeared to learn faster 
than any other treatment including vehicle controls. Statistical analyses of acquisition across trial blocks 
demonstrated a non-significant main treatment trend (F[4,360] = 2.271, p = 0.079), a main effect of trial 
block (F[9,360] = 115.50, p < 0.0001), and an interaction trend of treatment and training block on 
percent correct (F[36, 360] = 1.33, p = 0.10). These data suggest that all rats learned but at slightly 
different rates due to PPT treatment. Similar to learning criterion findings, planned paired comparisons 
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revealed that only the 333 µg/kg PPT dose increased accuracy over trial blocks compared to rats 
receiving vehicle (F[9,144] = 3.88, p < 0.005; all other PPT doses, p > 0.80).  
 In contrast to its enhancement of place learning, PPT impaired response learning as rats treated 
with the highest doses required more trials to reach learning criterion (Fig 2B). There was a main effect 
of PPT on trials to criterion (F[4,40] = 9.95, p < 0.0001) with 333 µg/kg- and 1000 µg/kg-treated rats 
reaching criterion in significantly later trials than did vehicle controls (p < 0.01 and p < 0.001, 
respectively). The response learning curve shows that task acquisition across trial blocks was decreased 
by PPT particularly in the early and middle phases of training (Fig 2D), but by the seventh block of 
training rats in all treatment groups reached ~90% accuracy.   Repeated measures tests revealed a main 
effect of treatment (F[4,360] = 11.63, p < 0.0001), a main effect of trial block (F[9, 360] = 134.14, p < 
0.0001) and a significant interaction of treatment and trial block on percent correct (F[36,360] = p 
<0.0001), indicating that all rats learned but PPT decreased the rate at which the task was acquired. 
Paired comparisons showed that the 333 and 1000 µg/kg treatment groups demonstrated slower 
response task learning over trial blocks versus vehicle-treated rats (333 µg/kg: F[9,162] = 5.15, p < 
0.0001; 1000 µg/kg: F[9,162] = 11.13, p < 0.0001; other doses, p > 0.20).  
4.3.3 Effects of DPN on place and response learning 
 DPN treatment enhanced place learning, with almost every treatment group reaching learning 
criterion faster than vehicle-treated rats (Fig 3A). DPN treatment had a main effect on number of trials 
to criterion (F[4,39] = 4.64, p < 0.005), with the three highest doses needing significantly fewer trials to 
reach criterion compared to the control group (100 µg/kg: p < 0.05; 333 µg/kg: p < 0.0005; and 1000 
µg/kg: p < 0.005). For place task acquisition across trial blocks (Fig 3C), all treatment groups performed 
at similar levels of accuracy at the beginning and end of training but showed differences in learning rate 
during middle blocks. Analysis of the learning curve showed main effects of DPN treatment (F[4,351] = 
2.94, p < 0.05; Fig 3C) and trial block (F[9, 351] = 96.67, p < 0.0001), with a significant interaction of DPN 
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treatment and percent correct choices over blocks of trials (F[36,351] = 1.47; p < 0.05). Contrasting the 
trials to criterion data, only the 333 µg/kg dose of DPN significantly improved accuracy over trial blocks 
compared to vehicle (F[9,153] = 3.32, p < 0.001), with the 100 and 1000 µg/kg groups showing trends for 
the interaction between treatment and percent correct over trials (100 µg/kg: F[9,144] = 1.60, p = 0.122; 
1000 µg/kg: F[9,135] = 1.67, p = 0.102).  
 Likewise, DPN treatment significantly modulated response learning (Fig 3B), increasing the 
number of trials needed to reach criterion at the highest doses of 333 µg/kg (p < 0.05) and 1000 µg/kg (p 
< 0.05) versus vehicle controls. One-way ANOVA for trials to criterion data showed that there was a 
main effect of DPN treatment on response learning (F[4,40] = 3.38, p < 0.05).  This DPN-induced 
impairment of response task performance can also be seen via the learning curves (Fig 3D), as the 333 
µg/kg and 1000 µg/kg treatment groups reached high levels of accuracy only late in the training period. 
There was a main effect of DPN treatment (F[4,360] = 3.86, p < 0.01), a main effect of trial block 
(F[9,360] = 115.44, p < 0.0001), and a significant interaction of treatment and trial block on percent 
correct (F[36,360] = 2.12, p < 0.0005), indicating that all rats acquired the response task but accuracy 
across training was diminished by DPN treatment. Planned paired comparisons of learning curve data 
corroborate the learning criterion results, as only rats receiving 333 µg/kg or 1000 µg/kg showed 
changes in acquisition over trial blocks versus control rats (333 µg/kg: F[9,144] = 3.78, p < 0.005; 1000 
µg/kg: F[9,189] = 2.77, p < 0.005; other groups, p > 0.50).  
4.3.4 Effects of Br-ERb-041 on place and response learning 
   Place learning was improved by Br-ERb-041 treatment at a single dose (Fig 4A), although the 
magnitude of enhancement was not as great as that seen with the other selective agonists. One-way 
ANOVA showed no main effect of Br-ERb-041 on trials to criterion (F[4,33] = 1.45, p = 0.24), but post hoc 
paired comparisons revealed that the 100 µg/kg dose significantly decreased the number of trials 
required to reach criterion (p < 0.05). The performance of rats receiving higher and lower doses of Br-
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ERb-041 did not differ from vehicle as measured by learning criterion (all p > 0.30). The place task 
learning curve (Fig 4C) shows that all treatment groups performed at similar ranges of accuracy over the 
course of training, with the exception of some variation in percent correct during trial blocks 4 and 5, 
with rats receiving vehicle and 10 ug/kg treatments showing the lowest accuracy. Statistical analyses 
confirmed these observations: although all rats acquired the task over trial blocks (F[9, 297] = 72.65, p < 
0.0001), there was no main effect of treatment (F[4,297] = 1.58, p = 0.20) nor interaction between 
treatment and percent correct across trial blocks (F[36, 297] = 1.24, p = 0.17). Paired repeated measures 
tests show that no dose of Br-ERb-041 significantly altered learning of the place task over trial blocks 
(100 μg/kg: F[9,135] = 1.54, p = 0.14; all others, p > 0.40).  
 Aligning with findings in the place task, 100 μg/kg Br-ERb-041 also modulated response learning 
as rats treated with this dose attained learning criterion significantly later in training (Fig 4B). Br-ERb-041 
treatment had a main effect on trials to criterion (F[4,40] = 4.06, p < 0.01) driven primarily by the 
response learning impairment of the 100 µg/kg dose compared to vehicle (p < 0.001). There was a non-
significant impairment trend for 333 µg/kg Br-ERb-041 (p = 0.085) but lower doses did not differ from 
vehicle (all p > 0.50). Inspection of the response task learning curve (Fig 4D) also shows that the 100 
μg/kg treatment group reached high levels of accuracy at much later trial blocks than did the other 
groups of rats. One-way repeated measures ANOVA demonstrated a main effect of BR-ERb-041 
treatment (F[4,351] = 2.83, p < 0.05; Fig 4D), a main effect of training block (F[9,351] = 90.99, p < 
0.0001), and an interaction of block and treatment  on percent correct  (F[36,351] = 2.09, p < 0.0005). A 
priori pair-wise comparisons of treatment groups showed that 100 μg/kg of BR-ERb-041 significantly 
slowed acquisition of the response task over training blocks compared to vehicle (F[9,144] = 4.40, p < 
0.0001). Lower doses of Br-ERb-041 had no effect (p’s > 0.96) but the 333 μg/kg group showed a non-
significant interaction trend between treatment and response task accuracy over trials (F[9,144] = 1.82, 
p = 0.069).  
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4.4 Discussion 
 Young adult ovariectomized female rats demonstrated enhanced learning on the place task and 
impaired learning on the response task following 48 h of treatment with the ER-selective agonists PPT, 
DPN, or Br-ERb-041. These results indicate that activation of either ERα or ERβ is sufficient to modulate 
performance of the hippocampus- and dorsal striatum-sensitive tasks used in the current study. Discrete 
dose-response functions were observed for each compound and learning task, suggesting that the 
cognitive effects of estrogenic compounds will vary according to individual agonist pharmacology and ER 
distribution in the neural structures considered essential for optimal task performance.  We hypothesize 
that signaling through ERα and ERβ produces distinct molecular, chemical, and physiological changes in 
the hippocampus and striatum that underlie the observed shifts in learning performance. While the 
actions of ERα and ERβ may differ mechanistically, they produce similar outcomes of memory 
modulation at the behavioral level.  
4.4.1 Bioactivity of selective agonists 
 The uterotrophic response to estrogens is largely dependent on the downstream actions of ERα, 
the predominant estrogen receptor in the uterus (Couse et al., 1995; Kuiper et al., 1997). Of the three 
selective agonists, only PPT increased uterine horn wet weights, indicating activation of ERα as 
expected. Uterine horn proliferation occurred in a dose-dependent manner consistent with previous 
studies (Harris et al., 2002). Treatment with DPN and Br-ERb-041 did not measurably increase uterine 
horn weights, pointing to a relative lack of systemic ERα activation even at the highest doses of the ERβ-
selective agents used in these experiments.  
4.4.2 Selective activation of ERα or ERβ was sufficient to enhance hippocampus-sensitive learning 
Treatment with certain doses of PPT, DPN, and Br-ERb-041 each enhanced performance on the 
place learning task: PPT at 333 µg/kg, DPN at 100, 333, and 1000 µg/kg, and Br-ERb-041 at 100 µg/kg. A 
common pattern in these place learning results is the presence of inverted-U dose response functions, 
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whereby a particular dose of a compound exerted mnemonic actions while higher and lower doses were 
ineffective. Inverted-U dose response patterns for estrogenic modulation of memory processes that tap 
the hippocampus are well documented (Pisani et al., 2012; Inagaki et al., 2010; Barha et al., 2010; 
Holmes et al., 2002; Packard and Teather, 1997) and align more generally with non-linear dose-response 
functions for modulation of memory in males using a variety of pharmacological treatments (Gold, 
2006).  Moreover, the selective agonists used here have also previously shown hormetic dose responses 
on hippocampus-sensitive memory, including facilitation of object placement learning with acute PPT 
and DPN treatment (Phan et al., 2011) and prolonged social transmission of food preference following 
72 h of ERb-041 treatment (Clipperton et al., 2008). Importantly, the current demonstration of inverted-
U dose response patterns with ER-selective agonists indicates that a treatment aimed at ERα or ERβ may 
appear to be ineffective when in fact, behavioral outcomes are eclipsed by the selection of too high or 
too low a dose (see Baldi and Bucherelli, 2005; Calabrese, 2001; Calabrese and Baldwin, 2003 for 
relevant discussion and implications of the inverted dose response). The use of arbitrary or single 
agonist doses has likely contributed to the incongruous conclusions of various studies regarding the 
roles of ERα and ERβ in memory (for review, see Ervin et al., 2013).  
Many prior studies have indicated that ERβ appears to be the estrogen receptor subtype critical 
for improving hippocampus-sensitive learning and memory. Compounds selective for ERβ enhance 
memory in the spatial version of the swim task (Liu et al., 2008; Rhodes and Frye, 2006), radial arm maze 
(Liu et al., 2008), object placement and recognition (Walf et al., 2006; Frick et al., 2010; Jacome et al., 
2010; Phan et al., 2011), spontaneous alternation (Zhao et al., 2011), and social transmission of food 
preference (Clipperton et al., 2008). A previous experiment from our lab also points to the actions of 
ERβ, as treatment with the β-selective soy isoflavone genistein improved place learning (Pisani et al., 
2012). Studies using estrogen receptor knock-out (ERKO) mice further implicate ERβ signaling, as β-
ERKOs are insensitive to the enhancing effects of estrogens on object placement (Walf et al., 2008), 
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object recognition (Frick et al., 2010; Walf et al., 2008), a swim version of the Y maze (Liu et al., 2008), or 
contextual fear conditioning (Day et al., 2005), whereas treatment with estrogens enhanced 
performance of these tasks in wild-type or α-ERKOs. The results of the current study also support the 
conclusion that ERβ activation can improve hippocampus-dependent memory, as treatment with two 
different β-selective agonists enhanced place learning. Considering the collective results of these 
numerous studies, the evidence that estrogens can signal through ERβ to improve certain types of 
cognition is quite strong; however, the memory-enhancing role of ERβ may not be exclusive in that 
estrogens can modulate cognition through other ERs as well.  
 Activation of ERα can also modulate cognitive processes, as experiments using the object 
placement (Frye et al., 2007; Phan et al., 2011) and object recognition (Phan et al., 2011; Walf et al., 
2006) tasks found memory enhancements following treatment with PPT. Additionally, the ERα-selective 
compound 16α-iodo-estradiol improved object recognition but not object placement memory (Luine et 
al., 2003). Notably, these mnemonic effects mediated by ERα were observed following relatively acute 
exposures to the selective agonists: testing occurred within 40 min (Phan et al., 2011) or 4 h (Frye et al., 
2007; Luine et al., 2003; Walf et al., 2006) of treatment. As most classical genotropic actions begin to 
manifest approximately 6 h after administration of estrogens (Jensen and DeSombre, 1972; 
Katzenellenbogen, 1980) these findings suggest that rapid ERα signaling can affect memory for 
hippocampus-sensitive tasks.  In the current study, PPT treatment enhanced place learning following 48 
h of exposure and thus the possible contributions of rapid versus classical ERα signaling cannot be 
separated. In contrast, nearly all of the previously-mentioned studies reporting memory enhancements 
with ERβ-selective compounds administered treatments at least 24 h before behavioral testing.  For 
social transmission of food preference, ERβ agonist treatment improved memory when given over days 
but had no effect when administered acutely (Ervin et al., 2013). Thus, regulation of cognition through 
ERβ activation may mainly be genomic in nature. However, a relatively small set of experiments report 
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memory enhancements of DPN treatment with short term-exposures (Jacome et al., 2010, Phan et al., 
2011, and Walf et al., 2006), all using object recognition and placement tasks. Other studies point to 
durable cognitive actions of both ERα and ERβ, as PPT and DPN improve objection recognition and 
object placement memory when administered directly into the hippocampus 24-48 h before testing 
(Boulware et al., 2013) and facilitate spatial learning with several weeks of treatment (Hammond et al., 
2009; Qu et al., 2013). Together, these results indicate that independent ERα and ERβ activation both 
modulate hippocampus-sensitive learning and memory processes in a wide variety of exposure timing 
and behavioral paradigms.  
While the neurobiological processes that underlie potentiation of hippocampus-sensitive 
memory remain unknown, numerous studies have attributed changes in hippocampal function to the 
actions of ERα, ERβ, or both. Estrogens increase hippocampus plasticity and excitatory 
neurotransmission as examined via electrophysiological manipulations, phenomena that have been 
credited to both ERα and ERβ (Mukai et al., 2007; Foster et al., 2008; Fugger et al., 2001; Kramar et al., 
2009; Liu et al., 2008). The work of Woolley and colleagues has produced a framework in which both 
ERα and ERβ activation can acutely increase hippocampal excitability by modulating discrete 
neurotransmitter systems. Specifically, ERβ acts via a presynaptic mechanism to potentiate excitatory 
glutamate signaling (Smejkalova and Woolley, 2010), while ERα suppresses inhibitory transmission 
through an endocannabinoid-mediated decrease in the probability of GABA release (Huang and 
Woolley, 2012). Work by others also supports ERβ-induced enhancement of the hippocampal 
glutamatergic system, as β-selective agonist treatment leads to increased expression of AMPA receptor 
subunits (Liu et al., 2008; Waters et al., 2009). Furthermore, ultrastructural analysis detects ERβ 
primarily in granule and pyramidal cells, the major excitatory loops of the hippocampus (Milner et al., 
2005). A separate neurochemical model supported by in vivo manipulations and behavioral data posits 
that estrogens attenuate GABAergic inhibition in the hippocampus through augmentation of 
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acetylcholine signaling (Daniel and Dohanich, 2001; Dohanich et al., 2009; Marriott and Korol, 2003; 
McElroy and Korol, 2005). This model adds another layer to the in vitro findings of Huang and Woolley 
(2012) and further implicates ERα in the suppression of hippocampal inhibitory tone because ERα, but 
not ERβ, is intimately associated with cholinergic projections of the basal forebrain and hippocampus 
(Milner et al., 2005; Shughrue et al., 2000; Szego et al., 2006; Towart et al., 2003). In sum, functional and 
structural studies suggest that ER receptor subtypes work in concert to increase hippocampus 
neurotransmission, with ERβ increasing excitation and ERα attenuating inhibitory circuits. Importantly, 
these models provide an opportunity to further elucidate the mechanisms by which ERα and ERβ 
activation enhance hippocampus-dependent cognitive processes, as selective agonist treatment can be 
coupled with monitoring or blockade of specific neurochemical systems. 
In addition to neurochemical changes, a rapidly growing set of studies has focused on ERα and 
ERβ regulation of intracellular signaling cascades in hippocampal neurons. Estrogen-induced 
enhancements in hippocampus-sensitive memory appear to rely on the activation of several signaling 
molecules, including ERK, PKA, PI3K, and Akt (Fan et al., 2010; Fernandez et al., 2008; Frick et al., 2010; 
Harburger et al., 2009; Lewis et al., 2008; Walf and Frye, 2008). ERα and ERβ are capable of modulating 
these cascades in hippocampal neurons by coupling to distinct metabotropic glutamate receptor 
(mGluR) subtypes (Meitzen and Mermelstein, 2011). Briefly, baseline ERα stimulation results in ERK-
mediated increases in CREB phosphorylation via allosteric activation of Gq coupled, type 1a mGluRs, 
while ERβ signaling attenuates pCREB levels at rest by coupling to type 2 mGluRs acting through Gi/o 
proteins. However, when depolarization is induced concomitant with estrogenic treatment, both ERα 
and ERβ decrease CREB activation by attenuating L-type calcium currents via mGluR2 (Boulware and 
Mermelstein, 2009). 
 These findings provided an exciting framework through which ERα, but not ERβ, signaling might 
acutely enhance hippocampus-sensitive memory. However, subsequent in vivo and behavioral 
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experiments found that both PPT and DPN rapidly activated ERK and improved object memory 1-2 days 
after treatment in an mGluR1-dependent manner (Boulware et al., 2013). The variable of treatment 
timing on cognitive outcomes following ERα or ERβ may also be due to differences in signaling cascade 
kinetics: PPT-induced ERK activation is rapid and transient, while DPN results in more gradual and 
durable phosphorylation (Wade et al., 2001; Zhao and Brinton, 2007). Others postulate that specific ERα 
and ERβ signaling mechanisms converge on similar molecular targets but behavioral outcomes vary 
according to the relative expression of ERα/ ERβ and local estrogen levels (Bean et al., 2014; Foster, 
2012). Despite nuanced mechanisms at the cellular level, the results of the current study suggest that 
the downstream chemical and molecular changes following ERα or ERβ agonism are independently 
sufficient to improve hippocampus-sensitive memory.  
4.4.3 Response learning was impaired by agonists selective for ERα or ERβ 
 PPT, DPN, and Br-ERb-041 all impaired learning of the response task albeit at specific doses. Rats 
treated with PPT or DPN required significantly more trials to reach criterion at the highest doses of 333 
and 1000 μg/kg, while only the 100 μg/kg dose of Br-ERb-041 impeded response task performance. Very 
few other studies have examined the roles of particular ER subtypes in estrogenic modulation of 
cognitive tasks that engage the striatum. Prior results from our labs indicate that ERβ activation plays a 
central role in memory impairments, as treatment with ERβ-selective genistein hindered response 
learning in rats depleted of dietary phytoestrogens (Pisani et al., 2012). Chronic genistein treatment also 
impaired performance of delayed spatial alternation (DSA), an operant task that chiefly engages the 
prefrontal cortex but also taps cortico-striatal function (Neese et al., 2010; Neese et al., 2012). Long-
term DPN exposure disrupted DSA memory with an inverted-U dose response, with deficits resembling 
those produced by estradiol occurring only at the lowest dose used (Neese et al., 2010). Unlike the 
current study, Neese et al. (2010) did not observe robust cognitive impairments with ERα activation, as 
subtle DSA deficits emerged only with a high PPT dose and in the latest stage of training using long 
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delays. However, it is important to note that DSA experiments used chronic selective agonist treatment 
and a protracted operant training and testing paradigm, whereas here rats received 48 h of treatment 
and a single maze training episode. As discussed earlier, the contributions of ERα signaling to memory 
modulation appear to vary by timing and task cognitive demands, and these parameters likely play a 
role in the differing PPT effects observed for response learning versus DSA performance. Similar to our 
place learning results, the current data indicate that independent activation of either ERα or ERβ can 
impair striatum-sensitive response learning.  
 Despite robust effects of estradiol on striatum function, it was previously thought that the 
striatum was devoid of classical estrogen receptors because nuclear ERα and ERβ could not be detected 
by standard immunohistochemical methods (Roy et al., 1990; Shughrue et al., 1997). However, more 
sensitive detection methods have found low-to-moderate expression of both ERα and ERβ, with ERβ 
predominantly expressed in afferents but 5-fold greater ERα density within the striatum (Almey et al., 
2012; Mitra et al., 2003; Creutz and Kritzer, 2002; Shughrue and Merchenthaler, 2001; Kuppers and 
Beyer, 1999). Data conflict regarding the precise subcellular localization of ERs in the striatum, but 
receptors appear to be largely membrane-associated due to the rapid effects of estradiol on striatum 
function and the paucity of nuclear ER detection (Becker, 1999; Mermelstein et al., 1996; Schultz et al., 
2009). Experiments from our lab showing learning impairments on the response task within two hours 
after intra-striatal estradiol treatment (Zurkovsky et al., 2011) suggest that these rapid, likely 
membrane-mediated actions of striatum estrogen receptors contribute to learning impairments.  
Little is known regarding the chemical and molecular alterations that underlie estrogenic 
disruption of memory that taps the striatum. One possibility is that estrogen signaling interacts with the 
dopaminergic system to shift cognitive strategies (Daniel et al., 2006; Quinlan et al., 2008) and may do 
so via ERβ activation.  For example, striatal dopamine levels are reduced in β-ERKO mice compared to 
wild type mice regardless of estrogen status (Imwalle et al., 2005), and estradiol-induced increases in 
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dopamine transporter and D2 receptor densities are absent in β-ERKOs (Morissette et al., 2008). 
Treatment with ERβ-selective agonists increases levels of dopamine, dopamine transporters, and D2 
receptors in the striatum while PPT does not (Hughes et al., 2008; Le Saux et al., 2006; Le Saux and Di 
Paolo, 2006). Estrogen-induced increases in the striatal dopamine system are paradoxical considering 
high levels of the hormone also impair response learning, as elevated dopaminergic activity typically 
corresponds to better performance of reward-based operant learning (Wise, 2004). However, striatum-
sensitive memory may be impeded by potentiation of inhibitory D2 receptor signaling, leading to a 
decrease in striatal output (discussed in Korol, 2004). Alternatively, tonically high striatal dopamine 
levels may mask phasic bursts thought to be especially important for learning (Davis et al., 2005). While 
the exact relationship between striatal dopamine transmission and response task performance is still 
unknown, it appears that ERβ acts directly on the dopaminergic system while ERα does not.  
An examination of how estrogens modulate striatal function would be incomplete, however, 
without consideration of signaling through ERα. Ultrastructural analysis of ERα expression in the 
dorsomedial striatum showed the receptor localized to extranuclear sites in cholinergic but not 
dopaminergic axon terminals, and in local soma and dendrites proposed to be GABAergic  neurons  
(Almey et al., 2012).  Estrogens appear to act directly on GABAergic medium spiny neurons to attenuate 
Ca2+ currents and thus decrease firing, leading to overall disinhibition of dopamine terminals that 
receive collateral GABA synapses and ultimately greater DA release (Becker, 1999; Hu et al., 2006; 
Mermelstein et al., 1996). Over-expression of ERα in the striatum amplifies estradiol-induced 
attenuation of stimulated GABA release and increases contralateral rotations, a behavioral assay of 
estradiol-potentiated dopamine asymmetry between the striata (Schultz et al., 2009). Furthermore, 
ovariectomy leads to an increase in striatal AMPA receptors that is attenuated by estradiol and PPT but 
not DPN (Le Saux et al., 2006). This decrease in AMPA binding is proposed to reduce excitatory 
glutamate input and thus decrease striatal processing (Davis et al., 2005). Together, these findings 
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suggest that activation of ERα may contribute to estrogen-associated alterations in striatum function by 
reducing GABAergic inhibition and decreasing the efficacy of glutamate neurotransmission.  
As discussed previously, rapid, membrane-mediated ER actions appear to predominate in the 
striatum given the paucity of nuclear ER detection. Estradiol and selective ER agonists modulate Ca2+ 
currents and intracellular signaling cascades in striatal neurons, appearing to function chiefly through 
ERα (D'Astous et al., 2006; Mermelstein et al., 1996; Schultz et al., 2009). Similar to hippocampal 
mechanisms, ERs further interact with the striatal glutamatergic system by coupling to mGluRs (Meitzen 
and Mermelstein, 2011). At rest, ERα increases CREB phosphorylation through transactivation of 
mGluR5 while ERβ attenuates pCREB levels via allosteric activation of mGluR3. Notably, during 
stimulated depolarization both ERα and ERβ act through mGluR5 to decrease Ca2+ currents and diminish 
downstream signaling (Grove-Strawser et al., 2010). However, the behavioral consequences of these 
proposed ER signaling mechanisms on striatum function have never been evaluated.  
As with the hippocampus, it seems that ERα and ERβ signaling can substantially alter striatal 
transmission by acting on distinct cell populations and neurochemical systems. Striatum-sensitive 
learning tasks are quite under-studied in the field of behavioral neuroendocrinology, but the small 
amount of available data also indicate that activation of either ERα or ERβ can impair some types of 
learning and memory that engage the striatum. The results of the current study support these findings, 
as treatment with PPT, DPN, or Br-ERb-041 all impaired response learning.  
4.5 Conclusion 
 Overall, the results of these experiments suggest that no single estrogen receptor subtype drives 
the cognitive shifts associated with estrogen exposure. While many studies have emphasized the role of 
one receptor over another, our data indicate both ERα and ERβ signaling can independently modulate 
hippocampus- and striatum-sensitive learning. We propose that these cognitive shifts occur due to the 
unique downstream effects of ERα and ERβ in each neural structure. Like estradiol, the memory-
90 
 
enhancing or -impairing effects of ER-selective agonists vary according to treatment regimen, timing, 
and the demands of the behavioral task. Importantly, the emergence of non-monotonic dose response 
functions for these compounds indicate that future experiments should consider a range of agonist 
doses and not disregard low-dose effects. Lastly, the findings of this study may provide insight for the 
future development of therapies with distinct estrogen receptor pharmacology to preserve cognitive 
function over the lifespan.  
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CHAPTER 5: SYSTEMIC TREATMENT WITH AN AGONIST TO THE MEMBRANE ESTROGEN RECEPTOR GPER 
REGULATES PLACE AND RESPONSE LEARNING IN OVARIECTOMIZED YOUNG ADULT RATS ACCORDING TO 
DOSE AND TIMING 
5.1 Introduction 
The effects of estrogens on learning and memory are well established, with high hormone levels 
enhancing hippocampus-sensitive place learning and memory but impairing cognition engages the 
striatum such as egocentric response learning (Gold and Korol, 2010). Earlier investigations of the 
mnemonic effects of estrogens focused on the two subtypes of classical, nuclear estrogen receptors, 
ERα and ERβ. These receptors form a dimer complex with bound ligand and act as transcription factors, 
binding at estrogen response elements on DNA to modulate gene transcription (Pettersson and 
Gustafsson, 2001). Thus, the actions of classical ERs were thought to be chiefly genomic and exerted 
over the course of several hours to days. However, estrogens can dramatically alter neuronal 
excitability, connectivity, and signaling within minutes (Woolley, 2007), effects that are incongruent with 
the normal mechanisms of nuclear ERs. These rapid actions of estradiol and other estrogens point to the 
existence of membrane-associated receptors capable of quickly altering neuron physiology.  
 Rapid responses to estradiol are observed both in vitro and in vivo and can modulate behavior, 
such as learning and memory, in addition to cellular function through inter- and intracellular signaling 
cascades.  Estradiol treatment increases memory for object recognition, object placement, and 
inhibitory avoidance within 4 h (Rhodes and Frye, 2004; Inagaki et al., 2010; Luine et al., 2003), improves 
place learning (Scavuzzo et al., in preparation) but impairs response learning (Zurkovsky et al., 2011) 
within 2 h, and can enhance object placement, object recognition, contextual fear conditioning, social 
transmission of food preference, and radial arm maze performance with only 40 mins of exposure 
(Sinopoli et al., 2006; Barha et al., 2010; Phan et al., 2012; Ervin et al., 2013). Other studies suggest the 
involvement of membrane-mediated estrogen receptor signaling in cognitive modulation through the 
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activation of intracellular signaling cascades (see Frick, 2012 for review). Since rapid actions seem to play 
a significant role in the mnemonic effects of estrogens, we are interested in elucidating the 
contributions of membrane-localized estrogen receptors to shifts in learning and memory.  
While ERα and ERβ are detected at extranuclear sites in the hippocampus (Milner et al., 2001; 
Milner et al., 2005), these receptors are unlikely exclusive mediators of the fast actions of estradiol. In 
the hippocampus, significant increases in ERK activation are observed 5 mins after infusion of estradiol-
BSA, a hormone conjugate that is unable to penetrate the plasma membrane in that time frame 
(Fernandez et al., 2008; Kuroki et al., 2000). The rapid effects of estradiol-BSA on ERK phosphorylation 
are not blocked by administration of the classical ER antagonist ICI 182,780, suggesting a role for 
signaling via a membrane estrogen receptor distinct from or in addition to ERα and ERβ that is accessible 
extracellularly. Thus, the G-protein coupled estrogen receptor (GPER), previously referred to as GPR30, 
is an attractive candidate receptor for rapid estrogen signaling in the brain.  
GPER is a 7-transmembrane domain G-protein coupled receptor that is structurally and 
genetically unrelated to ERα and ERβ. This receptor originally generated interest due to its role in 
mediating rapid signaling in breast cancer cells (Prossnitz and Barton, 2009). GPER was subsequently 
found to be expressed throughout the brain, including structures involved in learning and memory 
(Brailoiu et al., 2007) such as the hippocampus and striatum, neural systems critical for allocentric place 
and egocentric response learning, respectively. The detection of high levels of GPER in the striatum was 
especially exciting as this brain region is very responsive to estrogens (Becker, 1999; Di Paolo, 1994) but 
was long thought to be devoid of nuclear ERα and ERβ (Shughrue et al., 1997). The development of a 
highly specific GPER agonist, called G1 (Bologa et al., 2006), has allowed researchers to parse out the 
effects of GPER in the brain. Like estradiol, G1 activates ERK in neurons (Liu et al., 2011), increases Ca2+ 
currents via L-type voltage gated calcium channels (Sun et al., 2010), and increases excitatory 
postsynaptic currents in hippocampal slices (Lebesgue et al., 2009).  
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Treatments with G1 typically enhance hippocampus-sensitive learning and memory (Ervin et al., 
2013; Hawley et al., 2014; Gabor et al., 2011; Hammond et al., 2009), indicating that GPER activation is 
sufficient to induce estrogenic patterns of memory modulation. GPER has also been proposed as a 
potential target for future estrogenic hormone replacement therapies, whereby cognitive function may 
be preserved through hormone loss with fewer proliferative and thrombotic actions than with 
traditional estrogens (Hammond and Gibbs, 2011). While the role of GPER in learning and memory is 
promising, further studies are needed to determine whether the effects of G1 result in hippocampal 
cognitive enhancement without impairing other classes of learning and memory and to identify the 
maximally effective dosing regimens. Only one of the three studies examining G1 effects on memory 
used multiple doses of G1 and found a non-monotonic dose-response pattern of modulation (Gabor et 
al., 2011). Additionally, despite its position as perhaps the most abundantly expressed ER in the 
striatum, no experiments have examined GPER activation in striatum-sensitive learning tasks. Studying 
the effects of GPER signaling on tasks that engage the striatum is also important because estrogens 
generally promote shifts in cognition whereby hippocampus-sensitive learning is improved but there is a 
decline in striatum-sensitive performance.  
 The present study sought to investigate the effects of GPER activation on hippocampus-sensitive 
place learning and dorsal striatum-sensitive response learning using systemic treatments of G1. Young-
adult Long-Evans rats were ovariectomized, treated with one of four doses of G1 or vehicle, and then 
trained on the place or response task two days later. This treatment schedule produced opposing effects 
on response learning according to dose: high doses of G1 impaired performance but low doses actually 
improved response learning, an enhancement that has not been previously shown under any other 
estrogenic treatment.  For the place task, we found improvements in place learning only after an 
additional acute exposure of G1 30 min prior to training. These results indicate that GPER activation 
produces unique patterns of memory modulation that vary by neural system engaged, dose, and timing.  
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5.2 Materials and Methods  
5.2.1 Subjects 
Virgin female Long-Evans rats (75-90 days old) were purchased from Harlan (Barrier 202, 
Indianapolis, IN). Rats were individually housed in clear plastic cages and lights maintained on a 12: 12h 
light: dark cycle. Access to food and water was ad libitum until initiation of food restriction for 
behavioral training. All rats underwent bilateral ovariectomies after a minimum of two days acclimation 
to the vivarium. Rats were maintained on phytoestrogen-free AIN-93G chow (Research Diets, New 
Brunswick, NJ) from the day of surgery. Ten days prior to training, rats were handled daily and food 
restricted to 80-85% free-feeding weight plus 5 g to account for normal growth. To reduce reward 
neophobia, each day of food restriction rats were given a small amount of the food to be used as reward 
during testing (45mg sucrose pellets; TestDiet, Richmond, IN). Vaginal smears were taken daily 
beginning seven days before behavioral testing to confirm ovariectomy and cessation of the estrous 
cycle. Immediately following training, rats were heavily anesthetized and decapitated.   
All procedures were in compliance with federal guidelines governing the use of animals in 
research and were approved by the University of Illinois Institutional Animal Care and Use Committee.  
5.2.2 Ovariectomy 
Three weeks prior to behavioral training, rats were ovariectomized via a dorsolateral approach 
under isoflurane anesthesia. Rats received pre-operative injections of penicillin (100,000 units/kg, i.m.) 
and carprofen (5 mg/kg, s.c.) and a post-operative saline injection (10 mL, s.c.). Drinking water was 
supplemented with ibuprofen (Children’s Motrin®, 2.35 mL/500 mL water) for overnight pain 
management. 
5.2.3 Treatments 
Beginning two days before behavioral testing, rats received subcutaneous injections of G1 or 
vehicle (sesame oil, 0.88% ethanol). For Experiment 1, 48 and 24 h before testing rats were injected with 
108 
 
one of the following G1 doses: vehicle, 3.3, 10, 33, or 100 µg/kg (Fig 5.1A). In Experiment 2, rats were 
injected 48 h, 24 h, and 30 min before place task training, receiving either vehicle, 3.3 µg/kg G1, or 10 
µg/kg G1 (Fig 5.1B). G1 was obtained from Tocris Bioscience (Ellisville, MO) and first dissolved at 25 
mg/mL in 100% ethanol, then further diluted in sesame oil to create injection solutions. The 
concentration of G1 solutions varied such that injection volume was held proportional to body weight at 
0.45 mL/kg and the final ethanol concentration adjusted to 0.88% in all solutions.  
Dose selection 
G1 binds to GPER with approximately 50% the affinity of estradiol and is very specific, having no 
affinity for ERα or ERβ up to 1 µM (Bologa et al., 2006). While pharmacokinetic data are not available for 
G1, it is known that treatments with G1 can enhance hippocampus-sensitive memory at doses of 1-30 
µg/kg per day (Ervin et al., 2013; Hammond et al., 2009; Hawley et al., 2014). Additionally, other effects 
of G1 in the brain including neuroprotection, induced peptide release, and modulation of 
neurotransmitter levels have been reported for doses between 1-100 µg/kg (Bourque et al., 2013; 
Lebesgue et al., 2010; Lebesgue et al., 2009; Wang et al., 2009). Given these data and previously 
observed mnemonic effects of estradiol at 4.5 and 45 µg/kg (Korol and Kolo, 2002; Pisani et al., 2012), 
we chose to use G1 at doses of 3.3, 10, 33, and 100 µg/kg.  
5.2.4 Behavioral Training 
General Training Protocol 
Rats were trained on a place or response learning task three weeks after surgery. All training 
was confined to a single day during the light phase. Rats were allowed to acclimate to the training room 
in a cleaning holding cage for 10 min prior to testing. Two floor lamps symmetrically aimed at the ceiling 
provided ambient lighting. The behavioral apparatus was a four-arm black Plexiglas® maze placed on a 
small table in the center of the room 70 cm off the floor (arm dimensions of 105 cm long x 13 cm wide, 
with 7 cm walls). The end of each arm contained a food boat with inaccessible sucrose pellets to reduce 
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the use of odor cues during testing. At the beginning of each trial, one arm was baited with an accessible 
food reward. The rat was placed into the start arm and given a maximum of 2 min to enter another arm. 
A choice was recorded when all four paws crossed the threshold of a single arm, and rats were allowed 
to remain in the arm for 10 s or until they turned to leave. The rat was then placed back in the holding 
cage for a 30 s intertrial interval, at which time the maze was randomly rotated and cleaned with dilute 
enzymatic solution (Alconox ®, White Plains, NY) if needed. Rats performed 100 trials, with learning 
criterion set as 9 out of 10 correct choices with at least 6 correct in a row.  
Place task 
Rats (n = 63) were trained to find the sucrose reward at the end of a goal arm remaining in a 
constant location relative to extra-maze room cues.  The goal arm location, north or south, was 
randomly assigned across rats within each treatment group. The start location was randomly selected 
and counterbalanced between arms east and west of the goal arm. The room contained a variety of 
visual cues, such as a door, stacks of books, a black curtain, shelves, bright posters and hanging objects.  
Response task 
Rats (n = 46) were trained to reach the sucrose reward by consistently performing a left or right 
turn at the choice point of the maze.  The direction of the rewarded turn was randomly assigned to each 
rat. The position of the goal arm varied to maintain its 90˚ relationship to the start arm, which was 
randomly assigned and counterbalanced across east and west arms of the maze.  Beige curtains were 
placed around the perimeter of the room and ceiling to obscure extra-maze visual cues.  
5.2.5 Tissue collection 
Immediately after training, rats were anesthetized with an overdose of sodium pentobarbital 
(75 mg/kg) and decapitated. Hippocampi and striata were removed, frozen on dry ice, and stored at -
80˚C for later biochemical analyses by Western blot (Ch. 6). Trunk blood was collected and uterine horns 
were removed, cleaned of fat and blood vessels, and weighed.  
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5.2.6 Statistical Analysis  
 Learning was assessed within each task by comparing trials to criterion and percent accuracy 
across training blocks between G1 treatment groups. Trials to criterion and uterine horn wet weights 
were compared by one-way analyses of variance (ANOVA) with G1 dose as the independent variable. 
Post hoc planned paired comparisons were conducted using Fisher’s PLSD tests. Acquisition curves were 
generated by plotting percent correct choices across blocks of ten trials. These learning curves were 
analyzed by repeated measure ANOVAs with trial block as the within-subjects variable, G1 treatment as 
the between-subjects variable, and percent correct as the dependent measure.  All tests were run with 
α = 0.05. Tests with results in which p > 0.05 but p ≤ 0.12 were reported as trends. 
5.3 Results 
5.3.1 Experiment 1: G1 treatment twenty-four and forty-eight hours before training bidirectionally 
altered response learning but did not modulate place learning 
 Administration of G1 twenty-four and forty-eight hours before training had no significant effects 
on place learning. There was no main effect of treatment on learning criterion (F[4,34] = 1.14, p = 0.36), 
and no single dose significantly altered the number of trials to reach criterion (Fig 5.2A). There was a 
corresponding absence of G1 effects on the acquisition curves, with significant learning across training 
seen by a significant effect of trial block (F[9, 306] = 95.36, p < 0.0001, Fig 5.2C), but  no main effect of 
treatment (F[4, 306] = 1.02, p = 0.41) and no interaction between trial and G1 treatment on percent 
correct choices (F[36,306] = 0.72, p = 0.88). These data indicate that all rats acquired the place task but 
treatment with G1 did not affect the rate at which they learned.  
G1 treatment produced the expected impairment of response learning at the highest dose used 
in this experiment but also showed a novel low-dose enhancement of egocentric learning. There was a 
main effect of treatment on trials to criterion in the response task (F[4,41] = 7.65, p < 0.001; Fig 5.2B), 
with rats that received 100 µg/kg G1 requiring more trials to acquire the task (p < 0.005). Unexpectedly, 
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rats treated with the lowest G1 dose of 3.3 µg/kg reached learning criterion in significantly fewer trials 
compared to vehicle-treated rats (p < 0.05), opposite to the usual direction of estrogenic modulation in 
this task. Response task learning curves showed a main effect of G1 treatment (F[4,369] = 4.69, p < 
0.005; Fig 5.2D), a main effect of trial block (F[9,369] = 69.86, p < 0.0001), and a significant interaction of 
treatment and trial blocks on percent correct (F[36, 369] = 2.46, p < 0.0001).  Thus, all rats learned the 
response task and G1 treatment modulated how quickly they improved in accuracy to acquire the task. 
Examination of the learning curves shows the opposing effects of low- and high-dose G1 treatment on 
response task acquisition. Rats treated with 3.3 µg/kg G1 acquired the task very quickly, reaching high 
levels of accuracy early in training. Rats receiving the highest dose of G1, 100 µg/kg, showed impaired 
response learning by making a high percentage of correct choices only in the latest training blocks.   
5.3.2 Experiment 2: Exposure to G1 treatment 48 h, 24 h, and 30 min prior to training enhanced response 
learning 
 To determine if the lack of G1 modulation of place learning in Experiment 1 related to the time 
elapsed since treatment, a third administration of G1 was added to the protocol (Fig 5.1B). A prior 
report of spatial memory enhancement following G1 treatment used a continuous method of 
administration such that the compound was circulating during the learning experience (Hammond et al., 
2009). Thus, rats received an additional acute exposure of G1 to explore whether modulation of place 
learning depended on concurrent activation of GPER. To minimize the use of rats, only low G1 doses 
were administered in Experiment 2 according to treatment trends observed in Experiment 1, including 
the trend for improvement on the place learning task with 10 µg/kg G1 (p = 0.12, Fig 5.2A) and the non-
canonical enhancement of response learning at 3.3 µg/kg (Fig 5.2C). The highest doses of G1 were not 
included as our previous experiments demonstrated that inverted-U dose-response functions for place 
learning are shifted leftward compared to response learning (Ch. 2; Pisani et al., 2012).  
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 G1 treatment enhanced place learning when administered 48 h, 24 h, and 30 min before 
training. There was a main effect of treatment on trials to criterion (F[2,21] = 8.32, p < 0.005, Fig 5.3A), 
as rats treated with 10 µg/kg G1 needed significantly fewer trials to reach learning criterion (p < 0.005). 
For place learning acquisition, there was a main effect of G1 treatment on accuracy (F[2,189] = 7.39, p < 
0.005; Fig 5.3B), a main effect of trial block (F[9,189] = 60.80, p < 0.0001), and an interaction of 
treatment and trial block on percent correct across blocks (F[18,189] = 3.40, p < 0.0001). Thus, while all 
rats learned the place task, G1 treatment significantly altered the rate at which the task was acquired. 
The learning curve plots demonstrate the enhancement of place learning with 10 µg/kg G1, as these rats 
reached high levels of accuracy significantly faster than the vehicle and 3.3 µg/kg groups did.  
5.3.3 G1 uterine bioactivity 
 As expected, no dose of G1 in either treatment paradigm increased uterine horn wet weights 
(F[4,104] = 0.77, p > 0.55; with ranges from 12.68 ± 0.63 mg to 14.22 ± 0.84 mg) or altered the cytology 
of vaginal secretions evaluated through microscopic staging (data not shown).  
5.4 Discussion 
 The results of the present study suggest that activation of the membrane estrogen receptor 
GPER can lead to alterations in learning and memory that engage different neural structures. Low-dose 
G1 treatment led to a novel enhancement of the dorsal striatum-sensitive response task, while a high G1 
dose impaired response learning. G1 treatment had no significant effects on hippocampus-sensitive 
place learning when administered 48 and 24 h prior to training, but when an additional acute exposure 
was given 30 minutes before testing, rats demonstrated enhanced learning on the place task. Thus, 
activation of GPER alone, i.e. without the involvement of classical estrogen receptors, may be sufficient 
to shift learning strategies. However, the complexity of our findings also suggests that membrane 
estrogen receptors have nuanced roles in memory modulation according to the brain region engaged, 
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dose, and timing of exposure, as a non-canonical, bidirectional effect was observed for striatum-
sensitive learning while hippocampus-sensitive learning appeared to be temporally-sensitive.  
 GPER is a relatively new target in studying the roles of specific estrogen receptors in learning 
and memory, and a small number of other investigators have observed improvements in hippocampus-
sensitive tasks with G1 administration. Chronic G1 treatment significantly enhanced the acquisition of a 
delayed matching-to-position T-maze (Hammond et al., 2009). Furthermore, administering a GPER-
specific antagonist, G15 (Dennis et al., 2009), blocks the enhancing effects of estradiol for this task and 
impairs task acquisition in intact cycling rats, suggesting that GPER activation contributes to normal 
estrogenic modulation of spatial learning (Hammond et al., 2012). Additionally, the phytoestrogen 
genistein has an appreciable affinity for GPER, approximately 15% that of estradiol, and has been shown 
to enhance place learning (Ch. 2, Pisani et al., 2012). Forty-eight and 24 h of G1 treatment to OVX 
female rats also improved memory for the novel arm in a Y-maze task thought to be hippocampus 
sensitive (Hawley et al., 2014). Lastly, activation of GPER may contribute to rapid modulation of memory 
by estrogens, as G1 treatment given 40 min prior to testing improved object location memory in an 
inverted-U fashion (Gabor et al., 2011).  
 GPER is expressed in every cell layer of the hippocampus, diffusely in the plasma membrane 
with a higher density of receptors localized to the endoplasmic reticulum and Golgi apparatus (Brailoiu 
et al., 2007; Matsuda et al., 2008). Co-localization with discrete neurotransmitter systems has not been 
determined in the hippocampus, but ultrastructural analysis detects GPER expression in the pyramidal 
cell layers and interspersed interneurons, especially in the hilus, pointing to expression in cholinergic, 
glutamatergic, and GABAergic profiles (Waters et al., 2012). In the medial septum and nucleus basalis 
magnocellularis, the major sources of cholinergic afferents to the hippocampus, 80-95% of ChAT-
positive neurons express GPER, while the receptor is detected in 20% of GABAergic neurons in the 
medial septum, which is reciprocally connected to the hippocampus via long GABAergic projections 
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(Hammond et al., 2011). Interestingly, these neuronal populations also appear to play a critical role in 
mediating estradiol enhancements of hippocampus-sensitive cognition (Gibbs, 2002; McElroy and Korol, 
2005). Indeed, GPER seems to be closely affiliated with the basal forebrain cholinergic system, as G1 
treatment augments stimulated acetylcholine release in the hippocampus to the same magnitude as 
estradiol treatment (Hammond et al., 2011). Estradiol-induced potentiation of potassium-stimulated 
acetylcholine release is also blocked by G15 (Hammond and Gibbs, 2011). Increased cholinergic 
neurotransmission in the hippocampus is thought to be a critical mechanism by which estradiol 
enhances hippocampus-sensitive memory (Dohanich et al., 2009; Korol, 2004; Marriott and Korol, 2003; 
McElroy and Korol, 2005) and GPER activation likely contributes to this effect.  
 Despite GPER’s key position in the hippocampus and the spatial memory enhancements 
observed by others, treatment with G1 48 and 24 h before testing had no effect on place learning 
performance in the current study. Administering estradiol benzoate according to this same treatment 
schedule has previously shown place learning enhancements (Pisani et al., 2012; Zurkovsky et al., 2006; 
Korol and Kolo, 2002). However, there may be key differences between the pharmacokinetics of 
estradiol benzoate and G1:  24 and 48 h of estradiol benzoate results in elevated estradiol levels at the 
time of testing (Pisani et al., 2012; Korol and Kolo, 2002), whereas the metabolism of G1 is 
undetermined and  may be more rapid than that of estradiol. A classic theme in behavioral 
neuroendocrinology is the idea of hormone thresholds, levels that must be obtained in order to evoke 
certain behaviors or physiological responses (Davidson et al., 1968). Therefore, acute G1 treatment may 
be necessary to elevate circulating levels of the compound above the threshold concentration needed to 
exert cognitive effects. Other exogenous estrogenic agonists, such as PPT and DPN, are essentially 
cleared from circulation 24 h after a single injection (Sepehr et al., 2012). However, it is unknown 
whether repeated dosings results in cumulative serum effects as observed with genistein treatment (Ch. 
2, Fig 2.2E) and if prior treatment is indeed necessary to reach threshold levels.  
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We hypothesized that activation of GPER by circulating compounds that reach the brain during 
the time of training may be required for enhancement in hippocampus-sensitive cognition, as previous 
improvements in spatial task performance were observed with continuous (Hammond et al., 2009) or 
acute (Ervin et al., 2013; Gabor et al., 2011) G1 administration. Treatment with an additional G1 dose 30 
mins prior to place task testing did enhance learning, suggesting that activation of membrane estrogen 
receptors must occur just before or concurrently at the time of learning to enhance performance. This 
finding is supported by the intimate association of GPER with the basal forebrain cholinergic system 
outlined above, as previous studies demonstrate that estrogen receptor signaling and neural activity 
must be concomitant to induce potentiation of acetylcholine transmission (Gibbs, 2010; Marriott and 
Korol, 2003).  
 The temporal sensitivity of membrane estrogen receptor actions has been observed by others, 
with the direction of mnemonic effects dependent on timing.  For example, a rapidly-metabolized form 
of estradiol, estradiol cyclodextrin, enhanced spatial working memory on the radial arm maze when 
infused intrahippocampally 40 mins before testing (Sinopoli et al., 2006). However, memory was 
impaired 24 h after estradiol infusion when the hormone is likely cleared from the brain, suggesting 
membrane estrogen receptors exert different rapid and durable effects in the hippocampus. Studies in 
our own lab found that place learning was enhanced when estradiol sulfate was infused into the 
hippocampus 2 h prior to training, but 15 mins of treatment unexpectedly impaired learning (Scavuzzo 
et al., in preparation). Phosphorylation of CREB in the hippocampus, considered a key biochemical event 
in hippocampus-sensitive learning and memory processes (Countryman et al., 2005; Colombo, 2004; 
Colombo et al., 2003; Barco et al., 2003), matched observed behavioral results as pCREB levels were 
increased in the 2 h group but not in the 15 min group. Both time points are short enough to largely 
exclude the genomic-levels actions of estrogen receptors (Jensen and DeSombre, 1972; 
Katzenellenbogen, 1980) and instead point to temporal alterations in signaling mechanisms. Data 
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indicate that the mnemonic effects of GPER activation are very time-sensitive, as G1 treatment rapidly 
improves social transmission of food preference memory (within 45 min) following a brief conspecific 
interaction but impairs social learning with a longer demonstrator interaction (10 min) and period of 
food preference assessment (85 min) (Ervin et al., 2013). Together, these results demonstrate that non-
canonical, bidirectional learning effects are possible when targeting membrane estrogen receptors. 
Additionally, the mnemonic actions of membrane estrogen receptors appear to differ as a function of 
time, suggesting that the relative state of downstream signaling events influence cognitive outcomes of 
concurrent estrogen receptor activation. Such changes in signaling may underlie the time-sensitive 
nature of our place learning enhancements and will be further examined in future studies.  
 As discussed above, serum pharmacokinetics and intracellular cascades are both subject to 
speculation regarding the contributions of previous “priming” drug exposures versus acute actions. 
While several studies have found that acute estrogen treatments are sufficient to enhance learning, the 
durability of these membrane-initiated signaling actions, as well as their ability to alter the cellular 
response to later hormone exposure, are unclear.  Estradiol can act via non-genomic cascades to 
enhance CREB phosphorylation, increase dendritic spines, and potentiate a number of signaling 
molecules (Vasudevan and Pfaff, 2008), perhaps increasing neuronal plasticity such that the brain is 
primed for learning (Gold and Korol, 2010; Korol and Gold, 2007; Korol et al., 2013).  
Membrane-initiated estrogen signaling is sufficient to induce behavioral changes following 
priming by classical ER actions, as administration of membrane-limited estradiol (E2-BSA) following a 
pulse of non-conjugated estradiol induced lordosis (Kow and Pfaff, 2004). Additionally, the rapid effects 
of estrogens converge with genomic actions, as priming doses of E2-BSA initiate rapid signaling cascades 
that potentiate the transcriptional effects of later estrogen exposures (Vasudevan and Pfaff, 2008). 
While ERE-mediated transcriptional changes are not relevant here due to our specific activation of 
GPER, rapid estrogen signaling can also alter transcriptional machinery not associated with classical ERs 
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(Hammes and Levin, 2007). Interestingly, both membrane-mediated and later transcriptional actions 
appear to depend on increases in intracellular Ca2+ (Vasudevan et al., 2005), implicating a role for acute 
estrogen signaling even in slower genotropic actions. GPER may play a critical role in controlling Ca2+ 
levels considering its localization to the endoplasmic reticulum (Brailoiu et al., 2007). Further 
experiments of Ca2+ dynamics show that GPER undergoes significant rapid desensitization (Brailoiu et al., 
2007), a common characteristic of GPCRs, which suggests that acute activation of the receptor may be 
required for neuronal modulation. It remains to be determined if possible long-lasting priming effects 
exerted by previous G1 treatments are necessary for mnemonic modulation following rapid exposure or 
whether acute exposures of G1 alone would be sufficient to enhance place learning. 
 While relatively little is known regarding the actions of GPER in the hippocampus, even less is 
known about its role in the striatum, especially for striatum-sensitive cognitive tasks. Neither estradiol 
nor G15 had any effect on performance in an operant discrimination and reversal learning task, a 
paradigm that is largely cortical but also engages the striatum due to its stimulus-response components 
(Hammond et al., 2012). Estradiol treatment potently modulates the striatal dopaminergic system (see 
for discussion Ch. 4; Davis et al., 2005; Korol, 2004), changes that appear to interact with estrogenic 
treatment to impair response learning (Daniel et al., 2006; Quinlan et al., 2008). G1 treatment in male 
mice led to increased striatal dopamine turnover, similar to the effects produced by estradiol, which 
were also blocked by co-administration of G15 (Bourque et al., 2013).  While GPER-induced alterations 
in neurotransmission are similar to those seen with estradiol and may underlie weakened striatum-
sensitive learning, we also observed a novel enhancement of response task performance with low-dose 
G1 treatment. This effect goes against the canonical pattern of estrogenic memory modulation and may 
be due to the striatum’s distribution of GPER and unique circuitry.  
 GPER is highly expressed in the striatum (Brailoiu et al., 2007), especially by cholinergic neurons, 
as 99.5% of ChAT-positive neurons also label for GPER (Hammond et al., 2011). Less than 0.4% of 
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GABAergic and 2% of dopaminergic neurons in the striatum express GPER (Almey et al., 2012; Hammond 
et al., 2011). In contrast, extranuclear ERα appears to  be robustly expressed by GABAergic neurons in 
the dorsomedial striatum and, like GPER, also localizes to cholinergic neurons with relatively little 
expression in dopaminergic terminals (Almey et al., 2012). Therefore, estradiol-induced increases in 
striatal dopamine (Di Paolo, 1994) appear to be due at least in part to its actions at other cell types, such 
as cholinergic interneurons and GABAergic neurons, which modulate the release of neurotransmitter 
from dopaminergic terminals (Threlfell and Cragg, 2011). 
 Estradiol attenuates the release of GABA by acting directly on  medium spiny neurons in the 
striatum by inhibiting L-type Ca2+ currents, leading to increased dopamine release via a proposed decline 
in recurrent collateral inhibition on dopaminergic terminals (Becker, 1999; Hu et al., 2006; Mermelstein 
et al., 1996). Therefore, specific activation of GPER likely dissociates from the actions of general striatal 
estrogen signaling: G1 would not be expected to act directly on GABAergic neurons due to their relative 
lack of GPER expression. Additionally, the proportion of total GPER detected at dendrites in the 
dorsomedial striatum is greater than that for ERα and ERβ, suggesting that GPER exerts its effects via 
pre- and post-synaptic signaling (Almey et al., 2012). Treatment with low doses of G1 may thus lead to 
mild increases in dopamine via it actions at cholinergic interneurons (Hammond et al., 2011; Threlfell 
and Cragg, 2011) that actually enhance response learning without reaching the tonically high DA levels 
hypothesized to interfere with phasic bursting and contribute to estradiol-induced impairments in 
striatum-sensitive tasks (Davis et al., 2005). However, the effects of G1 treatment on response task 
performance were bidirectional, with impairments emerging at high doses. Higher doses of G1 may lead 
to detrimentally high levels of dopamine due to a shift in the firing patterns of cholinergic interneurons 
(Threlfell and Cragg, 2011) following increased GPER activation as the striatum begins to more closely 
resemble its estradiol-altered state. While the mechanisms of estrogen-induced physiological changes in 
the striatum are still being determined, it is clear that the contributions of GPER are distinct from the 
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actions of ERα and ERβ. Under normal estradiol signaling, all receptor subtypes act in concert and their 
specific actions are thus indistinguishable. However, because its distribution across neuronal types and 
structures differs from that of the classical ER subtypes, specific GPER agonism with G1 unmasked a 
novel pattern of striatum-dependent learning modulation.  
 Unlike our findings in the place task, modulation of response learning did not require additional 
acute G1 exposure.  Assuming that our treatment regimen produces equivalent levels of G1 in the 
hippocampus and striatum, these behavioral results suggest that GPER-mediated cognitive changes are 
induced by qualitatively different mechanisms according to the neural structure involved, with striatum 
effects appearing to be more durable than actions in the hippocampus. Such structural specificity has 
previously been found when targeting the mnemonic actions of membrane estrogen receptors, as 
different time- and dose-responses are observed when estradiol is infused into the cortex versus the 
hippocampus (Sinopoli et al., 2006). Additionally, whereas opposing effects on learning were seen for 2 
h vs. 15 min estradiol exposures in the hippocampus (Scavuzzo et al., in preparation), striatal estradiol 
infusion impaired response learning when administered 2 h before the task but had no effect when 
given 15 mins prior to training (Zurkovsky et al., 2011). The results of the present study are the first 
report of non-canonical estrogenic memory modulation for a striatum-sensitive task, patterns which 
have also been observed for tasks that tap the hippocampus (Ervin et al., 2013; Sinopoli et al., 2006; 
Scavuzzo et al., in preparation). Overall, these results indicate that like general estrogenic modulation, 
the nature of membrane estrogen receptor actions on learning and memory are specific to the brain 
structure engaged and further vary by timing and dose.  
5.5 Conclusion 
 In sum, selective activation of GPER is sufficient to produce shifts in memory performance 
associated with estrogen treatment, enhancing hippocampus-sensitive learning and impairing learning 
for tasks that tap the striatum. However, agonism of GPER also led to novel patterns of 
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neuromodulation in which low doses of G1 enhanced response learning while improvements in place 
learning required acute G1 treatment. Future studies investigating the cell signaling events associated 
with GPER activation will further elucidate the neuronal-levels changes that underlie these unique shifts 
in cognitive performance. 
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CHAPTER 6: MAPK SIGNALING FOLLOWING LEARNING AND ESTROGEN RECEPTOR ACTIVATION: 
VIEWING THE ROLE OF ERK THROUGH A MULTIPLE MEMORY SYSTEMS LENS 
6.1 Introduction 
 Estradiol levels modulate learning and memory according to the cognitive demands of a task 
and the neural structures engaged. Typically, the downstream effects of estradiol have been thought to 
occur through the transcriptional activities of classical, nuclear estrogen receptors. However, rapid 
effects of estrogen are observed throughout the brain, including changes in neuronal excitability, signal 
transduction, dendrite morphology, and even reproductive behavior, and are thought to occur via 
membrane-initiated cascades (Roepke et al., 2011; Woolley, 2007). Membrane-mediated estradiol 
signaling appears to contribute significantly to the mnemonic effects of estradiol, as place learning is 
enhanced and response learning impaired with two hours of hormone exposure (Scavuzzo et al., in 
preparation; Zurkovsky et al., 2011) while improvements in memory for the radial arm maze, contextual 
fear conditioning, object placement, and object recognition occur in as little as 40 mins following 
estradiol treatment (Phan et al., 2012; Barha et al., 2010; Sinopoli et al., 2006).  Thus, it appears that the 
distinction between rapid and slow signaling events fails to account for the task-specific effects of 
estrogens on cognition. Moreover, results from Chapters 4 and 5 suggest that improvements and 
impairments in learning can result from the activation of ERα, ERβ, or GPER alone, further 
demonstrating that simple dissociations based on receptor class do not account for the opposing actions 
of estrogens on learning strategies.  
Perhaps, then, the underlying mechanisms of estrogen-induced cognitive shifts will be better 
understood by determining the cellular signaling cascades involved in rapid estradiol actions.  One 
molecule of interest is extracellular signal-regulated kinase (ERK), a member of the MAPK cascade. In the 
brain, phosphorylated ERK or the downstream molecules it activates act on ion channels and 
neurotransmitter receptors to alter neuron excitability and lead to the activation of transcription factors 
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(such as CREB) and immediate early genes (Adams and Sweatt, 2002). Estradiol treatment induces rapid 
activation of ERK via phosphorylation in vitro (Mannella and Brinton, 2006; Wade and Dorsa, 2003; 
Wade et al., 2001; Kuroki et al., 2000)and in specific brain structures in vivo, such as the hippocampus 
(Marosi et al., 2012; Fan et al., 2010; Harburger et al., 2009; Lewis et al., 2008; Fernandez et al., 2008; 
Bulayeva et al., 2004; Bi et al., 2003). ERK also appears to play an important role in learning and 
memory. Acquisition of memory tasks proposed to tap the hippocampus, such as contextual fear 
conditioning, swim task, object recognition, and step-down inhibitory avoidance activates ERK in the 
hippocampus to levels 1.5- to 4-fold higher than baseline (Goeldner et al., 2008; Giovannini et al., 2005; 
Kelly et al., 2003; Gooney et al., 2002; Blum et al., 1999; Atkins et al., 1998). Furthermore, blocking ERK 
phosphorylation by inhibiting its upstream kinase, MEK, results in memory impairments for these same 
tasks (Kelly et al., 2003; Selcher et al., 1999; Blum et al., 1999; Atkins et al., 1998).  
 Given that ERK is activated by estrogen signaling and contributes significantly to memory, it may 
also play a role in estradiol-induced shifts in learning and memory. Indeed, blockade of ERK signaling via 
MEK inhibition eliminates estradiol-induced memory for inhibitory avoidance (Walf and Frye, 2008) and 
object recognition (Fan et al., 2010; Fernandez et al., 2008). Thus, ERK activation is likely one critical 
pathway by which estradiol improves memory for tasks that engage the hippocampus. However, ERK 
activation is usually measured apart from memory task performance, with very few studies examining 
the independent and interactive effects of both estrogenic treatments and training on pERK levels. 
Additionally, the sensitivity of ERK to estrogen signaling in other memory systems, such as the striatum, 
and its role in estradiol-induced memory impairments, are unknown. Given the opposing effects of 
estrogens on hippocampus- and striatum-dependent cognitive processes, ERK activation may also 
increase or decrease in these distinct memory systems and thus provide a molecular correlate or 
learning modulation. Also largely undetermined are the in vivo ERK responses to compounds with 
selective affinity for certain estrogen receptor subtypes, such as phytoestrogens or selective agonists. 
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Studying the activation of ERK will help determine if estrogen receptor subtypes (ERα, ERβ, GPER) act 
through similar or distinct molecular mechanisms of neuromodulation.   
 The present study used quantitative Western blotting to examine changes in ERK activation in 
the hippocampi and striata of rats trained on the place or response learning task with or without 
estrogenic treatments. Brain samples from behaviorally-naïve rats were available in a subset of 
experiment to assess the possible activating effects of treatment alone. Simple increases and decreases 
in ERK phosphorylation that followed facilitation and impairment, respectively, were not observed. 
Instead a more complex set of findings emerged: in several instances relative ERK activation between 
neural systems corresponded to learning ability and effective drug dose. Specifically, rats that learned 
quickly tended to have lower levels of ERK activation in the hippocampus, a finding we hypothesize to 
represent a shift to habit or procedural memory over the course of training and thus a shift away from 
hippocampus involvement. These shifts in the activation of ERK also appeared to depend on ERβ 
signaling, as similar patterns were not observed in rats treated with compounds selective for ERα or 
GPER. Together, these results suggest a dynamic temporal relationship between neural system 
activation in different types of learning that is further modified by ERβ activity.  
6.2 Materials and Methods  
6.2.1 Tissue preparation 
Hippocampi (HC) and striata (Str) were previously obtained from ovariectomized (OVX) rats 
treated with estrogenic compounds (estradiol benzoate, genistein, equol, PPT, DPN, or G1) or vehicle 
(sesame oil, sucrose, or sesame oil +0.88% ethanol, as appropriate) and trained on a place or response 
learning task (Ch. 2-5). Immediately following behavioral testing, rats were anesthetized with sodium 
pentobarbital (75 mg/kg, i.p.) and decapitated. In a subset of experiments, tissue was also collected 
from a separate group of behaviorally naïve rats to assess the effects of treatment alone (young adult 
rats treated with genistein or veh, Ch. 2; middle-aged rats treated with estradiol, equol, or veh, Ch. 3). 
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Naïve rats were killed at the time behavioral training would have begun. Brains were removed and the 
hippocampi and striata isolated via blunt dissection. Brain regions were flash frozen on dry ice and 
stored at -80°C until homogenization. All animal procedures were approved by the University of Illinois 
Institutional Animal Care and Use Committee and adhered to institutional and federal guidelines for the 
use of animals in research.  
All subsequent tissue preparation steps were carried out with ice-cold reagents and tools, and 
care was taken to keep samples as cold as possible during processing. Each brain sample was 
mechanically homogenized in 800 μL Tissue Protein Extraction Reagent (T-PER; Thermo Scientific, 
Rockford, IL) plus protease inhibitors (cOmplete Mini tablets, Roche, Indianapolis, IN) and phosphatase 
inhibitors (Cocktail Set I, Calbiochem, La Jolla, CA) using either a dry-ice chilled ceramic mortar and 
pestle or a PolytronTM electric homogenizer (Kinematica, Bohemia, NY). Homogenates were centrifuged 
at 9280 X g for 5 min at 4°C and the supernatant collected and stored at -80°C. A small amount of 
supernatant was used to measure total protein content using a bicinchoninic acid protein assay 
(PierceTM BCA Protein Assay Kit, Thermo Scientific). Western blot samples were normalized to 2 µg/µL 
total protein with T-PER plus protease and phosophatase inhibitors then diluted 1:1 in 2x Protein 
Loading Buffer (LI-COR Biosciences, Lincoln, NE) with 10% β-mercaptoethanol for a final concentration of 
1 µg/µL protein and 5% β-mercaptoethanol. Pooled hippocampal and striatal homogenates were 
created for each pharmacologic treatment by collecting ~10 μL from each prepared sample within a 
given study to serve as intra-blot standards. Samples were boiled for 10 min and stored at -80°C until 
Western blot analysis. 
6.2.2 Western blot  
Samples from each brain region were run separately. To create a standard curve, pooled HC or 
Str homogenates (10, 20, and 30 µg total protein) were loaded on each gel along with individual 
samples. HC or Str sample homogenates (20 µg) were resolved by electrophoresis on 10% SDS-
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polyacrylamide gels then transferred to PVDF membranes (Immobilon-FL, Millipore, Billerica, MA). 
Protein transfer was visualized using Ponceau S reversible stain (Sigma-Aldrich, St. Louis, MO) and the 
membrane cut in half at approximately 50 kDa. Membranes were washed in 0.05M PBS until the stain 
was removed then blocked for 1 h with Odyssey Blocking Buffer (LI-COR Biosciences). Lower membrane 
sections were incubated with mouse anti-ERK1/2 (1:7000; #9107, Cell Signaling Technology, Danvers, 
MA)  and rabbit anti-pERK1/2 (1:1000; #4307, Cell Signaling Technology) while upper membrane 
sections were probed for the loading control with mouse anti-α-tubulin (1:25,000; T9026, Sigma-Aldrich) 
overnight at 4°C. Brain samples from G1-treated, response-trained rats were accidentally contaminated 
with ethanol and salt build-up from the homogenizer, leading to a loss of tubulin solubility (Black et al., 
1984; Emerson and Holtzer, 1967). Soluble cytoplasmic proteins, including ERK, were not adversely 
affected, so Cyclophilin A was instead used as a loading control in these samples (mouse α-Cyclophilin A, 
1:1000; ab58144, Abcam, Cambridge, MA). Following primary antibody incubation, membranes were 
washed four times for 10 min each in 0.05M PBS, 0.1% Tween 20 then incubated with secondary 
antisera for 1 hr at room temperature. Upper membrane sections were incubated with IRDye 680 Goat 
anti-Mouse (1:20,000; LI-COR Biosciences) and lower portions probed with IRDye 680 Goat anti-Mouse 
(1:8000) and IRDye 800CW Goat anti-Rabbit (1:1500; LI-COR Biosciences). Membrane strips probed for 
Cyclophilin A were incubated with IRDye 680 Goat anti-Mouse (1:1000). Membranes were again washed 
with 0.05M PBS, 0.1% Tween 20 four times for 10 min, followed by brief final rinses in PBS then ddH2O. 
Blots were allowed to dry, corresponding membrane halves were fit together, and bands visualized 
using the Odyssey Classic Infrared Imaging System (LI-COR Biosciences).  
6.2.3 Image analysis 
 Western images were analyzed using Odyssey software (LI-COR Biosciences). Each band was 
manually defined and integrated intensity, a measure of the band intensity multiplied by its area, with 
automatic background correction was calculated by the software. Relative amounts of ERK1, ERK2, 
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pERK1, and pERK2 were determined via linear regression from the standards included on each blot (Fig 
6.1B). Values were normalized by dividing by the integrated intensity of each intra-lane loading control 
band for either α-tubulin or Cyclophilin A. ERK activation was calculated by taking normalized phospho-
ERK/normalized total ERK. A reference value was created for each target protein by using the standard 
curves to calculate the integrated intensity for 20 μg tissue. The same linear regression and 
normalization steps were then applied to yield an idealized 20 μg reference value. Lastly, normalized 
sample values were expressed as percentage of the reference value for each protein. Computational 
analyses applied to raw blot data were adapted from Taylor and Posch (2014) and the Odyssey User 
Guide (version 2.1, LI-COR Biosciences) and are demonstrated in Table 6.1.  
6.2.4 Statistical analyses  
Only data for ERK2 were statistically analyzed, as ERK2 is the isoform implicated as critical for 
learning and responsive to estrogenic treatment, whereas ERK1 is not (Fernandez et al., 2008; Satoh et 
al., 2007; Selcher et al., 2001). One-way analyses of variance (ANOVA) were individually conducted for 
hippocampus and striatum samples for each task, followed by post hoc Fisher PLSD paired comparisons. 
To assess relative activation between memory systems in trained rats, HC to Str ERK activation ratios 
(HC: Str) were calculated. Larger ratio values would indicate greater HC activation relative to the Str, 
while smaller values indicate greater relative Str activation. HC: Str ratios were analyzed by one-way 
ANOVA with post hoc Fisher PLSD tests. For genistein experiments in which only two groups were 
compared, HC to Str ERK activation ratios were assessed via unpaired t-tests. In experiments that 
included samples from behaviorally naïve rats (i.e. genistein and middle-age estradiol/equol blots), two-
way ANOVAs were conducted to assess the effects of training experience and treatment, followed by 
post hoc Fisher PLSD paired comparisons. To determine if the HC: Str ERK activation ratios of individual 
rats correlated to task acquisition, simple linear regression analyses were performed using trials to 
criterion as the independent variable and the ratio of HC to Str ERK activation as the dependent variable. 
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All statistics were run with an alpha of 0.05. Tests with results in which p > 0.05 but p ≤ 0.12 were 
reported as trends. 
6.3 Results  
Experiments including behaviorally-naïve rats demonstrated that training experience 
significantly activated ERK in both the hippocampus and striatum approximately 2-fold. Across all blots, 
ERK phosphorylation did not simply increase or decrease as a function of treatment.  However, in 
several experiments ERK activation was altered at treatment doses that also modulated learning. No 
significant correlations were found between the ratio of HC: Str ERK activation and trials to criterion 
score in individual rats except in genistein experiments, as described below.   
6.3.1 ERK activation following estradiol benzoate treatment and training 
 Prior behavioral experiments showed that 4.5 μg/kg of estradiol benzoate enhanced place 
learning  (Ch. 2, Fig 2.3) in rats whose brain samples were analyzed here (Fig 6.2A-C). Treatment with a 
low (4.5 μg/kg) or high (45 μg/kg) dose of estradiol had no effect on total ERK protein in either the 
hippocampus (Fig 6.2A; F[2,30] = 1.75, p = 0.20) or striatum (F[2,30] = 0.43, p =0.96). Estradiol treatment 
also did not significantly change levels of ERK activation in each neural structure (Fig 6.2B; HC: F[2,30] = 
1.50, p = 0.24; Str: F[2,30] = 1.00, p = 0.38), although there was a non-significant pERK reduction in the 
HC of rats receiving 4.5 μg/kg estradiol compared to those receiving vehicle (p = 0.13). However, 
differences in ERK activation between treatment groups were observed in examining HC to Str ratios (Fig 
6.2C), as there was a main effect of treatment (F[2,30] = 3.26, p < 0.05) with the 4.5 μg/kg estradiol 
group having significantly lower HC: Str ratios than the vehicle group had (p < 0.04).  
 Treatment with estradiol benzoate was previously found to impair response learning at both low 
and high doses (Ch. 2, Fig 2.4). As in place-trained rats, estradiol treatment did not affect total ERK levels 
in the HC (Fig 6.2D; F[2,20] = 0.28, p = 0.76) or Str (F[2,20] = 0.14, p = 0.87) of response-trained rats. 
There was a main effect of estradiol treatment on ERK activation in the HC (Fig 6.2E; F[2,20] = 5.55, p < 
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0.02) as rats treated with 45 μg/kg estradiol had significantly reduced pERK/ERK levels compared to 
those treated with vehicle (p < 0.004). Treatment effects were not observed in the striatum (F[2,20] = 
0.65, p = 0.53). There were also no differences in HC: Str ERK activation ratios (Fig 6.2F; F[2,20] = 0.76, p 
= 0.48).  
6.3.2 ERK activation in naïve and place-trained middle-aged rats receiving estradiol or equol 
 Previously conducted behavioral experiments found that 4.5 μg/kg of estradiol benzoate 
improved place learning in middle-aged, ovariectomized rats while the isoflavone metabolite equol did 
not (Ch. 3, Fig 3.3). Hippocampi and striata were also collected from behaviorally-naïve OVX rats to 
assess the effects of training and treatment alone. Training significantly increased total ERK levels in the 
HC (Fig 6.3A; F[1,35] = 9.88, p < 0.004) while there was no effect of treatment (F[2,35] = 1.64, p = 0.21) 
nor an interaction between treatment and training (F[2,35] = 0.271, p = 0.76). Treatment and training 
had no effects on total ERK protein in the striatum (all p > 0.72).   
For ERK activation in the hippocampus (Fig 6.3B), pERK/ERK levels were elevated with training 
but the magnitude of increase varied by treatment. This was observed as a main effect of training 
(F[1,35] = 24.27, p < 0.0001), a nearly-significant main treatment trend (F[2,35] = 3.11, p = 0.057), a 
significant interaction of treatment and training (F[2,35] = 3.39, p < 0.045). Post hoc tests for individual 
treatments showed that estradiol (p < 0.012) but not equol (p = 0.16) significantly differed from vehicle 
across training conditions. Within training conditions, only the estradiol-treated, place-trained rats 
significantly differed from vehicle (p < 0.05), demonstrating a 55% decrease in ERK activation. Str ERK 
activation was significantly increased by training (F[1,35] = 43.57, p < 0.0001) with a main treatment 
trend (F[2,35] = 2.67, p = 0.08) but no interaction of treatment and training (F[2,35] = 0.33, p = 0.72). 
Post hoc analyses showed that there was a significant effect of treatment for equol-treated rats (p < 
0.03) but not estradiol-treated rats (p = 0.15) across training conditions. Within training conditions, 
individual treatments were not significantly different from vehicle (all p > 0.12). For HC: Str ERK 
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activation ratios (Fig 6.3C), there was a main effect of treatment (F[2,19] = 5.37, p < 0.015) with both 
equol (p < 0.02) and estradiol (p < 0.006) groups having lower ratios than the vehicle group had.  
6.3.3 ERK activation in naïve and place- or response- trained rats treated with genistein 
 Prior behavioral studies found that place learning in young adult OVX rats was enhanced by 
genistein treatment (Ch. 2, Fig 2.3). At the time of testing, brain samples were also collected from 
behaviorally naïve rats that received identical genistein dosing (Ch. 2, Fig 2.1B). Neither treatment 
(F[1,21] = 0.055, p = 0.82) nor training (F[1,21] = 0.132, p = 0.72) significantly affected HC total ERK 
protein (Fig 6.4A). Str levels of total ERK were significantly decreased by place training (F[1,21] = 4.64, p 
< 0.045) but there was no main effect of treatment (F[1,21] = 0.012, p = 0.91) nor interaction of 
treatment and training (F[1,21] = 0.023, p = 0.88). Place training significantly increased ERK activation 
(Fig 6.4B) in both the HC (F[1,21] = 6.21, p < 0.02) and Str (F[1,21] = 16.18, p < 0.0005), with no effects of 
treatment or treatment and training interactions (all p > 0.50). HC: Str ERK activation ratios did not differ 
according to sucrose or genistein treatment (Fig 6.4C; F[1,14] = 0.11, p = 0.74).  
 Genistein treatment also impairs response learning in young adult OVX rats, mimicking the 
modulatory actions of estradiol (Ch. 2, Fig 2.4). Total ERK protein in the HC was not altered by treatment 
(Fig 6.4D; F[1,23] = 0.022, p = 0.88) but there was a trend towards increased ERK levels with training 
(F[1,23] = 3.15, p = 0.09). There was no interaction between treatment and training (F[1,23] = 0.001, p = 
0.98). Str total ERK was elevated by response training (F[1,23] = 12.85, p < 0.002) but there was neither 
an effect of treatment nor interaction between training and treatment (both p > 0.45).  Response 
training greatly increased ERK activation levels in the HC (F[1,23] = 7.19, p < 0.015) and Str (F[1,23] = 
9.24, p < 0.006; Fig 6.4E). Treatment did not affect ERK activation in either structure and there were no 
treatment and training interactions (all p > 0.50).  Genistein treatment also had no effect on HC: Str ERK 
activation ratios (Fig 6.4F; F[1,16] < 0.0001, p = 0.99).  
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 Because no changes in ERK activation by treatment group were found with genistein 
administration despite robust behavioral effects, ERK phosphorylation was examined in the context of 
individual rat maze performance. The ratio of relative HC: Str activation, as measured by acetylcholine 
release, has previously been shown to correlate with the performance of place or response strategies 
(Chang and Gold, 2003; McIntyre et al., 2003). Therefore, we chose to compare the HC: Str ERK 
activation ratio of each rat to its trials to criterion score on the place or response task (Fig 6.5). Across 
both tasks, genistein-treated rats that learned the fastest (lowest trials to criterion scores) had smaller 
HC: Str ratios immediately after training, with ERK activation ratios increasing as criterion was met later 
in training.  This translates into a positive correlation between HC: Str ERK activation with trials to reach 
criterion (low = fast learning, high = slow learning) in rats that received genistein (Fig 6.5A; F[1,7] = 9.04, 
p < 0.03) but not sucrose control (F[1,7] =0.075, p = 0.79). Relative HC:Str ERK activation also correlated 
positively with trials to criterion performance of the response task (Fig 6.5B) for genistein-treated rats 
(F[1,8] = 11.46, p < 0.012) while there was a correlation trend for sucrose-treated rats (F[1,8] = 4.10, p = 
0.08).  The slopes for the regressions were similar in each task across fast learners (genistein-treated 
rats in the place task, m = 0.29, and sucrose-treated rats in the response task, m = 0.44) and across slow 
learners (sucrose-treated rats in the place task, m = -0.003, and genistein-treated rats in the response 
task, m = 0.009).  
6.3.4 ERK activation following DPN treatment and training 
 Treatment with the ERβ-selective compound DPN was previously found to improve place 
learning at doses of 100, 333, and 1000 μg/kg (Ch. 4, Fig 4.3A and C). In the hippocampi and striata of 
trained rats, DPN treatment had no effect on total ERK levels (Fig 6.6A; HC: F[4,39] = 1.13, p = 0.36; Str: 
F[4,39] = 0.41, p = 0.80). There was no main effect of treatment on ERK activation in the HC (Fig 6.6B; 
F[4,39] = 1.32, p = 0.28) though there appeared to be a dose-dependent decrease in ERK activation with 
DPN treatment. Post hoc paired comparisons show that levels in the 1000 μg/kg group were significantly 
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reduced compared to rats treated with vehicle (p < 0.04). Str ERK activation was not significantly 
affected by DPN treatment (Fig 6.6B; F[4,39] = 0.40, p = 0.81). There were also no effects of DPN 
treatment on HC: Str ERK activation ratios in place-trained rats (Fig 6.6C; F[4,39] = 0.44, p = 0.78).  
 In prior behavioral experiments, 333 and 1000 μg/kg DPN impaired response learning (Ch. 4, Fig 
4.3B and D). DPN treatment did not alter total ERK protein in the HC and Str of trained rats (Fig 6.6D; HC: 
F[4,40] = 0.38, p = 0.82; Str: F[4,39] = 0.66, p = 0.62). There was a main effect of treatment on HC ERK 
activation (Fig 6.6E, F[4,40] = 3.10, p < 0.03) driven by significantly increased pERK in the group treated 
with 333 μg/kg DPN (p < 0.006 vs. vehicle).  There were no treatment-dependent changes in Str ERK 
activation (F[4,39] = 1.26, p = 0.30). However, DPN treatment had a main effect on HC: Str ratios of ERK 
activation (Fig 6.6F; F[4,39] = 3.71, p < 0.012) with 333 μg/kg-treated rats having significantly increased 
ratios compared to vehicle controls (p < 0.003).  
6.3.5 ERK activation in rats treated with PPT and trained on the place or response task 
  Place learning in OVX young adult rats was enhanced by treatment with 333 μg/kg of ERα-
selective PPT (Ch. 4, Fig 4.2A and C). There was no effect of PPT on total ERK protein in the HC (Fig 6.7A; 
F[4,38] = 0.28, p = 0.89). PPT also had no main effect on Str ERK levels (F[4,38] = 1.32, p = 0.28) but a 
priori planned comparisons show that total ERK was significantly elevated from vehicle in rats treated 
with 100 μg/kg (p < 0.05). There were no significant effects of treatment on ERK activation (Fig 6.7B) in 
the HC (F[4,38] = 0.56, p = 0.69) or Str (F[4,38] = 0.50, p = 0.74). Accordingly, there were also no 
differences in HC: Str ERK activation ratios (Fig 6.7C) according to treatment (F[4,38] = 0.48, p = 0.75).  
 PPT impaired response learning at doses of 333 μg/kg and 1000 μg/kg in previously conducted 
behavioral experiments (Ch. 4, Fig 4.2B and D). Despite these results, there were no treatment effects of 
PPT on any ERK measure in the HC and Str of response-trained rats (Fig 6.7D-F; all p > 0.25).  
6.3.6 ERK activation following G1 treatment and place or response training 
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 G1 treatment enhanced place learning in OVX young adult rats at a dose of 10 μg/kg when 
administered 48 h, 24 h, and 30 min prior to behavioral testing (Ch. 5, Fig 5.3). There were no effects of 
G1 treatment in either brain region for total ERK levels (Fig 6.8A, both p > 0.79), ERK activation (Fig 6.8B, 
all p > 0.55), and HC: Str ERK activation ratio (Fig 6.8C, p > 0.90).  
 G1 had opposing effects on response learning, enhancing response task performance at 3.3 
μg/kg but impairing learning at 100 μg/kg when injected 48 and 24 h before testing (Ch. 5, Fig 5.2B and 
D). Total ERK protein (Fig 6.8D) was not changed with any dose of G1 in the HC (F[4,38] = 0.29, p = 0.88) 
but there was a non-significant main treatment trend in the Str (F[4,38] = 2.36, p = 0.07). There were no 
significant effects of G1 treatment on HC ERK activation (Fig 6.8E; F[4,38] = 0.63, p = 0.65). In the Str, 
there was a main trend of treatment on ERK activation (F[4,38] = 1.97, p = 0.12) and the group treated 
with 33 μg/kg G1 had significantly elevated levels compared to vehicle (p < 0.05). G1 treatment did not 
significantly affect HC: Str ERK activation ratios at any dose (Fig 6.8F; F[4,38] = 0.38, p = 0.82).  
6.4 Discussion 
 In the current study, quantitative Western blot analysis was used to measure ERK activation in 
the hippocampi and striata of rats trained on the place or response learning task with or without a 
variety of estrogenic treatments. Straightforward activation or attenuation of ERK was not observed, nor 
did pERK levels align with the magnitude and direction of shifts in place or response learning. Rather, 
there appear to be complex interactions between relative neural system activation, as measured by ERK 
phosphorylation, during the training experience that are also influenced by ERβ signaling. These results 
suggest that ERK activation corresponds to shifts in cognitive strategies and point to a dynamic temporal 
association, rather than a strictly competitive or independent relationship, between neural systems in 
the acquisition and performance of different types of learning. 
6.4.1 Estrogenic treatment alone did not activate ERK: contributions of time-sensitive signaling 
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 Notably missing from our findings in behaviorally naïve rats are any treatment-only effects of 
estradiol, genistein, or equol. Others have shown that systemic estradiol treatment to OVX mice 
increases ERK phosphorylation in the hippocampus by 30-50% (Fernandez et al., 2008; Harburger et al., 
2009; Lewis et al., 2008). However, all of these studies assessed ERK activation within 1 hr of injection 
whereas our rats were killed 24 h after the last estradiol injection or 30 min following oral 
genistein/equol treatment (Ch. 2, Fig 2.1A and B). While our time point was chosen to have a “molecular 
snapshot” of neural system ERK activation just prior to learning, it was not optimal in regards to ERK 
phosphorylation kinetics. Estrogen-induced ERK activation is extremely time-sensitive. Although 
observed maxima and decay vary by experiment, they are very rapid: pERK levels can be significantly 
elevated within 5 mins and return to baseline 15-60 min after treatment (Bulayeva et al., 2004; Kuroki et 
al., 2000; Mannella and Brinton, 2006; Srivastava et al., 2010; Wade and Dorsa, 2003). In vitro studies of 
MAPK phosphorylation dynamics determined the half-life of pERK2 to be a mere 55 seconds (Fujioka et 
al., 2006). Therefore, we likely missed the ideal window for assessment of treatment-induced ERK 
activation, collecting brains far too long after estradiol injections and too early following isoflavone 
consumption (serum levels become elevated 30 min after oral dosing). Extensive time course 
experiments would need to be conducted to accurately assess the effects of estrogenic treatment on HC 
and Str ERK activation.  Notably, estrogen-induced activation of CREB, a downstream target of ERK and 
transcription factor that appears to play a critical role in learning (Colombo, 2004), is also very 
temporally-sensitive: in the presence of estradiol, phosphorylation of CREB in cultured hippocampal 
neurons increases over 1-12 h of treatment, falls but remains above baseline at 24 h, and is attenuated 
below baseline levels at 48 h (Lee et al., 2004). The transient nature of ERK phosphorylation makes its 
critical role in learning and estrogen-induced memory enhancement all the more remarkable. However, 
even fleeting ERK activation serves as a coincidence detector capable of activating transcription factors, 
including CREB and immediate early genes, and shaping activity-dependent plasticity through changes in 
143 
 
dendrite morphology and function (Sweatt, 2001; Wu et al., 2001). In this way, increases or decreases in 
the function of cellular substrates will likely influence the future plasticity of specific memory systems, 
preparing and altering them for forthcoming learning experiences and thus acting as metamodulators 
(Korol and Gold, 2007; Sellers et al., 2014).  
6.4.2 Training-induced ERK activation and multiple memory system considerations 
Consistent with previous findings, training experience alone activated ERK approximately two-
fold from baseline levels in naïve rats. Specifically, learning significantly elevated ERK activation in both 
the hippocampi and striata of rats trained on either the place or response task. ERK activation occurred 
regardless of estrogenic treatment status (vehicle, estradiol, genistein, or equol) or subject age (young 
adult or middle-aged). Hippocampal pERK levels are known to increase 1.5- to 4-fold following training 
on tasks that tap the hippocampus, including inhibitory avoidance, contextual fear conditioning, object 
recognition, and the swim task (Atkins et al., 1998; Blum et al., 1999; Giovannini et al., 2005; Goeldner et 
al., 2008; Gooney et al., 2002; Kelly et al., 2003). However, these studies failed to examine the ERK 
response in other brain memory systems such as the striatum. In our results, ERK was activated in the 
hippocampus and striatum across both training paradigms, even though place and response learning are 
thought to rely on the hippocampus and striatum, respectively (Packard and McGaugh, 1996). However, 
in the presence of structurally and functionally intact neural systems, there appears to be a great deal of 
overlapping activation despite the performance of a hippocampus- or striatum-“dependent” cognitive 
task (Retailleau et al., 2012). Cholinergic neurotransmission and extracellular lactate increase in both the 
hippocampus and striatum during maze training, even when the rat is learning a task thought to 
specifically engage the opposing structure (Gold et al., 2013; Pych et al., 2005). Experiments in which 
recording electrodes were implanted in the hippocampus and striatum then rats trained on place or 
response task reveal that neuronal units in each structure respond to spatial and egocentric information 
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continuously, suggesting a great deal of parallel processing across neural systems regardless of cognitive 
demands (Mizumori et al., 2004).  
 While both the hippocampus and striatum may be active during maze learning tasks, the relative 
dominance of each structure appears to change over task acquisition. The current theory holds that 
striatal processing becomes increasingly important with extensive training. After multiple testing trials 
on a dual-solution T maze, rats shift from place to response strategies (Packard and McGaugh, 1996). In 
middle-aged female rats,   striatal lesions can disrupt the use of place strategies at asymptotic 
performance, with lesion size corresponding to the extent of place learning disruption (Jacobson et al., 
2012). Even within a single-day training session on the dual-solution T maze, rats shift to the use of 
response strategies later in the training period, corresponding to increases in striatum acetylcholine 
(Chang and Gold, 2003). In contrast, the hippocampus and other memory systems are engaged early in 
learning as conditional and contextual information are processed, with the striatum and other basal 
ganglia structures becoming more engaged as the task becomes habitual in nature (Graybiel, 2008). 
Indeed, the hippocampus appears to play a crucial role in task acquisition regardless of cognitive 
demands as neural activity tunes to context and expectation (Mizumori et al., 2004).  
6.4.3 Relative hippocampal to striatal ERK activation negatively correlates to learning speed  
This shift in the influence of multiple memory systems over learning is critical to interpreting our 
current ERK activation results in regards to previous training experience. Over several estrogenic 
treatments and both place and response tasks, rats that learned the fastest had relatively lower 
hippocampus ERK activation. In contrast, rats that reached learning criterion later in the training 
experience tended to have higher levels of HC pERK. Examination of learning curves from behavioral 
experiments (Fig 2.3C-D, Fig 2.4C-D, Fig 3.3B, Fig 4.2C-D, Fig 4.3C-D, Fig 5.2D, Fig 5.3B) shows that the 
fastest-learning groups reach asymptotic performance early in training and continue to perform the task 
with high accuracy for up to 40-60 trials. We hypothesize that rats that quickly acquire the place and 
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response task are over-trained and begin to adopt habit or procedural strategies, resulting in lower ERK 
activation in the HC relative to the striatum.  
Rats treated with 4.5 μg/kg estradiol had significantly reduced HC: Str ERK activation ratios, 
corresponding to enhancement of place learning with low but not high (45 μg/kg) estradiol treatment 
(Fig 6.2C). A similar pattern was observed in middle-aged rats treated with estradiol or equol and 
trained on the place task (Fig 6.3). Place learning was significantly improved only in estradiol-treated rats 
and this group also had significantly reduced pERK levels in the HC and decreased HC: Str ERK activation 
ratios. Equol-treated rats had intermediate levels of activated ERK in regard to groups treated with 
vehicle or estradiol, which parallels the equol group’s intermediate acquisition of the place task. In 
genistein-treated rats, neural system ERK activation corresponded to learning when examined on the 
level of individual maze performance (Fig 6.4). In both the place and response tasks, there were 
significant correlations between HC: Str ERK activation ratios and trials to criterion in rats treated with 
genistein, with the fastest learners having the lowest HC: Str pERK ratios. Results from DPN-treated rats 
continue this trend (Fig 6.5). Treatment with 1000 μg/kg DPN enhanced place learning, and rats from 
this group also had significantly lower levels of HC ERK activation as compared to vehicle. In contrast, 
rats trained on the response task and treated with 333 μg/kg DPN had significantly increased pERK in 
the HC. This group also demonstrated impaired response learning, and the high HC activation may be 
due to continued contextual processing (Mizumori et al., 2004) or perseverance to use a place strategy 
(Chang and Gold, 2003; McIntyre et al., 2003) as rats struggled to acquire response strategies. Together 
with previous behavioral findings, these Western data fit within the framework of a dynamic multiple 
memory system hierarchy.  
Supporting the current results are findings from many other investigators pointing to brain-
structure specific changes in a variety of molecular substrates based on cognitive experience, such as 
pCREB (Countryman et al., 2005), products of immediate early genes such as  c-Fos and c-Jun 
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(Countryman et al., 2005; Pleil et al., 2011; Smith et al., 2007; Teather et al., 2005), trophic factors such 
as BDNF (Korol et al., 2013), and metabolic substrates including glucose, glycogen, and lactate (Gold et 
al., 2013). Training in a dual-solution maze where rats could choose either place or response strategy 
significantly elevated pCREB and c-Fos in both the HC and Str immediately after training regardless of 
strategy. However, when examined one hour later, pCREB levels only remained significantly high in the 
canonical structure according to the strategy used (Colombo et al., 2003). Moreover, explicit place and 
response training in single-solution tasks led to structure- and experience-specific changes in c-Fos, with 
response-trained rats having high Str c-Fos levels that also correlated with the number of trials to 
criterion (Gill et al., 2007). These increases were observed 30 but not 90 min after criterion was reached, 
emphasizing the caveats of over-training and collection timing in the current study.  
Our speculation that decreased HC ERK activation in fast learners reflects a shift to striatal habit 
strategies is further supported by reports in which HC: Str ratios of acetylocholine release correlated to 
strategy use on a dual-solution maze. Rats performing place strategies had significantly higher HC: Str 
ratios of extracellular acetylcholine than rats using response strategies (McIntyre et al., 2003). Although 
no differences in brain ERK activation among behaviorally-naïve rats were observed here, previous 
studies from our lab found that baseline ratios of HC: Str acetylcholine release also predicted the use of 
place or response strategies. Thus, rats may be primed to preferentially use learning strategies 
according to the pre-existing molecular substrates in the HC or Str (Chang and Gold, 2003; McIntyre et 
al., 2003).  
6.4.4 Learning-associated patterns of ERK phosphorylation were observed with treatments targeting ERβ 
but not with compounds selective for ERα or GPER 
 Another conclusion drawn from the current results is that modulation of ERK through learning 
occurred only in rats treated with compounds capable of substantially activating ERβ: estradiol, 
genistein, equol, or DPN. No task-related changes in HC and Str ERK activation were found in rats 
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treated with ERα-selective PPT (Fig 6.7) or the GPER specific agonist G1 (Fig 6.8) despite significant 
modulation of place and response learning. While 33 μg/kg G1 did increase ERK activation in the Str of 
response-trained rats, it is unlikely that increase resulted from a shift to habit-based behavior as this 
dose did not significantly alter response learning. ERα, ERβ, and GPER are all capable of activating rapid 
MAPK signaling cascades (Abraham et al., 2004; Prossnitz and Barton, 2009; Wade and Dorsa, 2003) but 
show distinct response kinetics. ERα-induced ERK activation is rapid and transient, returning to near 
baseline levels 1 h after stimulation. However, increases in pERK via ERβ signaling are more gradual and 
durable, with levels remaining elevated up to 2 h after treatment (Wade et al., 2001; Zhao and Brinton, 
2007). GPER stimulation also results in rapid Ca2+ mobilization, an upstream activator of ERK 
phosphorylation, followed by rapid desensitization of the Ca2+ response (Brailoiu et al., 2007). These 
kinetic properties lend insight to the current Western results: modulation of ERK activation was 
observed in brain samples from rats receiving treatments capable of activating ERβ, which has long-
lasting ERK effects. In contrast, changes in ERK activation were not observed in rats treated with 
compounds targeting ERα and GPER, whose downstream ERK signaling is fast but transient. Had ERK 
activation been examined at an earlier time point after treatment, an ERα and GPER-mediated effect 
may have been observed. 
While the kinetics underlying ER subtype-specific attenuation of Ca2+ in the presence of 
neuronal activity (Meitzen and Mermelstein, 2011) remain unknown, it has been suggested that 
feedback and receptor/kinase desensitization mechanisms may contribute to transitory Ca2+ and ERK 
signaling.  It is also unclear how estrogenic modulation of ERK signaling interacts with learning-related 
increases in ERK, with task acquisition alone leading to 2-fold ERK activation as previously discussed. 
However, the available biochemical data suggest that ERα- and GPER-mediated modulation of ERK 
during learning could not be resolved due to our sampling time point. Brains were collected after rats 
completed 100 maze trials, a process that typically takes 1.5-2.5 h. Therefore, it is likely that any 
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changes in ERK activation were not present at the time of sample collection due to the rapid and fleeting 
nature of ERα and GPER signaling. Perhaps collecting brain samples based on behavioral parameters, 
such as immediately after learning criterion, rather than after a large, set number of trials would reveal 
more nuanced patterns of estrogenic ERK modulation during learning.  
6.4.5 ERK activation may be bi-directionally regulated according to estrogen dose 
 Though a large set of our ERK activation data are consistent with our hypothesis that 
phosphorylation of ERK shifts between memory systems concurrent with cognitive strategy and that ERβ 
signaling modulates this process, the functional and molecular basis of other results are not as clear. In 
trained rats, there was a tendency for the highest doses of estrogenic compounds to produce lower 
levels of HC ERK activation compared to other doses but in a manner that did not correspond to learning 
performance. While the reduction did not always reach significance, this trend was observed in 
response-trained rats treated with 45 μg/kg estradiol (Fig 6.2D), 1000 μg/kg DPN (Fig 6.6E and F), or 100 
μg/kg G1 (Fig 6.8E and F), and in place-trained rats receiving 1000 μg/kg PPT (Fig 6.7B and C). The 
attenuation of ERK activation was found at the highest doses of compounds used and thus may be due 
to an inverted-U pattern of signaling activation. Lower doses of estrogens increase phosphorylation of 
ERK but high doses have been found to attenuate or have no effect on ERK activation (Kirby et al., 2004; 
Kuroki et al., 2000; Wong et al., 2003; Zsarnovszky et al., 2005). The molecular and physiological basis of 
this inverted response is unknown, but one possibility is through the precise regulation of intracellular 
calcium. Estradiol can finely-tune Ca2+ dynamics through mitochondrial sequestration (Nilsen and Diaz 
Brinton, 2003) or attenuation of Ca2+ currents through L-type channels (Sribnick et al., 2009) in the 
presence of a potentially excitotoxic  stimulus. Signaling through both ERα and ERβ coupled to mGluR2 
(Gi/o) attenuates L-type channel Ca2+ currents in the hippocampus with concomitant neuronal 
depolarization (Meitzen and Mermelstein, 2011), but the activity- and dose-sensitivity of this process 
have not been characterized. Thus, the mechanisms behind HC ERK attenuation with high doses of 
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estrogens in our current Western results may be attributable to bi-directional estrogenic modulation of 
calcium. 
6.4.6 Changes in total ERK protein with training: evidence for rapid changes in protein synthesis 
 Other unexpected results involve changes in total ERK protein with training or treatment alone. 
Total ERK protein was significantly elevated by treatment only in the Str with 100 μg/kg PPT. As ERK 
(MAPK1) is not a known estrogen-responsive gene (ERGDB: Estrogen Responsive Genes Database), this 
increase in total ERK protein may be due to rapid changes in protein turnover, such as estrogen-induced 
activation of the mTOR pathway leading to increases in local protein synthesis (Sellers et al., 2014). 
mTOR also appears to play a critical role in estradiol-induced enhancements of object memory (Fortress 
et al., 2013). It is strange that no other estrogenic treatments elevated total ERK protein, as mTOR is 
rapidly activated by estradiol. However, estrogen-induced mTOR phosphorylation is dependent on ERK 
and Akt signaling and will thus be sensitive to treatment dose and timing, as discussed earlier. In 
experiments that included behaviorally naïve rats, training alone led to changes in total ERK protein: ERK 
protein levels were increased with training in the HC of middle-aged rats trained on the place task (Fig 
6.3A) and in the Str of response-trained rats receiving sucrose and genistein (Fig 6.4D) but decreased in 
the Str of sucrose- or genistein-treated rats trained on the place task (Fig 6.4A). It is unlikely that these 
outcomes are due to modulation of ERK degradation, as ERK2 has a protein half-life of 6-24 h (Sale et al., 
1995; Marchetti et al., 2004). However, learning causes the activation of mTOR in brain regions engaged 
by a task (Bekinschtein et al., 2007; Dash et al., 2006; Parsons et al., 2006), which leads to rapid 
increases in local translational capacity (Wang and Proud, 2006). Thus, behavioral training alone may 
have led to increased ERK levels due to a general potentiation of protein synthesis. Interestingly, these 
changes appear to have occurred in a memory system-specific fashion, with total ERK protein increased 
in the structure thought to be essential for task performance.  
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6.5 Conclusion 
 Originally we thought that modulation of ERK activation in hippocampus and striatum would 
mirror modulation of learning according to task attributes.  However, ERK activation was not simply 
increased or decreased by treatment with estrogenic compounds and training on the place and 
response tasks. As expected, learning experience significantly increased ERK phosphorylation in the 
hippocampi and striata of trained rats. However, ERK activation did not match the magnitude and 
direction of learning modulation but was instead altered across memory systems according to maze 
performance. Rats that demonstrated the fastest learning had lower relative ERK activation in the 
hippocampus, whereas hippocampal pERK levels were higher in rats that reached learning criterion later 
in training. Groups with modulated ERK activation also demonstrated learning enhancements or 
impairments in previous behavioral trainings. We hypothesize that the observed shifts in memory 
system ERK activation represent a greater use of habit-based strategies that engage the striatum over 
the course of the training experience. Furthermore, these patterns occurred only in rats receiving 
treatments capable of activating ERβ but not with the use of compounds aimed at ERα or GPER, as 
summarized in Fig 6.9. These findings are supported by ER signaling kinetics of durable ERK activation via 
ERβ signaling but transient phosphorylation through ERα and GPER. Other results point to the nuanced 
effects of ER activation on signaling cascades and the rapid molecular changes induced by learning. In 
sum, these data suggest that ERK phosphorylation is modulated by ERβ signaling and maps onto 
dynamic shifts in memory system activation during learning.  
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CHAPTER 7: CONCLUDING REMARKS 
The main objectives of this dissertation were to: 1) assess the efficacy of an isoflavone and 
isoflavone metabolite commonly found in phytoestrogen supplements to modulate memory; 2) evaluate 
the contributions of signaling via distinct ER subtypes to estrogen-induced shifts in learning and 
memory; and 3) examine activation of the MAPK cascade following learning and estrogenic treatments.  
In Chapter 2, the isoflavone genistein mimicked the cognitive effects of estradiol benzoate in 
young adult ovariectomized rats, enhancing place learning and impairing response learning. An inverted 
dose response was observed for estradiol-induced improvements in place learning, consistent with 
findings by others. Notably, this inverted response was not present for response learning impairments 
following estradiol treatment, stressing the dose-sensitivity of separate tasks and neural systems. Lastly, 
the pharmacology of genistein pointed to a role for ERβ and GPER in mediating shifts in learning and 
memory. 
Chapter 3 expanded the scope of our botanical estrogen studies by examining the effects of the 
isoflavone metabolite equol on place learning in middle-aged ovariectomized rats as compared to 
estradiol benzoate. Estradiol improved place learning in middle-aged rats at the same dose observed in 
Ch. 2, indicating that the mechanisms of estrogen-induced cognitive enhancements remain effective 
through mid-life, at the time of natural reproductive senescence. Unlike genistein, equol had no 
significant effects on place learning as compared to vehicle. While response learning was not tested in 
this study, results from our collaborators found no impairments on a delayed spatial alternation task 
with equol treatment. The pharmacological properties of equol suggested that the genomic actions of 
ERβ may contribute to learning modulation, as equol binds ERβ well but does not potently activate 
transcription.  
Chapter 4 addressed the second goal of this dissertation by treating young adult ovariectomized 
rats with compounds selective for ERα or ERβ prior to testing on the place or response learning tasks. In 
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order to assess dose response functions, four doses each of PPT, DPN, and Br-Erb-041 were compared to 
vehicle across both tasks. All compounds enhanced place learning or impaired response learning, but 
with distinct dose-response functions for each treatment and task. These data indicate that activation of 
either ERα or ERβ is sufficient to modulate learning and memory processes. Despite similar behavioral 
outcomes, we hypothesize that ERα and ERβ act via distinct mechanisms to alter neuronal plasticity as 
supported by the molecular and neurochemical findings of other investigators. 
Further investigating the role of distinct ER subtypes, the experiments in Chapter 5 used a 
specific agonist to assess the contributions of GPER to estrogen-induced shifts in place and response 
learning. G1 treatment had opposing effects on response learning according to dose: treatment with a 
high dose of G1 impaired response learning, while low-dose G1 treatment unexpectedly produced a 
non-canonical response learning enhancement. This finding may be due to the particularly robust 
expression of GPER in the striatum, namely on cholinergic interneurons. Thus, specific targeting of GPER 
may have yielded more finely-tuned changes in striatal neurotransmission and physiology than those 
that occur with general estrogen or ERα/β-selective agonist treatment, revealing a novel pattern of 
memory modulation. Enhancement of place learning with G1 treatment required an additional agonist 
exposure 30 min prior to behavioral training. This result suggests that an acute G1 exposure is needed to 
either a) raise circulating/brain G1 levels above an effective concentration threshold, and/or b) activate 
rapid receptor signaling cascades. These findings also point to qualitative differences in the mechanisms 
underlying GPER signaling and neuromodulation in the hippocampus and striatum, as acute G1 exposure 
was not needed for behavioral effects to emerge on the response task.  
The final goal of this work was addressed in Chapter 6, in which ERK activation in the 
hippocampi and striata of rats from previous behavioral experiments was examined via quantitative 
Western blot analysis. This study aimed to assess whether changes in ERK phosphorylation 
corresponded with 1) the direction and magnitude of learning modulation and 2) dose of effective 
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estrogenic treatments. Results were far more complex than expected, as simple increases and decreases 
in ERK activation did not occur. Rather, ERK activation largely reflected a shift in memory system 
activation over the course of training. For both place and response learning, rats that quickly acquired 
the tasks had decreased hippocampus ERK activation relative to the striatum, while rats that reached 
criterion later in training had greater pERK in the hippocampus. We hypothesize that these results 
represent a shift from hippocampal processing, engaged early in training as a task’s conditions and 
context are established, to the use of more striatal-dominant strategies late in training when the task 
becomes habitual in nature. Furthermore, these patterns of ERK activation were only observed in groups 
treated with compounds capable of activating ERβ, namely estradiol, the isoflavones, and DPN. In 
groups receiving treatments targeting ERα and GPER (PPT and G1), changes in pERK levels were not 
found. These results are supported by available kinetic data indicating that ERβ-mediated changes in 
MAPK signaling are more durable than the rapid and transient activation observed via ERα and GPER. 
Our hypothesis presented in Chapter 4 that the mechanisms underlying ERα- or ERβ-dependent learning 
modulation are distinct for each receptor subtype is supported by these Western findings. Furthermore, 
these results stand in contrast to the predominant practices in our field to a) measure estrogen-induced 
activation of ERK apart from behavioral task performance and b) implicate simple up- or-down-
regulation of pERK as a measure of the mnemonic efficacy of estrogenic treatments. We hope that these 
findings inspire our colleagues to examine rapid signaling cascades in more detail and in conjunction 
with behavioral assessments of learning and memory. Lastly, these Western data emphasize that rather 
than concentrating on a single neural system as if it acts in isolation, it is imperative to consider the 
contributions of multiple memory systems to a given cognitive task.  
In conclusion, this body of work has furthered our understanding of the receptor-mediated 
mechanisms that underlie estrogen-induced shifts in cognition. As a Medical Scholar student, I am 
particularly concerned with the translational applications of these findings for women’s health and how 
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they might further inform our understanding of menopause-associated therapies. There has been a 
recent resurgence in the popularity of post-menopausal hormone replacement therapies marked by the 
approval of a new SERM (ospemifene) indicated for the treatment of vaginal atrophy, whose brain 
effects remain either unstudied or undisclosed (DeGregorio et al., 2014). While many advertisements 
and indications for both new-generation and traditional hormone replacement therapies focus on the 
alleviation of hot flushes and sexual dysfunction, as a repercussion of WHI findings, disclaimers and 
current clinical practice guidelines still state an increased risk of stroke and dementia with hormone 
replacement (Manson and Bassuk, 2012). Additionally, an on-going NIA-sponsored clinical trial is 
currently examining the efficacy of a phytoSERM formulation containing genistein, daidzein, and S-equol 
to improve menopause-associated memory decline (Schneider and Brinton, 2012), further 
demonstrating the clinical relevance of phytoestrogen and selective agonist studies. As many 
investigators in the estrogens and memory field have discussed, there is a fundamental disconnect 
between medicine and the wealth of basic science data investigating the cognitive effects of estrogen 
treatment (Daniel, 2006; Daniel, 2012; Frick, 2012; Gibbs and Gabor, 2003; Sherwin and Henry, 2008). 
While the findings contained within this dissertation will likely have little direct effect on clinical practice 
and therapeutic development, it is my hope that this work broadens the knowledge base of the 
estrogens and memory field, challenges some of its current practices and assumptions, and informs the 
design of future studies to promote better applicability to human health.  
 
 
 
 
 
 
171 
 
7.1 References 
Daniel, J.M., 2006. Effects of oestrogen on cognition: what have we learned from basic research?. J. 
Neuroendocrinol. 18, 787-795. 
Daniel, J.M., 2012. Estrogens, estrogen receptors, and female cognitive aging: The impact of timing. 
Horm. Behav. 
DeGregorio, M.W., Zerbe, R.L., Wurz, G.T., 2014. Ospemifene: A first-in-class, non-hormonal selective 
estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar 
and vaginal atrophy. Steroids. 
Frick, K.M., 2012. Building a better hormone therapy? How understanding the rapid effects of sex 
steroid hormones could lead to new therapeutics for age-related memory decline. Behav. Neurosci. 
126, 29-53. 
Gibbs, R.B., Gabor, R., 2003. Estrogen and cognition: applying preclinical findings to clinical perspectives. 
J. Neurosci. Res. 74, 637-643. 
Manson, J.E., Bassuk, S.S., 2012. The Menopause Transition and Postmenopausal Hormone Therapy. In: 
D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J. Jameson, J. Loscalzo (Eds.), Harrison's Principles of 
Internal Medicine. McGraw-Hill, New York, NY. 
Schneider, L.S., Brinton, R.D., 2012. Phytoserms for Menopause Symptoms and Age-Associated Memory 
Decline (phytoSERM). ClinicalTrials. gov, National Library of Medicine (US) NCT01723917. 
Sherwin, B.B., Henry, J.F., 2008. Brain aging modulates the neuroprotective effects of estrogen on 
selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 29, 88-113. 
 
 
172 
 
